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Abstract 
 
The presented dissertation deals with the multiple functionalization of several N-heterocycles 
via palladium-catalyzed cross-coupling reactions. In this regard, different polyalkynylated, 
polyalkenylated and polyarylated pyridine, pyrazine and naphthyridine derivatives were 
synthesized. The exploration of site-selectivity of the reactions of initial halogenated pyridines 
was of particular interest. Absorption and emission spectroscopy was used to analyze the 
photophysical properties of the polyalkynylated compounds. Further, the electrochemical 
investigation of polyalkynylated pyrazines was carried out to validate the results gained by 
photophysical studies.  
In addition, various N-phenyl diarylpyrrols were synthesized by “ligand-free” palladium-
catalyzed C–H activation. The role of the reaction medium was investigated and a probable 
mechanism was proposed. 
 
 
 
Zusammenfassung 
 
Die vorliegende Dissertation beschäftigt sich mit der mehrfachen Funktionalisierung 
verschiedener N-Heterozyklen mittels Palldadium katalysierter Kreuzkupplungsreaktionen. In 
diesem Zusammenhang wurden verschiedene polyalkinylierte, polyalkenylierte und 
polyarylierte Pyridin-, Pyrazin- und Naphthyridinderivate hergestellt. Die Untersuchung der 
Regioselektivität der Reaktionen von halogenierten Pyridinen war dabei von besonderem 
Interesse. Absorptions- und Emissionsspektroskopie wurde zur Analyse der optischen 
Eigenschaften der synthetisierten polyalkinylierten Verbindungen eingesetzt. Außerdem 
wurden polyalkinylierte Pyrazine mittels elektrochemischer Methoden untersucht, um die 
Ergebnisse der photophysikalischen Messungen zu bestätigen.  
Des Weiteren wurden verschiedene N-Phenyl-diarylpyrrole durch „ligandenfreie“ Palladium 
katalysierte C–H Aktivierung synthetisiert. Die Rolle des Reaktionsmediums wurde studiert 
und ein möglicher Mechanismus postuliert.  
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1. General Introduction 
1.1 Background 
 
Application of catalysis as a technique has revolutionized the field of organic chemistry giving 
rise to the science not only in academic but also in industrial level.  
The concept of catalysis is known to mankind for many centuries, and a good example of that 
is the production of alcoholic beverages with yeast. The term itself was first introduced only in 
1836 by Berzelius who referred to catalysts as substances being able to ‘’awake affinities that 
are asleep at this temperature by their mere presence and not by their own affinity’’.[1] Three 
decades after, Ostwald gave the well-known definition of a catalyst as a ‘’substance that 
increases the rate of the chemical reaction without itself being consumed’’.[2] Since then the 
field of catalysis had undergone an incredible development with many transformations being 
discovered.  
The history of catalysis development can be conditionally represented by four milestone phases 
during each significant contributions to the specific fields of chemical industry were made 
(Figure 1).[3] 
 
 
Figure 1. Historical timeline of catalysis development in chemical manufacturing.  
 
In recent 50 years, thirteen scientists were awarded five Nobel Prizes collectively for their 
outstanding research on homogeneous transition metal catalysis only. In particular, the awards 
were granted for the distinguished contributions in polymerization (Ziegler and Natta 1963), 
sandwich compounds (Wilkinson and Fischer 1973), asymmetric catalysis (Knowles, Noyori 
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and Sharpless 2001), metathesis (Chauvin, Grubbs and Schrock  2005), and cross-coupling 
reactions (Heck, Negishi and Suzuki 2010).[4] 
Nowadays, many industrial productions including chemicals, petroleum, agriculture, 
pharmaceuticals, and electronics strongly depend on catalysis. In fact, the use of it is so 
demanded that at least 80% of all chemical processes at some stage involve catalysts.[3] 
The use of catalytic processes gives several advantages among which are cost reduction, energy 
saving, reaction selectivity, and diminishment of byproducts. Therefore, the implementation of 
catalysts is obviously essential for the optimization of many established procedures. Moreover, 
utilization of renewable sources and the use of harmless reaction media creates a significant 
potential for the development of environmentally friendly and sustainable procedures, which 
makes catalysis an important component of green chemistry. 
Throughout the evolution of catalysis, transition metals have come to play a critical role in 
organic synthesis by inducing the development of a large number of transition metal-catalyzed 
reactions.[5][6]  
 
Figure 2. Functionalization of ArX via different Pd-catalyzed cross-coupling reactions. 
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As such, outstanding examples are cross-coupling reactions.[7] Among them, palladium-
catalyzed cross-coupling reactions represent one of the most convenient and practical methods 
for the construction of carbon-carbon and carbon-heteroatom bonds.[8] Those reactions are 
highly efficient and versatile affording the synthesis of biologically active compounds including 
pharmaceuticals, agrochemicals, and materials such as polymers, liquid crystals, as well as 
materials for light-emitting devices.[9]  
Despite the fact that palladium has a relatively high price, it still predominantly prevails over 
other transition metals due to a number of advantages.[10] Particularly, palladium catalysts often 
show high activity making possible the conversion of less reactive substrates[11] and provide 
performance at comparably low temperatures.[12] Furthermore, palladium catalysts are 
relatively stable towards oxygen and moisture, they provide certain kinds of reaction selectivity 
features and offer broad versatility in terms of functional group tolerance.[13] Considering those 
advantages, a wide range of palladium-catalyzed cross-couplings have been established.[7,14,15] 
These reactions generally start with the generation of Pd(0) complex, followed by the oxidative 
addition of organic electrophile (typically aryl or vinyl halide), transmetallation of the second 
coupling partner, and reductive elimination to regenerate the catalyst and form the desired 
product. It is worth noting that aryl electrophiles with electron withdrawing substituents are 
more reactive in the oxidative addition step due to their lower activation barriers.[16] And often 
the main limitation for these reactions is the requirement to apply aryl bromides, triflates or 
iodides instead of less reactive aryl chlorides. However, application of bulky and electron-rich 
ligands, such as bulky trialkylphosphines, has proven to facilitate the oxidative addition 
processes of less reactive aryl halides (e.g. electron-rich aryl chlorides).[8,17,18]  
 
 
Figure 3. Examples of different sterically demanding ligand frameworks.[7] 
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Moreover, sterically demanding ligands also enhance the rates of reductive elimination step by 
the relief of steric congestion.[19] In this regard, the design and implementation of new ancillary 
ligand frameworks stay in the focus of organic chemists. 
Over the last decades, the development of a powerful repertoire of transition metal-catalyzed 
protocols has opened the way for the synthesis of new targets that were inconceivable earlier. 
Highly substituted aromatics bearing aryl, alkenyl and alkynyl moieties are among those targets.  
This kind of systems is very interesting given their structural features. On the one hand, 
aromatic groups are considered to be essential pharmacophores in medicinal chemistry and drug 
development. As an example, a review in 2007 showed that more than 75% of recent phase III 
and marketed pharmaceuticals had at least one aryl functionality.[20] And on the other hand, 
these molecules have extended conjugation making them potentially useful for optical and 
electronic applications e.g. semiconductors, nonlinear optical media, liquid crystals as well as 
sensors.[21] 
 
 
1.2 Research Goal and Objectives 
 
During recent years, palladium-catalyzed cross-coupling reactions of polyhalogenated 
heterocycles have gained significant importance. Palladium-catalyzed cross-coupling protocols 
such as Suzuki and Sonogashira reactions offer mild, little energy consuming, and 
environmentally friendly procedures towards the synthesis of highly substituted aromatic 
scaffolds that are not readily accessible by other methods. It should be emphasized that the 
utilization of aryl chlorides is rather challenging due to its poor reactivity. On the other hand, 
the implementation of chlorides is beneficial in terms of cost efficiency and availability of 
materials. In this regard, the development of new efficient methods for the synthesis of 
polysubstituted aromatics starting from aryl chlorides is of significant practical importance.  
The aim of the work is to extend the scope of palladium-catalyzed cross-coupling reactions as 
tools for the synthesis of multifunctionalized aromatics including polyaryl, polyalkenyl and 
polyalkynyl naphthyridines, pyridines and pyrazines. 
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The objectives that are chosen towards the achievement of the abovementioned goal are as 
follows: 
 the usage of polychlorinated heterocycles as starting materials, since they are 
(i) less costly and more available in both laboratory and industrial scale as well 
as (ii) less reactive and thus more challenging; 
 the investigation of site-selectivity of the cross-coupling reactions on 
tetrachlorinated pyridines to be able to finetune the substitution pattern; 
 the development of optimal reaction conditions for the efficient synthesis of 
products, and the synthesis of a range of products for the purpose of studying the 
scope of the reactions; 
 the investigation of photophysical and electrochemical properties of 
polyconjugated products  
 
Although there are several reports on cross-coupling reactions of aromatic systems, only little 
is known about multiple functionalizations of polychlorinated six-membered heterocycles. In 
this context, presented research is expected to be contributive in terms of enriching the 
knowledge on the subject of multiple functionalizations of perchlorinated pyridines and 
pyrazine.  
In addition to conventional methods, C–H activation reaction of N-phenyl pyrrole with aryl 
halides is chosen to be investigated in the context of the synthesis of multifuncionallized N-
heterocycles. The objectives are as follows: 
 studying the direct double arylation reaction under phosphine ligand-free 
conditions using an ionic salt as an environmentally benign reaction medium; 
 exploring scope and limitations of the reaction  
 proposing a possible reaction mechanism.  
 
The achievement of the set goal is believed to enhance the knowledge in the field of C–H 
activations and add to the understanding of the mechanism of ligand-free palladium-catalyzed 
arylation reactions in ammonium salts. 
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2. Polyfunctionalized Arenes with Extended Conjugation 
 
History of aromatic compounds has begun in 1825 when Faraday isolated benzene from the 
condensed phase of pyrolyzed whale oil. In 1861 Loschmidt first proposed benezen’s cyclic 
planar structure[22] which was fully understood only 70 years after with the emerging of 
Hückel’s theory[23] and the theory of resonance.[24] From the synthetic perspective, the starting 
point in the chemistry of aromatic compounds was probably the synthesis of aspirin, 
acetylsalicylic acid which was successfully commercialized by Bayer in 1900.[25] Prior to that 
polycycles like naphthalene, phenanthrene, pyrene and fluoranthene were isolated from coal-
tar and other petroleum products. In this regard, efforts of Graebe and Glaser greatly contributed 
to hydrocarbon diversity existing at that time and spread light in potential future topologies.[26] 
From that time on, an immense number of various reactions were used to synthesize different 
aromatic systems including ones with extended aromaticity.[27] 
Aromatic compounds with extended conjugation attracted a lot of attention due to their practical 
relevance in material sciences, design of molecular devices as well as in biological processes.[28] 
Mono and polycyclic aromatic hydrocarbons can serve as industrial polymers,[29] dyes and 
fluorescent materials[30] and liquid crystals.[31] Moreover, given their specific electronic 
properties such compounds have been very useful in the preparation of organic conductors,[32] 
solar cells,[33] photo- and electroluminescent devices,[34] optically active poymers[35] and non-
linear optical (NLO) materials.[36]  
 
Figure 4. Star-shaped structures introduced by Heck, de Meijere and Müllen.[28] 
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Conjugated aromatic molecules with acetylenic scaffolds have similar applications. This 
applies to both linear and branched structures. Acetylene moieties are structurally rigid and 
have good electronic communication which allows this molecule to show promising optical and 
electronic features. Arylene ethynylene based oligomers, dendrimers or polymers are now 
commonly accepted to be one of the most important semiconducting organic materials.[21]  
Shape-persistent acetylenic molecules can be useful in the preparation of tubular 
superstructures, two-dimensional networks, hosts for molecular recognition and adaptable 
systems able to conform to the external stimuli.[21] 
     
 
Figure 5. 2D carbon networks graphyne (left) and graphdiyne (right). 
Carbon network graphyne[37] having an equal number of sp and sp2 carbons and its analog 
graphdiyne[38] where acetylene linkages are replaced by butadyine units, were calculated to 
exhibit non-linear optical properties. They are considered as novel allotropes of carbon. 
Star-shaped polyalkynylated arenes have also great potential to be implemented in the areas of 
optics and electronics.[39,40] After the first synthesis of hexaethynyl benzene[41] using 
Sonogashira reaction, similar polyalkynylated compounds with different cores like 
thiophene,[42] pyrrole,[43] cyclobutadiene,[44] ferrocene[45] were also reported.  
There are different methods for the synthesis of polyfunctionalized aromatic structures, and 
cross-coupling reactions are among the most convenient tools used for that purpose as such 
scaffolds are often not easily accessible by other methods.[27] In continuation, C–H activation 
is another very attractive and relatively less mature approach for multiple functionalizations. 
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3. Palladium-Catalyzed Cross-Couplings 
3.1 General Mechanism 
 
With the exception of Heck reaction, Pd-catalyzed cross-couplings are generally proposed to 
have a similar catalytic cycle with distinctive steps that can be presented in a common 
simplified mechanism.[19] The active palladium(0) species is primarily formed in situ either by 
dissociation of two ligands derived from palladium(0)-type precatalyst or from the reduction of 
palladium(II) salts. Afterward, the oxidative addition of the organic electrophile Ar-X occurs 
onto the palladium(0) complex [LnPd0]. Initially, a cis-[PdIIArXLn] complex is formed which 
undergoes isomerization to form a more stable trans-[PdIIArXLn] complex. This phenomenon 
is called “transphobia” and is caused by a destabilizing interaction between mutually trans 
phosphorous donor and aryl ligands.[7] 
 
 
Figure 6. General simplified mechanism of Pd-catalyzed cross-couplings. 
 
It is worth noting that aryl electrophiles with electron-withdrawing substituents are more 
reactive in the oxidative addition step increasing the rate (I > OTf ≥ Br ≫ Cl).[46] In the case of 
less reactive aryl halides (e.g. chlorides), the oxidative addition is the rate-determining step. 
Likewise, electron-rich phosphine-ligands facilitate this reaction due to their stabilizing effect 
of the oxidation state.[6] During the next step called transmetalation, the diorganopalladium(II) 
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complex [PdIIArRLn] is formed by the reaction of palladium(II) halide complex with the 
organometallic compound M-R. When very reactive aryl halides (e.g. iodides) are employed, 
this step is the one, which determines the rate of the reaction. The final step in the catalytic 
cycle is reductive elimination. In a fast and irreversible reaction, the coupling product Ar-R is 
formed and the active palladium(0) species is regenerated, which subsequently undergoes 
another catalytic cycle.  
 
3.2 Sonogashira Reaction 
 
In 1975, Sonogashira reported the synthesis of substituted alkynes under mild conditions in the 
presence of palladium catalyst and copper iodide acting as a co-catalyst.[47] Independently, 
Heck[48] and Cassar[49] also reported similar reactions, but those were not implying the use of 
copper salts and were requiring harsh conditions. 
Sonogashira cross-coupling, which is a reaction between aryl or vinyl halides and terminal 
alkynes, is nowadays one of the most important and commonly used methods for the formation 
of sp2-sp carbon-carbon bonds. This method is advantageous due to several factors including 
mild reaction conditions, selectivity and wide range of functional group tolerance. In addition, 
the solvents and the reagents do not need to be rigorously dried and the syntheses can be carried 
out on a large scale (>100 g). Sonogashira reaction can also be considered as the improved 
catalytic alternative to Castro-Stephens coupling. In this regard, stoichiometric amounts of 
shock-sensitive copper acetylides are avoided due to the application of catalytic amounts of 
copper co-catalyst.[50]  
However, there are also several limitations. In particular, aryl chlorides and unreactive bulky 
substrates require harsh reaction conditions. Also, terminal alkynes are not stable towards high 
temperatures and generally undergo side reactions. 
A large number of modifications have been made to improve reaction outcome in terms of 
efficiency, due to which the Sonogashira cross-coupling reaction has become essential for the 
synthesis of pharmaceuticals, natural products and advanced materials.[7,51,52] 
A generally accepted mechanism assumes to include two independent catalytic cycles involving 
palladium and copper, respectively (Figure 7). 
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First, the active palladium(0) species [Pd0L2] is formed as described above. Next, the oxidative 
addition of the aryl or vinyl halide R1-X to [Pd0L2] affords the palladium(II) adduct of the type 
[PdIIL2R1X]. Oxidative addition is considered to be the rate-determining step for Sonogashira 
reaction. The intermediate subsequently undergoes transmetalation with the copper acetylide 
formed in cycle B to form [PdIIL2R1(C≡CR2)]. The last step is reductive elimination which leads 
to the formation of coupling product and regeneration of the active catalyst. In “copper-cycle” 
(B) π-alkyne copper complex is assumably being formed which increases the acidity of the 
acetylenic proton. 
Similar to many other couplings, the overall efficiency in Sonogashira cross-coupling reactions 
depends on the choice of reaction components.[53] For example, the choice of the solvent can 
affect the yield of the reaction by increasing the solubility of catalysts, reactants, and products. 
Often, dimethylformamide, dimethylacetamide, N-methyl-2-pyrrolidone, toluene, and 
tetrahydrofuran are employed in Sonogashira reactions as solvents. Also, the use of water and 
benign media have been reported.[54] In some cases, like in original protocol, no solvent is 
required while employed amine (e.g. Et3N) can serve as both base and solvent.[47] 
As bases, Et3N, Et2NH, and i-Pr2NH are commonly used, although piperidine, as well as 
pyrrolidine, are also utilized rather frequently.[55] The influence of bases in Sonogashira 
reactions have been studied and a general reactivity of bases was reported to have the following 
interrelationships: n-BuNH2 > Et3N > i-Pr2NH > Et2NH > K2CO3.[14,56] 
For Sonogashira cross-coupling reactions Pd(PPh3)4 and PdCl2(PPh3)2 are the most often 
employed catalysts as they are advantageous in terms of air and temperature stability, solubility 
in various solvents and commercial availability. However, other catalysts with bidentate ligands 
like Pd(dppe)Cl2 and Pd(dppf)Cl2 have shown to be efficient too.[57] The development of 
electron-rich and sterically hindered phosphine ligands like SPos, P(t-Bu)3, PCy3, 
cataCXium A, etc was a matter of more recent research focus. These ligands facilitate the cross-
coupling reactions of less activated aryl chlorides, allow lowering the catalyst loadings and 
carry out the reaction under milder conditions.[18,58] Additionally, water-soluble phosphine 
ligands,[59] NHC ligands,[60] as well as heterogeneous catalysts[39] have been reported in 
Sonogashira cross-coupling reactions.[56] 
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Sonogashira reaction is also presented in the total synthesis of natural products. For example, 
for the total synthesis of mappicine, the introduction of the necessary acetylenic moiety was 
achieved by the Sonogashira coupling of the corresponding 2-chloroquinoline derivative with 
TMS-acetylene.[63] Likewise, alkynyl cyclopropane derivative was coupled with the 
corresponding dienyl iodide in the last step to provide callipeltoside aglycon in excellent 
yield.[64] For the synthesis of heliannane-type sesquiterpenoid (–)-heliannuol E the Sonogashira 
coupling was used for the reaction of unprotected propargyl alcohol with heavily functionalized 
aryl iodide.[65] 
 
 
 
Figure 8. Natural products mappicine, callipeltoside aglycon and (–)-heliannuol E.[66]  
 
The synthesis of linear polymers and oligomers consisting of sp2- and sp-hybridized carbons 
via Sonogashira reactions have also been investigated because of interesting materials 
properties that products possess. Given their highly conjugated structure, 
poly(aryleneethynylene)s (PAEs) and corresponding oligomers (OAEs) can be considered as 
molecular wires due to their semiconducting properties.[67] 
 
 
3.3 Suzuki-Miyaura Reaction 
 
Initial report[68] by Suzuki and Miyaura dating back to 1979 is describing the reaction of 1-
alkenylboranes with aryl halide in the presence of palladium catalyst. Nowadays, Suzuki-
Miyaura reaction,[68,69] also known as Suzuki coupling, is a widely used method for the catalytic 
construction of carbon-carbon bonds. Typically, it is a palladium-catalyzed cross-coupling 
reaction of aryl halides or pseudo halides with boronic acids or esters.[7] This method has a 
number of advantages including mild reaction conditions, commercial availability of many 
Palladium-Catalyzed Cross-Couplings 
 
13 
 
ERURQLF DFLGV VWHUHR DQG UHJLRVHOHFWLYLW\ RI WKH UHDFWLRQV DV ZHOO DV WROHUDQFH RI VWDUWLQJ
PDWHULDOVWRZDUGVDZLGHUDQJHRIIXQFWLRQDOJURXSVDQGWRZDUGVWKHZDWHU
7KHUHDUHDOVRVHYHUDOFKDOOHQJHVWKDWQHHGWREHDGGUHVVHG$PRQJWKRVHLVORZUHDFWLYLW\RI
DU\O FKORULGHV WKH IRUPDWLRQ RI E\SURGXFWV OLNH KRPRFRXSOLQJ SURGXFWV GXH WR VROYHQW
GLVVROYHGR[\JHQDVZHOODVVLGHUHDFWLRQVOLNHUDFHPL]DWLRQRIRSWLFDOO\DFWLYHFRPSRXQGVGXH
WRWKHSUHVHQFHRIDEDVHZKLFKLVUHTXLUHGIRUWKLVUHDFWLRQV
6X]XNL0L\DXUDUHDFWLRQVKDGDYDULHW\RILPSURYHPHQWVGXULQJWKHODVWGHFDGHVXFKDVWKH
H[SDQVLRQ RI WKH VXEVWUDWH VFRSH D EHWWHU IXQFWLRQDO JURXS WROHUDQFH DQG WKH XVH RI PRUH
HQYLURQPHQWDOO\ IULHQGO\ SURFHGXUHV WKDW LQYROYH JUHHQ VROYHQWV FRPPHUFLDOO\ DYDLODEOH
VXEVWUDWHVDQGORZFDWDO\VWORDGLQJ>@
7KHPRVWHYLGHQWGLIIHUHQFHEHWZHHQ6X]XNLFRXSOLQJDQGWKHUHVWRIFURVVFRXSOLQJUHDFWLRQV
LVWKHUROHRIDEDVHJHQHUDWLQJDPRUHUHDFWLYHERURQDWHDQLRQEHLQJDJRRGFDUEDQLRQWUDQVIHU
UHDJHQW)LJXUH$>@(PSOR\HGEDVHRWKHUZLVHFDQDFWLYDWHSDOODGLXP,,KDOLGHVSHFLHV
WRIRUPPRUHDFWLYHSDOODGLXP,,EDVHVSHFLHV)LJXUH%>@7KHPHFKDQLVWLFLQYHVWLJDWLRQ
RIWKHUROHRIWKHEDVHLQWKHWUDQVPHWDODWLRQVWHSRIWKHFDWDO\WLFF\FOHRIWKH6X]XNLUHDFWLRQ
KDVEHHQUHSRUWHGE\VHYHUDOUHVHDUFKJURXSV>@



)LJXUH3URSRVHGPHFKDQLVPRIWUDQVPHWDODWLRQSDWKVLQ6X]XNLUHDFWLRQ

Palladium-Catalyzed Cross-Couplings 
 
14 
 
The implementation of organoboron compounds as coupling partners makes Suzuki reaction 
beneficial due to the high tolerance of those compounds towards a wide range of functional 
groups, stability towards air, humidity, user-friendliness and synthetic accessibility. Suzuki 
coupling proves to be advantageous also in terms of certain types of selectivity control features 
it provides including the regio-,[73] stereo-,[74] and chemo-selectivity.[75] 
Different solvents, bases, and catalytic systems can be used in Suzuki couplings varying the 
outcome of the reactions. Solvent effects on palladium-catalyzed cross-coupling reactions, and 
in particular Suzuki reaction has been studied.[76] These reactions are mainly done in organic 
solvents such as tetrahydrofuran, dimethylformamide, dioxane, toluene, and acetonitrile. 
Suzuki couplings have also been performed in environmentally friendly media e.g. water,[77] 
ionic liquids,[78] and polyethylene glycols[79] offering a more benign choice in comparison to 
classical solvents.[56] 
Often, carbonates, bicarbonates, phosphates, and alkoxylates of alkali metals are applied as 
bases. While less sterically hindered boronic acids can be efficiently converted into the product 
using weak bases, the conversion of sterically demanding arylboronic acids typically requires 
stronger bases.[14,80] With this regard, the influence of different bases on selected model 
reactions has been studied.[71,81] It has been shown that there is a strong correlation between the 
size of the cation and the reaction rate. Namely, larger-sized cations increase the rate and the 
yield of the Suzuki cross-coupling reactions.[56,82] 
The choice of the catalyst is a crucial factor in the productivity of Suzuki couplings. Typically, 
Pd(0) precatalysts such as Pd(PPh3)4 as well as in situ catalysts like PdCl2, Pd(OAc)2 and 
Pd2(dba)3 in the presence of phosphine ligands are implemented.[83] Not only the above-
mentioned catalysts but also palladium nanoparticles,[84] palladium catalysts supported on 
inorganic solids[85] and polymers[86] were successfully applied to form cross-coupling 
products.[56] 
The rate of palladium-catalyzed cross-coupling reactions is enhanced by the presence of bulky 
and electron-rich phosphine ligands.[87] In recent years, numerous new ligands have been 
designed and synthesized to increase the catalyst efficiency, selectivity, and reaction scope.[8,88] 
Examples of those ligands are P(t-Bu)3,[89] QPhos,[90] cataCXium A,[91] as well as biaryl 
phosphine ligands XPhos and SPhos.[92] Those allow the transformation of aryl and heteroaryl 
chlorides with low catalyst loadings even at room temperature. By the manipulations in the 
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substitution pattern of ligands, it is possible to tune the catalyst in order to operate a target-
oriented synthesis.[56,87] 
Most of the palladium-catalyzed coupling reactions make use of easily available starting 
materials allowing more efficient and selective synthesis of functionalized arenes and 
heteroarenes compared to non-catalytic pathways. In the last decade, several palladium-
catalyzed coupling reactions have been implemented into the industrial manufacture of 
pharmaceuticals, agrochemicals and fine chemicals. Additionally, these reactions proved to be 
useful in the synthesis of materials with optical and electronic applications.[10] Among 
palladium-catalyzed cross-coupling reactions, Suzuki reaction is probably one of the most 
widespread tools used in chemical manufacture. The range of its applications varies from the 
synthesis of natural products and intermediates for various biologically active compounds to 
the preparation of photo- and electroactive organic materials.[10] 
An outstanding example of implementation of the Suzuki reaction in the industry is the 
synthesis of fungicide Boscalid. This procedure allowed annual production volume of Boscalid 
in more than 1000 tons a decade after it has been patented by BASF.[93] Another example is the 
synthesis of the angiotensin II receptor antagonist Losartan. Developed by Merk, this 
methodology made a possible avoiding a number of drawbacks associated with previously 
described syntheses.[94]  
 
 
 
Scheme 2. Synthesis of Boscalid and Lozartan on an industrial scale by Suzuki reaction.  
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Suzuki cross-coupling is also represented in the total synthesis of many natural compounds. 
Examples include the synthesis of proteosome inhibitor TMC-95A,[95] antitumor compound 
epothilone A[96] and polyene antibiotic myxalamide A.[97] Similarly, the total synthesis of 
oximidine II was accomplished by intramolecular Suzuki-type cross-coupling of a 
corresponding alkenyl bromide and alkenyl potassium trifluoroborate.[98] 
 
 
 
Figure 10. Natural products myxalamide A and oximidine II.[66]  
 
 
3.4 Overview of the Phosphine Ligands 
 
In this work, different palladium precursors as well as sterically demanding and electron-rich 
phosphine ligands were employed for reactions. With an exception of PPh3, catalytically active 
species were generated in situ from palladium precursors and ligands in a ratio of 1 : 2, 
respectively. As a source of PPh3, common catalysts such as PdCl2(PPh3)2 and Pd(PPh3)4 were 
applied. In all the other cases phosphine ligands were employed with precursors Pd(OAc)2, 
PdCl2(CH3CN)2, Pd(dba)2 or Pd2(dba)3 to generate palladium(0) species by in situ reduction.  
In the context of gained results, SPhos and PCy3 provided the best yields for the straightforward 
full arylation reactions of initial polychlorinated pyridines and pyrazine. Whereas XPhos has 
proven to be the most efficient ligand for multifold alkynylation reactions. Tetrafold 
alkenylation of pyrazine gave excellent yields when cataCXium A was used. 
In contrast, site-selectivity of the reactions was better controlled with the use of Pd(PPh3)4, 
which was applied for twofold functionalizations of starting pyridines.  
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Figure 11. Phosphine ligands used in this work. 
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4․ C–H Activation  
Palladium-catalyzed C–H activation reactions are highly valuable methods for the 
functionalization of aromatic and heteroaromatic compounds. In contrast to the conventional 
cross-couplings, C–H activation field is comparably less mature from an application point of 
view. These methods are highly attractive because they can proceed without any halide leaving 
group, just by using an oxidant. 
Transition metal-catalyzed C–H activation methodology has been largely investigated after the 
first related paper was published in 1963.[99] Enormous possibilities of potential 
functionalizations of C–H bonds have triggered extensive research over the course of the recent 
two decades. Currently, C–H activation[100] is considered as an extremely powerful tool for the 
formation of carbon-carbon as well as carbon-heteroatom bonds prevailing over traditional 
routes in terms of atom economy, environmental impact and cost-efficiency.[101,102]  
 
Scheme 3. Mechanisms of inner-sphere transition metal-mediated C–H bond cleavage.[103] 
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The first palladium-catalyzed C–H arylation reaction was discovered in 1982 by Ames.[115] 
While studying various palladium-catalyzed reactions of 4-substituted-3-bromociannolines, he 
observed the formation of intramolecular C–H activation product, instead of expected Heck 
reaction (Scheme 5). 
 
Scheme 5. Synthesis of benzofuro[3,2-c]cinnoline by C–H activation.[115,116] 
Synthetic procedures based on functionalization of aromatic C–H bonds as an alternative to 
traditional cross-coupling reactions have gained much interest over recent years. In comparison 
to conventional cross-coupling reactions where stoichiometric amounts of both aryl halides and 
organometallic reagents are used as coupling partners, C–H arylation reactions represent a more 
promising option in terms of atom economy, cost-effectiveness and environmental impact. This 
method is advantageous also allowing the last-stage transformations of biologically relevant 
complex organic molecules.[117] Reduction or avoidance of the metallic side products is 
especially important in the pharmaceutical and agrochemical industry where undesired 
contamination is highly unwelcomed. 
Several leading global pharmaceutical corporations proposed C–H activation reactions as one 
of the most perspective and sustainable strategies in the production of medicines.[20] In fact 
palladium-catalyzed C–H activation is used in the total synthesis of many biologically relevant 
molecules including anticancer agents (+)-linoxepin,[118] rhazinilam[119] together with its 
congener rhazinal,[120] and euchrestifoline[121] possessing potential antituberculosis activity. 
 
However, there are challenges in the field of C–H activation chemistry. For example, the 
difficulties of selective functionalization of a targeted C–H bond preferentially over others 
should be addressed. Particularly, developments on catalyst-controlled regioselectivity and 
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stereoselectivity of a C–H activation via ligand design would be a significant step forward in 
the field. In addition, reducing catalyst loading would be another aspect of development.[116] 
 
 
 
Figure 12. Natural products (+)‐linoxepin, rhazinal and euchrestifoline. 
 
Further developments in this field would have a significant impact on our abilities to manipulate 
organic molecules. Thereby it will most likely have an immediate impact not only on medicinal 
chemistry to process routes for the synthesis of active pharmaceutical ingredients, but also for 
the synthesis of crop protecting agents, fluorescent dyes and building blocks for organic 
conductors. A better sustainability and environmental compatibility is another important 
driving force for the development of this field. 
 
Multiple Sonogashira Reactions of Polychlorinated Pyridines and Pyrazine 
 
22 
 
5. Multiple Sonogashira Reactions of Polychlorinated  
Pyridines and Pyrazine 
Being the most prominent method for the alkynylation of sp2-carbon atoms, the Sonogashira 
reaction is currently used almost in all fields of organic chemistry. Its applications range from 
the total synthesis of natural products to the synthesis of new materials (cf. Chapter 3.2).[14,52,122] 
Given the practical importance in the areas of optics and electronics, a number of different 
heavily substituted arenes and heteroarenes bearing alkynyl moieties have been synthesized. 
Those molecules can be used as discotic liquid crystals,[40,123] nonlinear optical materials[124] 
and scaffolds for dendritic molecules.[125] It should be mentioned that there are only a few 
reports on the synthesis of polyalkynylated six-membered heterocycles.[126] 
In this chapter, multiple functionalizations of polychlorinated pyridines and pyrazine by 
palladium-catalyzed Sonogashira reactions will be discussed together with the results of 
photophysical and electrochemical investigations.  
 
5.1 Synthesis of 2,3,5,6-tetraalkynyl-4-(4-aryl)pyridines 
 
5.1.1 Site-selective alkynylation of 2,3,5,6-tetrachloro-4-(aryl)pyridines 
 
Sonogashira reaction is a very powerful tool for the synthesis of fine chemicals, natural products 
and other materials, especially when applied in a site-selective manner. Due to the electronic 
changes induced by the heteroatom, heterocycles become highly valuable substrates for such 
transformations.  
4-Aryl substituted 2,3,5,6-tetrachloropyridines (4) have been chosen as starting materials and 
synthesized following a known literature method[127] (Scheme 6). Аryl group was introduced to 
decrease the reactivity of the pyridine ring and, thereby improving site-selectivity of the 
Sonogashira cross-coupling reactions. Furthermore, the rate of the Sonogashira reaction at 
positions 3 and 5 of the pyridine is assumed to be decreased by steric effects with the site-
selectivity being improved. It can be expected that alkynyl moieties with a different electronic 
character attached to heterocycle and the presence of a donor or acceptor substituent located at 
position 4 of the pyridine moiety may allow fine-tuning the photophysical properties of the 
molecules with regard to their emission wavelengths and quantum yields.[128] 
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Scheme 6. Synthesis of initial tetrachloropyridines; i: DMAP, DCB, 60 ºC, 20 h; ii: NaOMe, 
MeOH, reflux, 6 h; iii: n-BuLi, 4-BrPhR, Et2O, -78 ºC to 20 ºC. 
 
 
Scheme 7. Synthesis of 3,5-dichloro-2,6-dialkynylpyridines 5a-e; i: Pd(PPh3)4 (5 mol%), CuI 
(5 mol%), 1,4-dioxane, HN(i-Pr)2, 100 ºC, 20h. 
 
Table 1. Synthesis of 5a-e. 
Product R1 Alkyne [eq.] Yield [%]a 
5a OMe 
 
2.1 59 
5b OMe  
2.1 36 
5c CF3  
3.0 62 
5d CF3  
3.0 64 
5e CF3  
3.0 69 
a Yields of isolated products. 
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The Sonogashira reaction of pyridines 4 with various alkynes afforded the 2,6-dialkynyl-3,5-
dichloropyridines 5a-e (Scheme 7, Table 1). The products were obtained using Pd(PPh3)4 as the 
catalyst, CuI as co-catalyst and 1,4-dioxane as a solvent.  
Reactions of 4-aryl-2,3,5,6-tetrachloropyridine 4b, containing an electron-poor 4-CF3-phenyl 
group, afforded 2,6-dialkynylpyridines 5c-e with very good site-selectivity. The yields of 
products 5c-e were higher than those of 5a, b (Scheme 7, Table 1). A correlation between the 
amount of alkyne and the success of the reactions of 4-aryl-2,3,5,6-tetrachloropyridines 4a and 
4b was observed. The reaction of pyridine 4a gave relatively better results with 2.1 equiv. of 
phenylacetylene (59%) in comparison to the procedure with 2.4 equiv. (56%) for the desired 
product 5a. In contrast, the starting pyridine 4b required 3.0 equiv. of the corresponding alkyne 
to provide improved yields (42% yield of 5c when 2.4 equiv. were used).  
After the site-selective alkynylations of starting tetrachlorinated pyridines were successfully 
performed, follow up conversion of remaining C–Cl bonds of products 5 were carried out to 
obtain structures with mixed alkynyl moieties. 
 
 
 
Scheme 8. Synthesis of unsymmetrical 2,3,5,6-tetraalkynylpyridines 6a-d; i: PdCl2(CH3CN)2 
(4 mol%), XPhos (8 mol%), CuI (3 mol%) 1,4-dioxane, HN(i-Pr)2, 100 ºC, 20h. 
 
 
The Sonogashira reaction of 2,6-dialkynyl-3,5-dichloropyridines 5 with various alkynes 
afforded the 2,3,5,6-tetraalkynylpyridines 6 (Scheme 8, Table 2). The application of the same 
catalytic system did not prove to be efficient. However, reactions could be successfully 
accomplished with the use of bulky and highly basic XPhos ligand. Moreover, an excessive 
amount of alkynes were taken (3.5 equiv.) for the complete conversion of starting materials into 
corresponding products. All reactions proceeded in high yields ranging from 61 to 90%.  
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Table 2. Synthesis of 6a-d. 
Product Substrate R1 Alkyne [eq.] Yield [%]a 
6a 5a OMe  
3.5 62 
6b 5c CF3  
3.5 68 
6c 5c CF3  
3.5 61 
6d 5e CF3  
3.5 90 
a Yields of isolated products.  
 
5.1.2 Full alkynylation of 2,3,5,6-tetrachloro-4-(aryl)pyridines 
 
After title 2,3,5,6-tetraalkynylpyridines with mixed alkynyl moieties have been synthesized the 
focus was made on the one-pot synthesis of the corresponding symmetrical analogs. Direct 
four-fold Sonogashira reaction of starting pyridines 4a and 4b was not successful with the use 
of Pd(PPh3)4, whereas combination of more reactive PdCl2(CH3CN)2 (4 mol%) and XPhos 
(8 mol%) afforded desired 2,3,5,6-tetraalkynylpyridines 7 and 8 in moderate to high yields 
reaching up to 80% (Scheme 9, Table 3). However, product 7g derived from aliphatic 1-hexyne, 
was obtained in only 26% yield.  
All tetrafold alkynylations with initial pyridines 4a and 4b were carried out with an excess of 
6.5 equivalents of alkyne. When taken less than 6.5 equivalents the conversion of starting 
material into desired product remains incomplete according to the TLC analysis of the reaction 
mixture. Moreover, a reasonable amount of the three-fold alkynylated side product can be 
obtained when using 5.5 equivalents. So it has been found that the increase in the amount of 
alkyne leads to full conversion of starting material and reduces the amount of alkynylated by-
products. 
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Scheme 9. Synthesis of 2,3,5,6-tetraalkynylpyridines 7 and 8; i: PdCl2(CH3CN)2 (4 mol%), 
XPhos (8 mol%), CuI (3 mol%) 1,4-dioxane, HN(i-Pr)2, 100 ºC, 20h. 
 
Table 3. Synthesis of compounds 7-8. 
Product R1 Alkyne [eq.] Yield [%]a 
7a OMe 
 
6.5 80 
7b OMe 
 
6.5 58 
7c OMe 
 
6.5 73 
7d OMe 
 
6.5 71 
7e OMe 
 
6.5 63 
7f OMe 
 
6.5 71 
7g OMe  6.5 26 
8a CF3  
6.5 50 
8b CF3  
6.5 56 
8c CF3  
6.5 63 
8d CF3  
6.5 75 
8e CF3  
6.5 74 
a Yields of isolated products.  
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5.1.3 Photophysical properties 
 
UV/Vis and fluorescence properties of 2,3,5,6-tetraalkynylpyridines 7a-c and 8a-c were 
explored by steady-state absorption and fluorescence spectroscopy (Table 4). The 
photophysical data of 2,3,4,5,6-penta(alkynyl)pyridine 9a14 and 2,3,5,6-tetra(alkynyl)pyridines 
10a-c15 are also shown for comparison with the gained results.  
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Figure 13. Normalized absorption and emission spectra of 7-10. 
 
As a matter of fact, absorption spectra of 7-10 show two transitions at 290-340 nm and 340-
400 nm, respectively. The absorption and fluorescence spectra of the corresponding 2,3,5,6-
tetraphenylethynyl and 2,3,5,6-tetra(4-fluorophenylethynyl)-substituted pyridines are almost 
the same, whereas the absorption peaks of the 2,3,5,6-tetra(4-methoxyphenylethynyl)pyridines 
(7b, 8b) are bathochromically shifted. The absorption band of compounds 7a-c and notably for 
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compounds 8a-c are rather narrow revealing a band structure. The conjugation between the 
pyridine moiety and the substituent located at the 4-position is rather poor. This assumption is 
supported by the comparative data of tetra(alkynyl)pyridine 10a and the corresponding 4-aryl 
substituted derivatives 7a and 8a. Moreover, in case of 2,3,4,5,6-penta(alkynyl)pyridine 9a – a 
derivative with a better conjugation over alkynyl moiety - the presence of an additional alkynyl 
group leads to a bathochromic shift of the absorption and emission spectra.  
 
Table 4. UV/Vis absorption and fluorescence data of 7-10 in dichloromethane.  
 
𝜆𝑚𝑎𝑥
𝑎𝑏𝑠 [𝑛𝑚] 
(𝜀𝑎𝑏𝑠 [10
−4𝑀−1𝑐𝑚−1]) 
𝜈𝑆𝑡𝑜𝑘𝑒𝑠
 
[𝑐𝑚−1] 
𝜆𝑚𝑎𝑥
𝑓𝑙𝑢𝑜 
[𝑛𝑚] 
𝜙 
7a 319 (6.9), 374sh  2100 406 0.25 
7b 345 (14.2), 390 (8.4) 1900 421 0.31 
7c 319 (7.9), 374sh  2100 406 0.25 
8a 320 (6.1), 358 (3.6), 378 (3.6) 2250 413 0.44 
8b 346 (11.8), 374 (7.3), 397 (7.6) 2300 437 0.60 
8c 320 (10.2), 357 (6.2),375 (6.2) 2500 414 0.41 
9a 338 (11.0), 376 (4.6), 421 (1.4) 750 438 0.55 
10a 317 (10.0), 353 (5.7), 370 (5.8) 1500 392 0.42 
10b 340 (10.9), 387 (6.8) 1600 412 0.45 
10c 317 (11.4), 354 (6.6), 373 (6.6) 1300 392 0.43 
 
The quantum yields of 4-methoxyphenylethynyl substituted pyridines are higher than ones from 
corresponding 4-fluorophenylethynyl and phenylethynyl products. The intramolecular charge 
transfer contributions of investigated compounds are apparently small. This can be explained 
by small Stokes shifts, the shape of the fluorescence bands and relatively high quantum yields. 
Considering these criteria, ICT might be relatively larger for 4-(4-methoxyphenyl)pyridine 7a 
in comparison to literature known 9a14 and 10a.15 The highest fluorescence quantum yield of 
60% was detected for derivative 8b.  
To conclude, relatively high fluorescence quantum yields were detected for 4-aryl-2,3,5,6-
tetraalkynylpyridines bearing an electron-withdrawing substituent at position 4 of the pyridine 
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core and alkynyl groups with electron-donating substituents. This correlation is likely 
associated with the push-pull substitution pattern of the molecules. 
 
5.1.4 Liquid-crystalline properties 
 
In addition, fluorinated alkynylpyridine 8c was investigated with regard to its liquid-crystalline 
properties. Characterization and determination of the liquid-crystalline phase sequences with 
transition temperatures were carried out using polarized optical microscope equipped with a hot 
plate. The phase sequences of tested compounds were investigated only during the heating cycle 
due to the decomposition of the compound at higher temperatures.  
 
 
Crystall Liquid- Crystall
Isotropic
Phase
227 oC 274 oC *
 
 
Figure 14. Phase sequences and transition temperatures of compound 8c; *compound starts to 
decompose at 250 °C. 
 
 
 
Figure 15. The liquid-crystal texture of compound 8c observed by POM. 
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Figure 16. DSC plot with a phase diagram of 8c. 
 
5.1.5 Conclusion 
 
In conclusion, site-selective Sonogashira reactions of 4-aryl substituted tetrachloropyridines 
were developed. Synthesis of 2,6-dialkynyl pyridines was achieved in good yields with 
Pd(PPh3)4 as a catalyst of choice. Next, the synthesis of various symmetrical and non-
symmetrical tetraalkynylated pyridines was carried out in good to excellent yields. In addition, 
UV/Vis and fluorescence spectra of several tetraalkynylated pyridines were measured together 
with quantum yields. Generally, synthesized tetraalkynylpyridines show high quantum yields 
which makes them ideal compounds for various optoelectronic applications. Variation of the 
functional groups of the alkynyl moieties and of the substituent located at position 4 of the 
pyridine moiety gives a possibility to switch prospective properties of those compounds and 
improve quantum yields. Moreover, the liquid-crystalline properties of selected fluorinated 
alkynyl pyridine by means of differential scanning calorimetry technique and polarized light 
microscopy was investigated.  
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5.2 Synthesis of 2,3,5,6-tetraalkynylpyrazines 
 
5.2.1 Synthesis 
 
Herewith, results for the first synthesis of tetraalkynylpyrazines together with photophysical 
and electrochemical investigations of obtained products is disclosed. Additionally, the 
influence on photophysical properties of an additional nitrogen atom in the pyrazine core was 
investigated and the results were compared with the corresponding tetraalkynylated pyridine 
and benzene analogs. 
Starting material tetrachloropyrazine was synthesized following a known literature method by 
the reaction of 2,5-dioxopiperazine (11) with phosphorus pentachloride and phosphoryl 
chloride (Scheme 10).[129] 
 
 
Scheme 10. Synthesis of starting material tetrachloropyrazine. 
 
After having the starting material, the reaction conditions of tetra-fold Sonogashira couplings 
were optimized. For the model reaction, phenylacetylene was chosen as the alkyne (Scheme 11, 
Table 5). Among all tested phosphine ligands, XPhos proved to be the most efficient one. The 
title product 13a was isolated with the most optimal yield of 84% when the catalytic system 
was used in combination diisopropylamine base and 6 equivalents of alkyne. This result was 
achieved with amounts of catalyst and ligand being 3 mol% and 6 mol%, respectively. 
 
 
Scheme 11. Optimization of the conditions for the synthesis of 13a. 
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Table 5. Optimization of the synthesis of 13a. 
Entry Catalyst and ligand Co-catalyst 
Alkyne 
[equiv.] 
Base Yield [%] a 
1 Pd(PPh3)4  [5 mol%] CuI [5 mol%] 8 HN(i-Pr)2 14 
2 PdCl2(CH3CN)2  [5 mol%] 
XPhos [10 mol%] 
CuI [5 mol%] 8 HN(i-Pr)2 75 
3 PdCl2(CH3CN)2  [5 mol%] 
cataCXium A [10 mol%] 
CuI [5 mol%] 8 HN(i-Pr)2 64 
4 PdCl2(CH3CN)2  [5 mol%] 
[(t-Bu)3PH]BF4 [10 mol%] 
CuI [5 mol%] 8 HN(i-Pr)2 68 
5 PdCl2(CH3CN)2  [5 mol%] 
XPhos [10 mol%] 
CuI [5 mol%] 8 HN(i-Pr)2 88 
6 PdCl2(CH3CN)2  [5 mol%] 
XPhos [10 mol%] 
CuI [5 mol%] 6 NEt3 74 
8 PdCl2(CH3CN)2  [3 mol%] 
XPhos [6 mol%] 
CuI [5 mol%] 6 HN(i-Pr)2 84 
9 PdCl2(CH3CN)2  [1 mol%] 
XPhos [2 mol%] 
CuI [5 mol%] 6 HN(i-Pr)2 44 
10 
PdCl2(CH3CN)2  [3 mol%] 
XPhos [6 mol%] 
- 6 HN(i-Pr)2 65 
 
a Yields of isolated products.  
 
 
 
 
Figure 17. Phosphine ligands used during optimization reactions. 
 
 
The yield of the reaction essentially decreases when the loading of the catalyst is reduced 
further. The presence of copper iodide as a co-catalyst proves high yields, although the product 
can be isolated in reasonable yield even in the absence of co-catalyst (Entry 10). 
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With the optimal reaction conditions in hands, the scope of the reaction was explored with the 
utilization of various alkynes. Tetraalkynylpyrazines 13a-m were obtained in good to very good 
yields and all of them were strongly blue fluorescent under UV light (Scheme 12, Table 6). 
Several compounds like 13e, 13j, 13k, were isolated in lower yield because of difficulties 
associated with the chromatographic purification. 
 
 
Scheme 12. Synthesis of 13a-m; i: PdCl2(CH3CN)2  (3 mol%), XPhos (6 mol%), CuI 
(5 mol%), HN(i-Pr)2, 1,4-dioxane, alkyne (6.0 eq.), 100 °C, 20 h. 
 
 
Table 6. Synthesis of 10a-m. 
Product Alkyne Yield [%]a 
13a 
 
84 
13b 
 
88 
13c 
 
83 
13d 
 
0 b 
13e  44 
13f  78 
13g 
 
82 
13h 
 
60 
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13i 
 
79 
13j 
 
50 
13k 
 
49 
13l 
 
81 
13m 
 
60 
a Yields of isolated products. b Product 13d could not be isolated due to solubility problems. 
 
 
After the reaction scope was investigated, it was also possible to gain the parent 2,3,5,6-
tetraethynylpyrazine (14) in 86% yield by treating the silylated derivative 13f with TBAF 
(Scheme 13). Later this procedure and compound were used by Sakamoto et al. for the synthesis 
of pyrazine-incorporated graphdiyne.[130]  
Regrettably, attempts to perform site-selective double or mono alkynylations on 
tetrachloropyrazine failed. The reason is not only because of the symmetric structure of the 
molecule but also on the reactivity of the molecule which increases after every coupling step. 
 
 
 
 
Scheme 13. Synthesis of 14; i: TBAF, THF, 0 to 20 °C, 2 h. 
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5.2.2 Photophysical properties 
 
UV/Vis and fluorescence properties of tetraalkynyl pyrazines were studied using 
dichloromethane as a solvent. Steady-state absorption and fluorescence spectra of 13a, 13g and 
13j were compared and shown in Figure 18. It has been observed that measured compounds 
show two absorption regions at 318 nm - 349 nm and 390 nm – 412 nm, respectively with 
fluorescence maxima between 429 nm and 461 nm. 
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Figure 18. Normalized absorption and emission spectra of 13a, 13g and 13j. 
 
As can be seen, phenylethynyl moiety with σ-donating methyl group causes only slight 
bathochromic shift of the absorption- and fluorescence spectra. Whereas tertaalkynylpyrazine 
13j with extra π-donating methoxy group leads to significant redshift (Figure 18 and Table 7). 
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This redshift indicates a more pronounced π-electron delocalization relative to the other 
measured tertaalkynylpyrazines.  
In order to understand how the introduction of an additional nitrogen atom into the central 
aromatic ring influences on the photophysical properties of molecules, the absorption and 
emission spectra of tetrakis(phenylethynyl)pyrazine (13a) was compared with its corresponding 
pyridine[131] (10a) and benzene (15) analogs (Figure 19, Table 7).  
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Figure 19. Comparison of absorption and fluorescence spectra of tetrakis(phenylethynyl)-
pyrazine (13a) with its corresponding pyridine (10a) and benzene (15) derivatives. 
 
While the first transitions in the UV/Vis spectra of 13a, 10a and 15 have almost the same 
wavelengths of maximum absorbance, the second transition shifts to higher wavelengths as the 
number of nitrogens in the aromatic ring grows. Nonetheless, comparison of absorption 
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coefficients of transitions for pyrazine, pyridine and benzene derivatives shows that the second 
transition is almost the same for all compounds whereas the absorption coefficients of the first 
transition of 13a are approximately twice smaller than those of 10a and 15. 
The emission spectra of compounds shift bathochromically as the number of nitrogens grows 
in the aromatic ring. This can be explained by the push-pull pattern of the molecules causing 
the biggest intramolecular charge transfer contributions for the pyrazine derivative. It has been 
also observed that the substitution pattern of the peripheral substituents affect the quantum 
yields marginally, while the situation is different when the central aromatic ring is changed. To 
this extent, the quantum yields of tetraalkynyl pyrazine 13a are approximately two times higher 
than those of corresponding pyridine 10a and benzene 15 analogs. (Table 7).  
 
 
Table 7. UV/Vis absorption and fluorescence data of 13, 10a and 15 in 
dichloromethane.  
 
𝜆𝑚𝑎𝑥
𝑎𝑏𝑠 [𝑛𝑚] 
(𝜀𝑎𝑏𝑠 [10
−4𝑀−1𝑐𝑚−1]) 
𝜈𝑆𝑡𝑜𝑘𝑒𝑠
 
[𝑐𝑚−1] 
𝜆𝑚𝑎𝑥
𝑓𝑙𝑢𝑜 
[𝑛𝑚] 
𝜙  
13a 318 (5.4), 390 (4.8) 2330 429 0.81 
13c 328 (5.8), 398 (5.5) 2350 439 0.83 
13g 324 (4.2), 393 (4.7) 2350 433 0.77 
13h 323 (5.4), 394 (5.1) 2290 433 0.85 
13j 349 (4.9), 412 (5.8) 2580 461 0.79 
10a 317 (10.0), 353 (5.7), 370 (5.8) 1520 392 0.42 
15 317 (12.6), 347 (4.5) 3050 388 0.45 
 
 
5.2.3 Electrochemical studies 
 
Electrochemical experiments were performed to determine the potential values, 
electrochemical activity and the influence of the substitution pattern of selected compounds. 
The cyclic voltammograms of 13, 10a and 15 are shown in Figure 20. In all cases, two redox 
events were observed. The first redox event is represented by the oxidation of measured 
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compounds at potentials of around 1.5 V [vs. Ag/AgCl/LiClsat. in ethanol]. The oxidation event 
is electrochemically non-reversible and thus data from the corresponding reduction potentials 
are not depicted in Table 8. The second redox event was depicted at potentials below -0.5 V 
[vs. Ag/AgCl/LiClsat. in ethanol] and is electrochemically reversible. Based on the measured 
potentials the HOMO and LUMO levels of the compound were calculated[132] (Table 8). HOMO 
and LUMO levels were calculated using the peak potentials of the oxidation event 1 and the 
reduction event 2 using equations IP = Epeak
1−ox + 4.4 eV and EA = Epeak
2−red + 4.4 eV,[133] 
respectively. In order to compare the values of the band gaps obtained by optical spectroscopy, 
the electrochemical band gaps were calculated (EEC = IP –EA).[132] As a matter of fact, these are 
a little larger than the numbers corresponding to band gaps from optical spectroscopy. However, 
a comparable correlation between the structure and the band gap can be observed.[134] 
 
 
 
 
Figure 20. Cyclic voltammograms of tetrakis(phenylethynyl)pyrazine 13a with its 
corresponding pyridine and benzene analogs 10a and 15, respectively. 
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Table 8. Redox properties of compounds 13a-e, 10a and 15 in acetonitrile.1 
Compd 
Eopt. 
[eV] 
𝐸𝑝𝑒𝑎𝑘
1−𝑜𝑥  
[V vs. 
Ag/AgCl] 
𝐸𝑝𝑒𝑎𝑘
1−𝑜𝑥  
[V vs. 
NHE] 
IP 
[eV] 
𝐸𝑝𝑒𝑎𝑘
2−𝑟𝑒𝑑  
[V vs. 
Ag/AgCl] 
𝐸𝑝𝑒𝑎𝑘
2−𝑟𝑒𝑑  
[V vs. 
NHE] 
𝐸𝑝𝑒𝑎𝑘
2−𝑜𝑥  
[V vs. 
Ag/AgCl] 
𝐸𝑝𝑒𝑎𝑘
2−𝑜𝑥  
[V vs. 
NHE] 
EA 
[eV] 
EEC 
[eV] 
13a 2.98 2.05 2.19 6.63 -1.21 -1.06 -1.13 -0,99 3.38 3.25 
13c 2.92 2.04 2.18 6.62 -1.21 -1.06 -1.14 -1.00 3.38 3.24 
13h 2.97 1.98 2.13 6.57 -1.25 -1.10 -1.17 -1.03 3.34 3.23 
13g 2.96 1.97 2.12 6.56 -1.19 -1.05 -1.11 -0.97 3.39 3.17 
13j 2.81 2.02 2.16 6.60 -0.82 -0.68 -0.72 -0.58 3.76 2.84 
10 3.23 2.03 2.17 6.61 -1.43 -1.29 -1.33 -1.19 3.15 3.46 
15 3.28 1.84 1.98 6.42 -1.53 -1.39 -1.47 -1.33 3.05 3.37 
 
As can be seen in the table, ionization potentials for all compounds are rather comparable 
meaning that the energies for the oxidation of measured benzene, pyridine and pyrazine 
derivatives are in the same range. Contrary, pyrazine 13j bearing a methoxy group has the 
highest LUMO energy level among other measured compounds making this derivative prone 
to an easier reduction. The lowest values of optical and electrochemical band gaps of 13j 
correlate with its push-pull substitution pattern. 
 
5.2.4 Conclusion 
 
In conclusion, an efficient method for the one-pot synthesis of tetraalkynyl pyrazines was 
developed. Each coupling step of tetra-fold Sonogashira reaction requires only 0.75 mol% of a 
palladium catalyst. Further, photophysical and electrochemical investigations were carried out 
on tetraalkynyl pyrazines and the results were compared with their corresponding pyridine and 
benzene counterparts. The obtained alkynylated pyrazines proved to show very high quantum 
yields which makes them potential candidates to be used in optoelectronics. Given the good 
electronic communication of the molecules, the fluorescence can be fine-tuned by switching 
the peripheral substituents. While comparing the aromatic cores it has been demonstrated that 
the introduction of a nitrogen atom remarkably improves the fluorescence quantum yield. As a 
matter of fact, because of the push-pull character of the tetraalkynylated pyrazines, their 
                                                          
1 Electrochemical measurements were performed by Dr. Annette-Enrica Surkus from the Leibniz-Institue for 
Catalysis at the University of Rostock. 
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quantum yields are significantly higher than those of all corresponding pyridine and benzene 
analogs studied earlier. Electrochemical studies also showed a similar correlation between the 
structure and activity of the molecules. Cyclic voltammetry measurements were performed and 
HOMO and LUMO levels together with electrochemical band gaps were determined, which 
proved to be comparable with the data gained by optical spectroscopy. It has been also observed 
that the reduction event 2 is connected to the central aromatic ring. Moreover, reduction 
potentials and so the LUMO levels get higher by the number of nitrogen atoms increases in the 
central aromatic core. 
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6. Multiple Suzuki-Miyaura Reactions of Polychlorinated  
Pyridines and Pyrazine 
Today, Suzuki-Miyaura reaction is by far the most widely used palladium-catalyzed cross-
coupling reaction. As already mentioned in Chapter 3.3, it owes its success to the large variety 
of commercially available boronic acids, their low toxicity and high stability towards air, 
moisture and heat. Moreover, Suzuki coupling is beneficial because of the selectivity control 
features that it can provide.[135] 
In the recent decade, interest in polyarylated compounds has largely increased given the 
promising properties of molecules which have a great potential to be used in optoelectronics. 
Therefore, a lot of research has been carried out towards the new synthetic methods to form 
polyaromatic heterocycles. The synthetic methods are represented by two general approaches: 
(i) either aryl functional groups are introduced in the starting materials and only after the ring 
closure takes place to form the heterocycle; (ii) or the functional groups are introduced directly 
to the heterocycle itself. Due to the great importance of pyridines and pyrazines in the 
pharmaceutical and agrochemical fields, as well as the increased attention in their electronic 
applications, the development of new synthetic methods towards the appropriate polyarylated 
heterocycles is of great importance.[136] In this regard, given the wide variety of commercially 
available boronic acids and polychlorinated heterocycles, the Suzuki-Miyaura reaction 
represents an interesting tool for the construction of multiply functionalized pyridines and 
pyrazines starting from corresponding polyhalogenated heterocycles.[73] 
This chapter deals with the preparation of various pyridine and pyrazine derivatives by 
palladium-catalyzed Suzuki-Miyaura reactions starting from corresponding polychlorinated 
heterocycles. Both aryl and alkenyl boronic acids were applied as coupling partners and site-
selectivity on pyridines was investigated. 
 
6.1 Synthesis of 2,3,5,6-tetraaryl-4-(4-methoxyphenyl)pyridines 
 
6.1.1 Site-selective arylation of 2,3,5,6-tetrachloro-4-(4-methoxyphenyl)pyridine 
 
The site-selective Suzuki reactions on polyhalogenated heterocycles have been a subject of 
intensive research in recent years.[73,137] The selectivity of the cross-coupling reactions can be 
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tuned by the choice of the catalytic system, which is possible because of the contrasting 
distribution of electron density in the pyridine core. 
Two-, three-, and tetra-fold Suzuki-reactions on corresponding chlorinated pyridine are 
presented below. The site-selective synthesis of various pentaarylated pyridines containing two 
or three different aryl moieties was easily achieved in two steps.[138]  
First of all, starting tetrachloropyridine 4a was synthesized in a three-step procedure as already 
described in Chapter 5.1 (Scheme 6). The selective diarylation reactions were performed with 
the use of Pd(PPh3)4 as a catalyst and 3 equivalents of aryl boronic acid. The title pyridines 16 
were obtained in moderate to good yields. 
 
 
Scheme 14. Synthesis of 16a-d; i: Pd(PPh3)4  (5 mol%), Ar1-B(OH)2 (3.0 eq.), K3PO4 (3.0 eq.), 
toluene, 100 °C, 20 h. 
 
Table 9. Synthesis of 16a-d. 
Product Boronic acid Yield [%]a 
16a 
 
69 
16b 
 
63 
16c 
 
47 
16d 
 
71 
a Yields of isolated products. 
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In order to get additional information and to prove expectations about the structure of 
synthesized regioisomers 2D NMR experiments, in particular, COSY and NOESY were 
performed. The characteristic NOESY correlations between neighboring aryl groups could not 
be determined because the aryl moieties are located far from each other, which indirectly proves 
the structure of 16d excluding the option where aryl rings are attached to positions 3 and 5 
(Figure 21).  
 
 
 
Figure 21. 2D NMR correlations for 16d. 
 
In the next step, the synthesized 3,5-dichloro-2,4,6-triarylpyridine 16b was efficiently 
converted into the pentaarylpyridine 17 bearing different aryl moieties. The use of highly active 
catalytic system containing Buchwald’s biaryl phosphine ligand SPhos provided 99% yield of 
the reaction (Scheme 15).  
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Scheme 15. Synthesis of 17; i: PdCl2(CH3CN)2 (5 mol%), SPhos (10 mol%), Ar2-B(OH)2 (4.0 
eq.), K3PO4 (4.0 eq.), toluene, 100°C, 20h. 
 
 
Table 10. Synthesis of 17. 
Product Substrate Boronic acid Yield [%]a 
17 16b 
 
99 
a Yield of isolated product.  
 
 
After, selective three-fold Suzuki reaction of the initial 4a was performed. It was found, that 
the reaction selectivity can be switched by using a stronger catalytic system like 
PdCl2(CH3CN)2/ SPhos. The target pyridines 18 were successfully isolated in moderate to good 
yields. (Scheme 16) 
 
 
Scheme 16. Synthesis of 18; i: PdCl2(CH3CN)2 (5 mol%), SPhos  (10 mol%), Ar1-B(OH)2 (3.0 
eq.), K3PO4 (3.0 eq.), toluene, 100°C, 20h. 
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Table 11. Synthesis of 18a-d. 
Product Boronic acid Yield [%]a 
18a 
 
54 
18b 
 
34 
18c 
 
62 
18d 
 
40 
a Yields of isolated products.  
 
 
Like in case of diarylated products, here also follow up Suzuki reaction towards the synthesis 
of pentaarylpyridines with mixed aryl moieties was performed. Reactions provided excellent 
yields (Scheme 17). 
 
 
Scheme 17. Synthesis of 19; i: PdCl2(CH3CN)2 (5 mol%), SPhos (10 mol%), Ar2-B(OH)2 (2.5 
eq.), K3PO4 (2.5 eq.), toluene, 100°C, 20h. 
 
Table 12. Synthesis of 19. 
Product Substrate Boronic acid Yield [%]a 
19a 18a 
 
98 
19b 18b 
 
93 
a Yields of isolated products.  
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6.1.2 Full arylation of 2,3,5,6-tetrachloro-4-(4-methoxyphenyl)pyridine 
 
Along with the site-selective two- and three-fold Suzuki couplings, it was also possible to 
perform one-pot full arylations of initial tetrachloropyridine 4a. The Suzuki reaction of starting 
material with various boronic acids containing electron-donating and withdrawing groups 
successfully afforded pentaarylpyridines 20 with symmetric structure. The application of SPhos 
proved to be very efficient and the products were isolated in 61 - 81% yields (Scheme 18, Table 
13).  
 
 
Scheme 18. Synthesis of 20a-d; i: PdCl2(CH3CN)2 (5 mol%), SPhos  (10 mol%), Ar1-B(OH)2 
(8.0 eq.), K3PO4 (8.0 eq.), toluene, 100°C, 20h. 
 
 
Table 13. Synthesis of 20a-d. 
Product Boronic acid Yield [%]a 
20a 
 
78 
20b 
 
61 
20c 
 
81 
20d 
 
79 
a Yields of isolated products.  
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Also in case of product 20b, COSY and NOESY experiments were additionally performed in 
order to get insights into the structure. As a result, characteristic NOESY correlations between 
neighboring aryl groups were determined (Figure 22).  
 
 
Figure 22. 2D NMR correlations for 20b. 
 
 
6.1.3 Conclusion 
 
In conclusion, syntheses of various pentaaryl pyridines via palladium-catalyzed multiple Suzuki 
reactions were developed for the first time. Two- and three-fold site-selective arylation 
reactions were performed providing moderate to high yields of products with mixed aryl 
moieties. In addition, one-pot tetra-fold Suzuki couplings were carried out and the title 
symmetric pyridines were isolated in very high yields. Established protocols allow easy access 
to diverse polyarylated pyridines from easily available corresponding chlorinated starting 
materials. 
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6.2 Synthesis of 2,3,5,6-tetraarylpyrazines 
 
Functionalized pyrazines can be found in different natural products and many of them possess 
pharmacological activities.[139] Particularly, several pyrazines with aryl functionalities were 
shown to act as cyclooxygenase-2 inhibitors,[140] anti-platelet aggregants,[141] regulators of 
estrogen receptors,[142] antihyperglycemics,[143] cannabinoid receptor 1 antagonists[144] etc. 
Moreover, given their photophysical characteristics, a number of arylpyrazines are considered 
as promising materials for medical imaging applications.[145] 
There is a number of reports on the synthesis of aryl-substituted pyrazines and most of them 
include cyclization reactions of already prefunctionalized starting materials.[146,147] Those 
methods, like many others, have several drawbacks including the low outcome of the reactions, 
high-pressure condition or prefunctionalization of the starting compounds. In this regard, the 
development of new procedures for the straightforward and easy preparation of 
tetraarylpyrazines is of particular relevance. Over recent years, several palladium-catalyzed 
cross-coupling reactions have been used for the functionalization of dichloropyrazines.[148] A 
single example of a Sonogashira reaction on tetrahalogenated pyrazine has been reported so far 
using an excessive amount of catalyst.[149] Herewith, the first examples of multiple Suzuki-
Miyaura cross-coupling reactions of tetrachloropyrazine are developed allowing a 
straightforward synthesis of symmetrical tetraarylpyrazines in very high yields.[145] 
At first, starting tetrachloropyrazine (12) was synthesized following a procedure already 
described in Chapter 5.2 (Scheme 10). To find out reaction conditions providing the best yields 
a thorough optimization was carried out. Different catalysts were screened in the model reaction 
of 12 with phenylboronic acid (Scheme 19). 
 
 
 
Scheme 19. Optimization of the synthesis of 21a. 
 
The employment of Pd(PPh3)4 with a common combination of the solvent and base resulted in 
title 2,3,5,6-tetraphenyl pyrazine in 83% yield (Table 14, Entry 1). It has been shown that the 
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application of bulky ligands like cataCXium A,[91] SPhos[150] or P(Cy)3 provides yields higher 
than 90%. In particular, application of Pd(OAc)2 (5 mol%) and P(Cy)3 (10 mol%) afforded 21a 
in 97% yield. Advantageously, the catalyst loading can be decreased twenty times without 
affecting the outcome of the reaction (Entries 7-10). However, further lowering of the catalyst 
amount slightly decreases yield to 88% (Entry 11). The optimization reactions were carried out 
at 100 °C and stirred for 18 h. It has been found that shortening the duration of the reaction to 
10 h decreases the yield for around 15%. A decline of the yield is observed also when amounts 
of the base and boronic acid are decreased from 8.0 to 6.0 or 5.0 equivalents (Entries 5 and 6). 
  Table 14. Optimization of the synthesis of 21a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Yields of isolated products; conditions: catalyst, tetrachloropyrazine, PhB(OH)2, K3PO4, 
toluene, 100 °C, 18 h. 
 
Entry Catalyst and ligand 
K3PO4 :  
Ph-B(OH)2 
Time [h] 
Yield  
[%] a 
1 Pd(PPh3)4  [5 mol%] 8:8 18 83 
2 
Pd(OAc)2  [5 mol%] 
SPhos  [10 mol%] 
8:8 18 96 
3 
Pd(OAc)2 [5 mol%] 
cataCXium A [10 
mol%] 
8:8 18 92 
4 
Pd(OAc)2 [5 mol%] 
P(Cy)3 [10 mol%] 
8:8 18 97 
5 
Pd(OAc)2 [5 mol%] 
P(Cy)3 [10 mol%] 
5:5 18 86 
6 
Pd(OAc)2 [5 mol%] 
P(Cy)3  [10 mol%] 
6:6 18 90 
7 
Pd(OAc)2 [3 mol%] 
P(Cy)3 [6 mol%] 
8:8 18 96 
8 
Pd(OAc)2 [1 mol%] 
P(Cy)3 [2 mol%] 
8:8 18 97 
9 
Pd(OAc)2 [0.5 mol%] 
P(Cy)3 [1 mol%] 
8:8 18 96 
10 
Pd(OAc)2 [0.25 mol%] 
P(Cy)3 [0.5 mol%] 
8:8 18 97 
11 
Pd(OAc)2 [0.1 mol%] 
P(Cy)3 [0.2 mol%] 
8:8 18 88 
12 
Pd(OAc)2 [0.25 mol%] 
P(Cy)3 [0.5 mol%] 
8:8 10 82 
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Figure 23. Structures of phosphine ligands used during optimization. 
 
After identifying the best reaction conditions, different aryl boronic acids were applied to study 
the preparative scope of the reaction. Yields of isolated title compounds 21a-j were in the range 
of very good to excellent. In some cases (21k-p), catalyst loading was increased to achieve 
better yields. In fact, aryl boronic acids with electron-donating and electron-withdrawing 
substituents were successfully applied to give similarly good yields. Moreover, the vinyl group 
was also tolerated giving the target compound in 76% isolated yield. Compounds 21a,[151] 
21c[152] and 21e[153] were previously prepared by other methods. However, there was no 
spectroscopic data described for 21c. 
 
 
Scheme 20. Synthesis of 21a-p; i: Ar-B(OH)2 (8.0 equiv.), K3PO4 (8.0 equiv.), toluene, 100 °C, 
18 h, for 21a-j: Pd(OAc)2 (0.25 mol%), P(Cy)3 (0.5 mol%), for 21k-p: Pd(OAc)2 (2 mol%), 
P(Cy)3 (4 mol%). 
 
 
Table 15. Synthesis of 21a-p. 
Product Boronic acid Yield [%]a 
21a 
 
97 
21b 
 
85 
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21c 
 
93 
21d 
 
96 
21e 
 
90 
21f 
 
96 
21g 
 
87 
21h 
 
99 
21i 
 
81 
21j 
 
94 
21k 
 
92 
21l 
 
76 
21m 
 
99 
21n 
 
99 
21o 
 
74 
21p 
 
50 
a Yields of isolated products.  
 
It was possible to obtain a single crystal of 21b and to independently confirm its molecular 
structure by X-ray analysis. It was found that the aryl rings are twisted out of the pyrazine plane 
by 32-50 °forming a propeller-like arrangement (Figure 24). Given such conformation of 
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terminal functionalities, tetraarylpyrazines possess aggregation-induced emission (AIE)[154] 
properties which makes them ideal candidates for being used as solid-state luminogens.[147] 
 
Figure 24. ORTEP of 21b with displacement ellipsoids drawn at the probability level of 30%. 
 
In conclusion, a facile procedure for the first synthesis of tetraaryl pyrazines via Suzuki-
Miyaura reaction have been elaborated. An accurate optimization of the reaction conditions 
allowed the preparation of title products in good to excellent yields with the use of palladium 
catalyst as low as 0.25 mol% for tetra-fold coupling. The established method represents a new 
route towards symmetrical tetraarylated pyrazines and is more cost-efficient, provides better 
yields and has broader functional group tolerance in comparison to the methods reported earlier. 
The synthesized tetraaryl pyrazines are potential solid-state luminogens. 
 
6.3 Synthesis of 2,3,5,6-tetraalkenylpyrazines 
 
6.3.1 Synthesis 
 
In continuation of the previous sub-chapter, results on multiple Suzuki-Miyaura reactions of 
tetrachloropyrazine with functionalized styryl boronic acids are presented herein. There are 
several reports on tetraalkenyl pyrazines and similar cross-shaped molecules with the focus on 
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the electronic and optical properties of the compounds.[155] For example, owing to the two-
photon absorption characteristics, several tetraalkenyl pyrazines serve as sensors and are used 
in the medical sphere.[156] Previously, several tetraalkenyl pyrazines were prepared by the 
condensation reaction of tetramethyl pyrazine with corresponding aldehydes.[156,157] 
Nonetheless, the application of the Suzuki-Miyaura reaction allows much milder and easier 
access to the target molecules providing very high yields. 
 
 
 
  Scheme 21. Optimization of the synthesis of 22a. 
 
 
    Table 16. Optimization of the synthesis of 22a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Yields of isolated products; conditions: catalyst, tetrachloropyrazine, styrylboronic acid (8.0 
equiv.), K3PO4 (8.0 equiv.), 1,4-dioxane, 100 °C, 20 h.  
b Conditions: catalyst, tetrachloropyrazine, styrylboronic acid (8.0 equiv.), K3PO4 (8.0 equiv.), 
toluene, 100 °C, 20 h (identical to the conditions for the synthesis of tetraarylpyrazines, Scheme 
20). 
Entry Catalyst and ligand Solvent 
Yield 
[%]a 
1 
Pd(OAc)2 [2 mol%] 
P(Cy)3 [4 mol%] 
toluene 12 b 
2 
Pd(dba)2  [5 mol%] 
cataCXium A [10 mol%] 
dioxane 99 
3 
Pd(dba)2  [4 mol%] 
cataCXium A [8 mol%] 
dioxane 98 
4 
Pd(dba)2  [2 mol%] 
cataCXium A [4 mol%] 
dioxane 97 
5 
Pd(dba)2  [1 mol%] 
cataCXium A [2 mol%] 
dioxane 95 
6 
Pd(dba)2  [0.25 mol%] 
cataCXium A [0.5 mol%] 
dioxane 60 
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As a starting point, the reaction of starting material 12 with styryl boronic acid was tested under 
the conditions already developed for the synthesis of tetraarylpyrazines. Interestingly, the 
desired product was isolated only in 12% yield (Table 16, Entry 1). Nonetheless, the yield of 
the title compound 22a was improved to quantitative by changing the phosphine ligand and the 
solvent.[131] As a matter of fact, the application of more sterically demanding cataCXium A 
(10 mol%) with palladium precursor and 1,4-dioxane as the solvent proved to be extremely 
efficient for this reaction. 
 
 
 
Scheme 22. Synthesis of 22; i: Pd(dba)2 (2 mol%), CataCXium A (4 mol%), alkenylboronic 
acid or -pinacol ester (8.0 equiv.), K3PO4 (8.0 equiv), 1,4-dioxane, 100 °C, 20 h. 
 
 
    Table 17. Synthesis of 22a-e. 
Product Coupling partner Yield [%]a 
22a 
 
97 
22b 
 
95 
22c 
 
99 
22d 
 
93 
22e 
 
70 
    a Yields of isolated products.  
 
Next, loading of the catalytic system was decreased to find out the most optimal amount for the 
efficient outcome of the reaction. It has been shown that the quantitative yield can be obtained 
even with 2 mol% of Pd-precursor and 4 mol% of phosphine ligand. Further, decrease to 
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0.25 mo% /0.5 mol% lowers the yield of desired tetrastyryl pyrazine to 60% (Table 16, Entry 
6) Therefore, the reaction scope was investigated with the use of 2 mol% of Pd(dba)2 and 
4 mol% of the cataCXium A (Table 17). 
Various alkenyl boronic acids or their corresponding esters containing electron-withdrawing 
and electron-donating groups were employed to give tetraalkenyl pyrazines in good to excellent 
yields.  
 
6.3.2 Photophysical Properties 
 
As already mentioned, tetrastyryl pyrazines and similar cross-shaped structures possess various 
photophysical features. In this regard, it was interesting to study the UV/Vis and fluorescence 
properties of the synthesized 2,3,5,6-tetraalkenyl pyridines 22a, 22c and 22e. It is known that 
similar molecules tend to undergo various photochemical reactions like isomerization or 
polymerizations under UV irradiation and even under daylight.[158] Therefore all the 
measurements were carried out with special care and only using freshly prepared probes. 
The absorption wavelengths of all measured tetraalkenyl pyrazines are in the range of 323 nm 
– 459 nm and the spectra have three conspicuous transitions. The absorption of compound 22d 
bearing electron-donating methoxy substituent is redshifted relative to the absorptions of 22a 
and its fluorinated analog 22c showing almost identical pictures. A similar tendency is observed 
in the emission spectra of the measured molecules. The emission spectrum of tetralkenyl 
pyrazine 22d is redshifted with the fluorescence maximum of 522 nm. This shift suggests a 
more pronounced π-electron delocalization relative to the other measured analogs which is true 
in case of methoxy derivative given the push-pul pattern of the molecule. In contrast, emission 
maxima of products 22a and 22c correspond to 498 and 497 nm, respectively. The fluorescence 
spectra of the measured compounds have a small shoulder at lower wavenumbers. In 
comparison to absorbance and emission spectra, quantum yields of the measured compounds 
were only slightly affected by the nature of peripheral substituents of the tetraalkenyl pyrazines. 
The quantum yields of the products are rather high ranging from 0.55 to 061. Moreover, 
relatively small Stokes shifts and rather high quantum yields indicate weak intramolecular 
charge transfer (ICT) contributions of the measured tetraalkenyl pyrazines. 
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Figure 25.  Normalized absorption and emission spectra of 22a, 22c and 22d. 
 
 
Table 18. UV/Vis absorption and fluorescence data of 22a, 22c and 22d in dichloromethane.  
 
𝜆𝑚𝑎𝑥
𝑎𝑏𝑠 [𝑛𝑚] 
(𝜀𝑎𝑏𝑠 [10
−4𝑀−1𝑐𝑚−1]) 
𝜈𝑆𝑡𝑜𝑘𝑒𝑠
 
[𝑐𝑚−1] 
𝜆𝑚𝑎𝑥
𝑓𝑙𝑢𝑜 
[𝑛𝑚] 
𝜙 
22a 323 (4.3), 373 (5.0), 441 (2.6) 2600 498 0.55 
22c 324 (4.4), 371 (5.4), 441 (2.6) 2560 497 0.57 
22d 353 (5.0), 388 (6.0), 459 (3.1) 2630 522 0.61 
 
 
Multiple Suzuki-Miyaura Reactions of Polychlorinated Pyridines and Pyrazine 
 
57 
 
6.3.3 Conclusion 
 
In conclusion, straightforward syntheses of several tetraalkenyl pyrazines by tetra-fold Suzuki-
Miyaura reactions were performed. The desired products were isolated in high to quantitative 
yields consuming 0.5 mol% of palladium catalyst for each step. In addition, absorption and 
fluorescence spectra, as well as quantum yields of selected tetraalkenylated pyrazines, were 
measured. Prepared tetraalkenyl pyrazines show rather high quantum yields representing a 
potential candidacy for different optical and electronic applications.  
 
6.4 Synthesis of 2,7-diaryl-1,8-naphthyridines 
 
Functionalized naphthyridines have received attention due to their wide-ranging properties. For 
example, the feature to operate via non-covalent interactions allowed naphthyridines to be 
effectively used in supramolecular chemistry.[159,160] Several naphthyridines are used as 
sensitive probes towards biologically relevant molecules[161] and metal ions.[162] Moreover, the 
capacity to interact with human receptors by serving as multiple hydrogen bond acceptors 
makes naphthyridines interesting from the standpoint of pharmacology. It has been shown that 
several 2-aryl substituted 1,8-naphthyridines demonstrate high affinity towards A1 adenosine 
receptor subtype. At the same time significant selectivity for the adenosine receptor A1 as 
compared to the adenosine receptor subtypes A2a and A3 is determined. Consequently, those 
molecules can be considered as selective antagonists for A1 subtype of adenosine receptor.[163] 
Another report showed that arylated naphthyridines may also serve as non-competitive 
antagonists of G protein-coupled metabotropic glutamate receptor 5 (mGluR 5). In this regard, 
non-competitive antagonists of mGluR 5 have considerable potential in the treatment of 
anxiety, pain, Parkinson’s disease and gastroesophageal reflux disease.[164] In addition to the 
above mentioned, 1,8-naphthyridines also possess a number of other pharmacological 
activities.[165] 
Given the practical importance of the substituted 1,8-naphthyridines number of various 
reactions, including palladium-catalyzed cross-couplings were applied for the synthesis of new 
derivatives.[160,166] However, Suzuki-Miyaura reaction, which would provide a very elegant and 
convenient access towards the synthesis of 2,7-diaryl-1,8-naphthyridines, has not been reported 
before. In this sub-chapter results on the two-fold arylation of 2,7-dichloro-1,8-naphthyridines 
by palladium-catalyzed Suzuki coupling is presented.[167] 
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First of all, starting material 2,7-dichloro-1,8-naphthyridine (26) was synthesized in three steps 
following a known literature method.[168] 
 
Scheme 23. Synthesis of 2,7-dichloro-1,8-naphthyridine; i: Malic acid, H2SO4, 110 ºC, 3 h; ii: 
NaNO2, H2SO4, 20 °C, 5 min; iii: PCl5, POCl3, reflux, 2 h. 
 
 
Scheme 24. Optimization of the synthesis of 27a. 
 
Table 19. Optimization of the synthesis of 27a.2 
Entry Catalyst Solvent Base T [ºC] 
Yield 
[%]a 
1 Pd(PPh3)4 THF Cs2CO3 60 27 
2 Pd2(dba)3 / HP(tBu)3BF4 THF Cs2CO3 60 51 
3 Pd2(dba)3 / P(Cy)3 THF Cs2CO3 60 46 
4 Pd2(dba)3 / X-Phos THF Cs2CO3 60 62 
5 Pd2(dba)3 / S-Phos THF Cs2CO3 60 65 
6 Pd2(dba)3 / S-Phos dioxane Cs2CO3 100 85 
7 Pd2(dba)3 / S-Phos toluene Cs2CO3 100 75 
8 Pd2(dba)3 / S-Phos dioxane K3PO4 100 90 
 
a Yields of isolated product. 
                                                          
2 Optimization reactions were performed by Dr. Peter Ehlers from the University of Rostock. 
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After having the starting material, conditions for the synthesis of 27a were optimized to identify 
the best combination of catalyst, solvent and base. As a result, the highest yield was obtained 
when Pd2(dba)3 / S-Phos was used as the catalyst. At the same time, the use of potassium 
triphosphate and 1,4-dioxane proved to be important for reaching the most favorable result 
(Table 19, Entry 8).  
 
 
Scheme 25. Synthesis of 27; i: Pd2(dba)3 (2.5 mol%), S-Phos (10 mol%), K3PO4,  
1,4-dioxane, 100 ºC, 20h. 
 
Table 20. Synthesis of 27a-h. 
Product Boronic acid Yield [%]a 
27a 
 
90 
27b 
 
84 
27c 
 
92 
27d 
 
72 
27e 
 
82 
27f 
 
93 
27g 
 
64 
27h 
 
91 
a Yields of isolated products.  
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Having the best conditions in hands, preparative scope was studied by utilization of various 
boronic acids (Table 20). Advantageously, the reaction has a good functional group tolerance 
and substituents like fluorine, acetyl- and vinyl groups were readily tolerated. Additionally, 
employment of trans-2-phenylvinylboronic acid successfully resulted in appropriate distyryl 
naphthyridine 27h.  The reaction with both electron-poor and electron-rich boronic acids 
proceeds with good to excellent yields. A slightly decreased yield (64%) of vinyl derivative 27g 
may be the result of competing Heck reaction on the double bond.  
In conclusion, a convenient and easy approach for the synthesis of 2,7-diaryl-1,8-
naphthyridines by Suzuki-Miyaura reactions was developed. A range of different substituents 
are tolerated and products are obtained in good to excellent yields. Moreover, by the application 
of appropriate boronic acids 2,7-dialkenyl-1,8-naphthyridines can also be prepared and isolated 
in very good yields. 
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7. Double Arylation of N-Phenylpyrrole by Palladium-Catalyzed  
C–H Activation 
Pyrrole ring is represented in many important compounds in different fields of chemical 
research.[169] In particular, arylated pyrroles are widespread in nature and are widely used for 
the design and synthesis of pharmaceuticals as well as advanced materials.[170] Examples of 
natural products, containing pyrrole include pentabromopseudiline isolated from Alteromonas 
luteo-violaceus and the seabird hexahalogenated bipyrrole. Moreover, a number of different 
polymers with applications varying from biosensors to polymer light-emitting diodes have been 
synthesized based on pyrroles. Additionally, several arylated pyrroles have been reported to 
show inhibitory activity against lipoxygenase, myosin ATPase and β-secretase enzymes.[171] 
 
 
Figure 26. Several applications of aryl pyrroles.  
Due to the practical importance of functionalized pyrroles, the elaboration of new and more 
convenient methods for the synthesis of aryl pyrroles is of great importance. In this regard, 
palladium-catalyzed cross-couplings are highly valuable.[58] Nonetheless, although transition 
metal-catalyzed traditional cross-coupling reactions are one of the most powerful and 
convenient tools, the development of new procedures providing better sustainability and 
environmental compatibility is in continuous demand. The importance of C–H activation[103] 
reactions in this regard has significantly increased over recent years given their advantages with 
respect to atom economy, cost-efficiency and environmental impact (cf. Chapter 4). However, 
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the challenges of these reactions concerning regioselectivity still need to be addressed.[172] 
Additionally, C–H bond activation reactions often require solvents with relatively high toxicity 
and high temperatures which make them less attractive in terms of environmental 
friendliness.[173] 
In recent years, functionalization of different five-membered heterocycles via palladium-
catalyzed C–H activation reactions has been intensively investigated by several groups.[101,174] 
The high value of these conversions is based on the fact, that reaction selectivity can be better 
controlled owing to the polarization of the molecule induced by the heteroatom. Despite the big 
number of publications describing direct arylations of heterocycles, the majority of studies are 
related to monoarylations,[175] whereas multiple C–H activation is investigated much less.[176] 
One of the important aspects of this field is the development of environmentally friendly 
processes with regard to reaction media.[173] Furthermore, there is also a great interest in 
protocols providing ‘’ligand-free’’ conditions for C–H activation reactions.  
In 2009, the group of Doucet reported monoarylation of different pyrroles through palladium-
catalyzed C–H activation.[177] Later, the same research group published a paper describing the 
double arylation of N-substituted pyrroles using PdCl(C3H5)(dppb) as the catalyst, KOAc as the 
base and DMAc as the solvent.[178] Independently, in our research group, a convenient method 
allowing the synthesis of diaryl pyrroles from another perspective has been investigated at the 
same time.[171] In particular, the emphasis was made to avoid the use of phosphine ligand and 
toxic solvents like DMA. 
The reaction of N-methylpyrrole with bromobenzene was chosen as a model reaction for ligand-
free arylations (Scheme 26). The first optimization tests with typical conditions using Pd(OAc)2 
and KOAc showed that the ratio of 29 and 30 is strongly affected by the solvent with 
monoarylated pyrrole being a major product. When tetrabutylammonium acetate (TBA-Ac) 
was used as the solvent the ratio changed dramatically towards the diarylation product with 
proportion 1:37 providing title compound in 75% yield (Table 21, Entry 5). The successful 
results of the application of TBA-Ac can be correlated with the reports stating that phase 
transfer catalysts can positively influence on the C–H activation reactions[179] and that the 
acetate ions can be actively involved in the catalytic cycle.[180] The importance of TBA-Ac was 
even more emphasized after poor results with other ionic liquids. Finally, while studying the 
influence of catalyst and base it was found that the combination of Pd(OPiv)2 and CsOPiv 
allows the exclusive formation of the desired diarylated pyrrole derivative.  
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  Scheme 26. Optimization of the synthesis of 30; R=Me. 
 
Table 21. Optimization of 303 
Entry PdX2 Base Solvent Additive 
Ratio 
29/30a 
Yield of 
30 [%]b 
1 Pd(OAc)2  KOAc NMP - 2/1 21 
2 Pd(OAc)2  KOAc DMA - 3/1 7 
3 Pd(OAc)2  KOAc PEG-400 - 1/2 41 
4 Pd(OAc)2  KOAc PEG-400 TBA-Ac 1/1 34 
5 Pd(OAc)2  KOAc TBA-Ac - 1/37 75 
6 Pd(OAc)2  KOAc TBA-Br - 1/1 28 
7 Pd(OAc)2 KOAc [C2MIM][BF4] - 0 0 
8 Pd(OPiv)2  CsOPiv TBA-Ac - 0/1 79 
9 Pd(OPiv)2  CsOPiv TBA-OPiv - 0/1 63 
10 Pd(OPiv)2  - TBA-Ac - 0/1 43 
11 - KOAc TBA-Ac - - 0 
12 Pd(OPiv)2  CsOPiv [C2MIM][OAc] - - 0 
a Determined by 1H NMR-spectroscopy of the crude product; b yield of isolated products; 
conditions: Pd(X)2 (1 mol%), base (3.0 equiv.), Ph-Br (3.0 equiv.), solvent, additive, 140 °C, 
20 h. 
 
 
Having the optimal reaction conditions in hands, the two-fold arylation of N-phenylpyrrole with 
aryl halides was investigated to explore the scope and limitations of the developed method. In 
fact, reaction with N-phenylpyrrole worked smoothly to give corresponding diarylated pyrroles 
                                                          
3 Optimization reactions were performed by Dr. Peter Ehlers from the University of Rostock. 
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in moderate yields (Table 22). In comparison, the reaction with N-methyl pyrrole worked 
better[181] whereas N-Boc protected pyrrole did not provide reasonable yields.  
 
Scheme 27. Synthesis of 32a-j; i: Pd(OPiv)2 (1 mol%), CsOPiv, TBA-Ac, 140 ºC, 20h. 
 
Table 22. Synthesis of 32a-j. 
Product Aryl halide Yield [%]a 
32a Br
 
52 
32b BrF3C
 
40 
32c BrMe
 
37 
32d BrO2N
 
33 
32e BrMeO
 
15 
32f BrNC
 
63 
32g 
Br
F3C  
31 
32h ClF3C
 
22 
32i ClO2N
 
35 
32j ClMeO
 
5b 
a Yields of isolated products. b XPhos (2 mol%) is required. 
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According to the proposal, anionic palladate complexes are formed as a result of the reaction 
between ammonium salt and palladium(II) precursor. Meanwhile, at high temperatures, 
tetrabutylammonium acetate partly undergoes Hofmann elimination to from tributylamine. 
Subsequently, formed tributylamine molecules reduce positively charged palladium atoms into 
catalytically active palladium(0) species.[185] The application of ammonium acetate is 
substantial in terms of the multifunctional role that it plays. In such a manner, ammonium salt 
stabilizes catalytically active palladium(0) species, thus preventing its agglomeration to 
‘’palladium black’’. Moreover, it functions as a ligand for palladium which runs a catalytic 
cycle. Also, ammonium salt increases the solubility of the organometallic complexes which are 
formed during the reaction.  
In conclusion, a variety of aryl bromides and electron-poor aryl chlorides were used to 
synthesize different 2,5-diaryl-N-phenylpyrroles by twofold direct arylation of the 
corresponding pyrrole. The products were isolated in moderate yields and in contrast to the 
procedure suggested by Doucet et al., these reactions proceed under ‘‘ligand-free’’ conditions, 
which reduces the cost of the reactions. Moreover, the reactions were carried out in molten 
ammonium acetate and no toxic solvents were used. In fact, this approach is very advantageous 
in terms of both cost-effectiveness and environmental sustainability.  
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8. Summary and Outlook 
The presented work describes the functionalization of various polychlorinated pyridines and 
pyrazine by Sonogashira and Suzuki cross-coupling reactions. The use of sterically demanding 
and highly basic monodentate phosphine ligands led to high yields of the corresponding 
products. With this synthetic approach, various tetraalkynylated pyridines and pyrazines were 
prepared. In addition, a number of different pentaarylpyridines, tetraarylpyrazines, 
diarylnaphthyridines as well as tetraalkenylpyrazines have been synthesized.  
A number of polyalkynylated and polyalkenylated compounds were examined with regard to 
their optical properties by UV/ Vis and fluorescence spectroscopy and compared. When 
comparing the results it has been observed that the introduction of a nitrogen atom into the 
aromatic core remarkably improves the fluorescence quantum yield. So, given the push-pull 
character of the tetraalkynylated pyrazines, their quantum yields are almost twice higher than 
those of corresponding pyridine and benzene analogs. Electron donating substituents on the 
peripheral alkynyl residues resulted in an increase of the quantum yields. Compound 13d was 
found to have the highest quantum efficiency of 85%. Electrochemical studies of 
tetraalkynylpyrazines were also performed showing similar structure-activity correlation. 
Synthesized tetraalkynyl heterocycles have great potential for optical and electronic 
applications. 
Furthermore, the site-selective Suzuki and Sonogashira reactions of polychlorinated pyridines 
were investigated. In this context, pyridines bearing different functional groups have been 
isolated. This study is particularly interesting as the properties of molecules can be fine-tuned 
by varying the substitution pattern.  
Next, the synthesis of 2,7-diaryl-1,8-naphthyridines by Suzuki-Miyaura reaction of the 
corresponding dichloronaphthyridine was developed. The products have been obtained in good 
to excellent yields and may potentially be biologically active. 
Additionally, two-fold "ligand-free" C–H arylations of N-phenylpyrrole were performed. The 
reaction was carried out in molten tetrabutylammonium acetate as a solvent. The procedure is 
of interest in terms of environmental sustainability since an ionic liquid was used instead of 
toxic solvents. A possible mechanism of the reaction was proposed. The obtained products can 
be of particular interest from the perspective of pharmaceutical chemistry. 
The gained results are expected to encourage further research interest towards the 
methodologies to access multiply functionalized heterocycles.  
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Appendix 
Experimental Section 
General Remarks 
 
All reactions involving moisture- or air-sensitive reagents were carried out in oven-dried 
pressure tubes under argon atmosphere. Anhydrous solvents were purchased from commercial 
sources or dried by the usual methods. Solvents for column chromatography and extraction 
were always distilled before use. All chemicals, unless otherwise indicated, were obtained from 
commercial sources and were used without further purification steps. The synthesis of the 
starting materials, if not purchased, was carried out by literature methods. 
Thin layer chromatography (TLC): Merck Silica 60 F254 on aluminum tin foil from 
Macherey-Nagel. Detection with UV light at 254 nm and/or 366 nm without dipping reagent  
Column chromatography: Separation on Fluka silica gel 60 (0.063-0.200 mm, 70-320 mesh). 
Eluents were distilled before use. 
1H NMR-Spectroscopy: Bruker AV 300 (300 MHz), Bruker AV 400 (400 MHz), and Fourier 
300 (300 MHz). Unless otherwise mentioned, all NMR spectra were collected in CDCl3 
solution. Chemical shifts are given as δ-values in ppm relative to the residual signal peak of the 
deuterated solvent. Coupling constants are indicated as J with residual peaks of CHCl3 at 
δ = 7.24 ppm and DMSO at δ = 2.49 ppm. Peak characterization: s = singlet, bs = broad singlet, 
d = doublet, dd = doublet of doublet, t = triplet, q = quartet, sept = septet, m = multiplet. In 
several cases, 2D NMR techniques (NOESY, COSY) were performed confirming the structures 
of the synthesized molecules. The spectra were measured with a standard number of scans.  
13C NMR-Spectroscopy: Bruker AV 300 (75 MHz), Bruker AV 400 (100 MHz), and Fourier 
300 (75 MHz). Unless otherwise mentioned, all NMR spectra were collected in CDCl3 solution. 
All chemical shifts are given in ppm. Coupling constants are indicated as J with residual peaks 
of CHCl3 at δ = 77.0 ppm and DMSO at δ = 39.52 ppm. Peak characterization: d = doublet, q = 
quartet. DEPT method was used for determining the presence of primary, secondary, tertiary 
and quaternary carbon atoms. All spectra were measured with a standard number of scans.  
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19F NMR-Spectroscopy: Bruker AV 300 (282 MHz). Spectra were measured with a standard 
number of scans.  
Mass Spectrometry (MS): Finnigan MAT 95 XP (electron ionization EI, 70 eV) or LCQ 
(electrospray ionization, 70 eV). The ratio of mass to charge is indicated with intensities relative 
to the base peak (I = 100). 
Gas Chromatography MS (GCMS): Agilent HP-5890 with an Agilent HP-5973 mass 
selective detector (EI) and HP-5 capillary column with helium carrier gas.  
High resolution MS: Agilent 1969A TOF (ESI) or Finnigan MAT 95 XP (EI). Only the 
measurements with an average deviation from the theoretical mass of ± 2 mDa were accounted 
as correct.  
Infrared spectroscopy (IR): Nicolet 550 FT-IR spectrometer with ATR sampling technique. 
Liquid probes were measured as film, solid probes were measured neat. Absorption is given in 
wavenumbers (cm-1). Signal characterization: w = weak, m = medium, s = strong.  
UV/Vis spectroscopy: Lambda 5 (Perkin Elmer) or Specord 50 (Analytik Jena) or Perkin-Elmer 
Compounds were measured in dichloromethane and a concentration of 5 × 10−6 M was applied 
for the quantitative determination of molar extinction coefficients. 
Fluorescence spectroscopy: Fluoromax-4 Spectrofluorometer (Horiba Scientific). Compounds 
were measured in dichloromethane in a concentration of 5 × 10−6 M. A solution of quinine sulfate 
in 0.05 M sulphuric acid was applied as a standard for the measurement of the fluorescence quantum 
yields (ϕf = 0.52).[186] Air-equilibrated solutions of the sample and standard with an absorbance of 
∼0.1 at the excitation wavelength were used in the fluorescence measurements. 
Electrochemistry: Autolab (PGSTAT 302N, Metrohm). All electrochemical studies were 
performed at room temperature in anhydrous acetonitrile under an argon atmosphere with 0.1 M 
tetrabutylammonium hexafluorophosphate as conducting salt. A glassy carbon disk electrode (d = 2 
mm) was used as working electrode, a Pt-electrode as the counter electrode and an 
Ag/AgCl/LiClsat. in EtOH-system as the reference electrode (all electrodes: Metrohm). All potentials 
mentioned in this work were measured with respect to this reference system and were checked by 
using the ferrocenium/ferrocene-internal reference system (potential of Fc+/Fc: 0.51 V [vs. 
Ag/AgCl/LiClsat. in EtOH]. The CV scans were done three times at a scan rate of 40 mV s−1. The 
measurements were performed with 2 mM compound dissolved in the electrolyte. 
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X-Ray crystallography: STOE IPDS II diffractometer as well as Bruker Kappa APEX II Duo 
using graphite-monochromated MoKα radiation. The structures were solved by direct methods 
and refined by full-matrix least-squares procedures on F2 with the SHELXTL software 
package.[187]  
Differential Scanning Calorimetry (DSC): Mettler Toledo DSC 823e/2007. Phase transitions 
were determined in heating and cooling runs, respectively.  
Polarization Microscopy (POM): LaborLux 12 Pol-5, Leica.  
Elemental analysis: C/H/N/S – Microanalysator TruSpec CHNS (Leco). Abbreviated as EA.  
Melting point determination (mp): Micro-Hot-Stage GalenTM III Cambridge Instruments. 
The melting points are not corrected.  
 
General Procedures and Product Characterization 
 
Synthesis of 3,5-dichloro-2,6-dialkinylpyridines  
0.025 mmol (5 mol%) Pd(PPh3)4, 0.025 mmol (5 mol%) CuI and 0,5 mmol of the 2,3,5,6-
tetrachloropyridine 4a or 4b were added to an argon-flushed glass pressure tube. The solids 
were diluted with 5 ml of dry 1,4-dioxane and 2 ml of diisopropylamine. The solution was 
stirred at ambient temperature for ten minutes. Afterward, the appropriate alkyne was added. 
The pressure tube was closed with a teflon cap and the reaction mixture was stirred at 90 °C. 
After 20h the reaction was cooled down to room temperature and diluted with distilled water 
and dichloromethane. The water phase was extracted with dichloromethane (three times). The 
combined organic layers were dried with sodium sulfate, filtered and the solvent was evaporated 
under reduced pressure. Column chromatography (eluents: hexane/dichloromethane) was used 
to purify the desired dialkynylpyridines. 
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Dichloro-2,6-bis(phenylethynyl)-4-(4-methoxyphenyl)pyridine (5a) 
 
According to the general procedure, compound 5a was isolated as a dark yellow solid  
(107 mg, 59%); mp. = 160 – 162 °C.  
1H NMR (300 MHz, CDCl3): δ = 3.87 (s, 3H, OCH3), 7.00 - 7.05 (m, 2H, CH), 7.19 - 7.24 (m, 
2H, CH), 7.32 - 7.39 (m, 6H, CH), 7.60 - 7.64 (s, 4H, CH). 
13C NMR (75 MHz, CDCl3): δ = 55.2 (OCH3), 85.6, 95.2 (C≡C), 114.0 (CH), 121.7, 126.8 (C), 
128.4, 129.5, 130.0, 132.2 (CH), 133.2, 140.7, 147.7, 160.0 (C). 
MS (EI, 70 eV): m/z (%) = 453 (M+, 100), 374 (5), 340 (9), 226 (10), 170 (5), 128 (5). 
HRMS (EI, 70 eV): calcd. for C28H17Cl2NO: 453.06817; found: 453.068246.  
IR (ATR, cm-1): ~  = 2930 (w), 2836 (w), 2214 (m), 1608 (m), 1504 (s), 1441 (m), 1369 (s), 
1291 (m), 1248 (s), 1211 (m), 1175 (s), 1028 (m), 752 (s), 684 (s), 528 (s). 
 
3,5-Dichloro-2,6-bis((4-fluorophenyl)ethynyl)-4-(4-methoxyphenyl)pyridine (5b) 
 
According to the general procedure, compound 5b was isolated as a yellow solid  
(70 mg, 36%); mp. = 121 – 123 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.81 (s, 3H, OCH3), 6.94 - 7.03 (m, 6H, CH), 7.12 - 7.16 (m, 
2H, CH), 7.51 - 7.57 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.3 (OCH3), 85.4, 94.2 (C≡C), 114.0 (CH), 115.8 (d,  
2JC–F = 22.5 Hz, CH), 117.8 (d, 4JC–F = 3.2 Hz, C), 126.7 (C), 130.0 (CH), 133.2 (C), 134.3 (d, 
3JC–F = 8.3 Hz, CH), 140.6, 160.0 (C), 163.2 (d, 1JC-F = 251.9 Hz, CF). 
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19F NMR (282 MHz, CDCl3): δ = -108.0 (s, 2F, CF). MS (EI, 70 eV): m/z (%) = 489 (M+, 
100), 376 (11), 246 (8), 231 (8), 174 (7), 137 (5).  
HRMS (EI, 70 eV): calcd. for C28H15Cl2F2NO: 489.04933; found: 489.049254.  
IR (ATR, cm-1): ~  = 3048 (w), 2933 (w), 2840 (w), 2216 (m), 1599 (m), 1508 (s), 1371 (m), 
1292 (m), 1227 (s), 1153 (s), 1025 (m), 830 (s), 768 (s), 528 (s), 399 (m).  
EA: calcd. for C28H15Cl2F2NO (490,33): C, 68.59; H, 3.08; N, 2.86; found: C, 68.76; H, 3.16; 
N, 2.81. 
 
3,5-Dichloro-2,6-bis(phenylethynyl)-4-(4-(trifluoromethyl)phenyl)pyridine (5c) 
 
According to the general procedure, compound 5c was isolated as a yellow solid  
(86 mg, 62%); mp. = 208 – 210 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.34 - 7.42 (m, 8H, CH), 7.60 - 7.64 (m, 4H, CH), 7.78 (d, 
2H, 3J = 8.2 Hz, CH).  
13C NMR (75 MHz, CDCl3): δ = 85.3, 95.9 (C≡C), 121.5 (C), 123.8 (q,  
1JC–F = 272.3 Hz, CF3), 125.7 (q, 3JC–F = 3.6 Hz, CH), 128.4, 129.1, 129.6 (CH), 131.2 (q,  
2JC–F = 32.8 Hz, C), 132.2 (CH), 132.3, 138.1, 140.9, 146.6 (C). 
19F NMR (282 MHz, CDCl3):δ =-62.3 (s, 3F, CF3).  
MS (EI, 70 eV): m/z (%) = 491 (M+, 100), 351 (7), 294 (20), 245 (7), 127 (6). 
HRMS (EI, 70 eV): calcd. for C28H14Cl2F3N: 491.04499; found: 491.04493. 
IR (ATR, cm-1): ~  = 3055 (w), 2925 (w), 2211 (m), 1372 (m), 1321 (s), 1167 (m), 1120 (s), 
1062 (s), 1018 (m), 846 (m), 754 (s), 685 (s), 527 (m). 
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3,5-Dichloro-2,6-bis((4-fluorophenyl)ethynyl)-4-(4-(trifluoromethyl)phenyl)pyridine (5d) 
 
According to the general procedure, compound 5d was isolated as a yellow solid  
(95 mg, 64%); mp. = 179 – 181 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.01 - 7.09 (m, 4H, CH), 7.39 - 7.41 (m, 2H, CH), 7.56 - 7.63 
(m, 4H, CH), 7.76 - 7.79 (m, 2H, CH). 
13C NMR (75 MHz, CDCl3): δ = 85.0 (d, 5J = 1.3 Hz, C≡C), 94.8 (C≡C), 115.9 (d,  
2JC–F = 21.8 Hz, CH), 117.5 (d, 4JC–F = 3.8 Hz, C), 123.7 (q, 1JC–F = 272.5 Hz, CF3), 125.8 (q, 
3JC–F = 3.8 Hz, CH), 129.1 (CH), 131.2 (q, 2JC–F = 32.8 Hz, C), 132.3 (C), 134.3 (d,  
3JC-F = 8.3 Hz, CH), 138.0, 140.8, 146.6 (C), 163.3 (d, 1JC–F = 252.3 Hz, CF). 
19F NMR (282 MHz, CDCl3): δ = -62.3 (s, 3F, CF3), -107.6 (s, 2F, CF).  
MS (EI, 70 eV): m/z (%) = 527 (M+, 100), 387 (7), 312 (22), 264 (8), 145 (13).  
HRMS (EI, 70 eV): calcd. for C28H13Cl2F5N ([M+H]+): 528.034; found: 528.034.  
IR (ATR, cm-1): ~  = 2216 (m), 1600 (m), 1508 (s), 1372 (m), 1321 (s), 1231 (s), 1155 (s), 1063 
(s), 1018 (m), 833 (s), 770 (s), 529 (s), 445 (s).  
 
3,5-Dichloro-2,6-bis((4-propylphenyl)ethynyl)-4-(4-(trifluoromethyl)phenyl)pyridine 
(5e) 
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According to the general procedure, compound 5e was isolated as a brown oil  
(112 mg, 69%). 
1H NMR (300 MHz, CDCl3): δ = 0.92 (t, 6H, 3J = 7.3 Hz, CH3), 1.56 - 1.69 (m, 4H, CH2), 2.58 
(t, 4H, 3J = 7.6 Hz, CH2), 7.15 - 7.19 (m, 4H, CH), 7.39 - 7.41 (m, 2H, CH), 7.51 - 7.55 (m, 4H, 
CH), 7.76 - 7.78 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 13.7 (CH3), 24.2, 38.0 (CH2), 85.0, 96.3 (C≡C), 118.6 (C), 
123.8 (q, 1JC–F = 272.3 Hz, CF3), 125.7 (q, 3JC–F = 3.8 Hz, CH), 128.6, 129.1 (CH), 131.1 (q, 
2JC–F = 32.6 Hz, C), 131.9 (C), 132.2 (CH), 138.2, 141.0, 144.8, 146.4(C).  
19F NMR (282 MHz, CDCl3): δ = -62.2 (s, 3F, CF3). MS (EI, 70 eV): m/z (%) = 575 (M+, 100), 
546 (57), 518 (12), 258 (48), 207 (16), 73 (13), 60 (14), 44 (37), 36 (17). 
HRMS (ESI): calcd. for C34H27Cl2F3N ([M+H]+): 578.14469; found: 578.14466. 
IR (ATR, cm-1): ~  = 2959 (w), 2930 (w), 2871 (w), 2212 (m), 1513 (m), 1371 (m), 1321 (s), 
1165 (m), 1062 (s), 1019 (m), 842 (m), 813 (m), 731 (m). 
 
Synthesis of 2,3,5,6-tetraalkynylpyridines from 3,5-dichloro-2,6-dialkynylpyridines 
0.006 mmol (2 mol%) PdCl2(CH3CN)2, 0.012 mmol (4 mol%) XPhos, 0.006 mmol (2 mol%) 
CuI and 0,3 mmol of the corresponding 3,5-dichloro-2,6-dialkynylpyridine 5 were added to an 
argon-flushed glass pressure tube. The solids were diluted with 4.0 ml of dry 1,4-dioxane and 
2 ml of diisopropylamine. The solution was stirred at ambient temperature for ten minutes. 
Afterward, the appropriate amount of acetylene was added. The pressure tube was closed with 
a teflon cap and the reaction mixture was stirred at 90 °C. After 18h the reaction was cooled 
down to room temperature and diluted with distilled water and dichloromethane. The water 
phase was extracted with dichloromethane (three times). The combined organic layers were 
dried with sodium sulfate, filtered and the solvent was evaporated under reduced pressure. 
Column chromatography (eluents: hexane/dichloromethane) was used to purify the 
corresponding tetraalkynylpyridines. 
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4-(4-Methoxyphenyl)-2,6-bis(phenylethynyl)-3,5-bis((4-fluorophenyl)ethynyl)pyridine 
(6a) 
 
According to the general procedure, compound 6a was isolated as a yellow solid  
(77 mg, 62%); mp. = 207 – 209 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.81 (s, 3H, OCH3), 6.83 - 6.91 (m, 4H, CH), 6.94 - 6.99 (m, 
2H, CH), 7.16 - 7.30 (m, 10H, CH), 7.51 - 7.54 (m, 4H, CH), 7.56 - 7.61 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.3 (OCH3), 85.7 (d, 5J = 1.3 Hz, C≡C), 88.2, 94.6, 99.0 
(C≡C), 112.9 (CH), 115.7 (d, 2JC–F = 21.8 Hz, CH), 118.7 (d, 4JC–F = 3.2 Hz, C), 120.7, 122.1, 
128.3 (C), 128.4, 129.3, 131.3, 132.1 (CH), 133.4 (d, 3JC–F = 8.4 Hz, CH), 143.8, 152.2, 160.1 
(C), 162.7 (d, 1JC-F = 251.0 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -108.9 (s, 2F, CF).  
MS (EI, 70 eV): m/z (%) = 621 (M+, 100), 590 (14), 577 (19), 503 (62), 459 (13), 207 (7).  
HRMS (ESI): calcd. for C44H26F2NO ([M+H]+): 622.1977; found: 622.1975. 
IR (ATR, cm-1): ~  = 3051 (w), 2206 (m), 1597 (s), 1494 (s), 1387 (m), 1296 (m), 1222 (s), 
1022 (s), 835 (s), 754 (s), 689 (s), 527 (s).  
 
 
4-(4-(Trifluoromethyl)phenyl)-2,6-bis(phenylethynyl)-3,5-bis((4-propylphenyl)ethynyl)–
pyridine (6b) 
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According to the general procedure, compound 6b was isolated as a yellow solid  
(135 mg, 68%); mp. = 198 – 200 °C. 
1H NMR (300 MHz, CDCl3): δ = 0.90 (t, 6H, 3J = 7.3 Hz, CH3), 1.54 - 1.66 (m, 4H, CH2), 2.55 
(t, 4H, 3J = 7.6 Hz, CH2), 7.06 - 7.14 (m, 8H, CH), 7.31 - 7.39 (m, 6H, CH), 7.62 - 7.65 (m, 4H, 
CH), 7.76 - 7.82 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 13.7 (CH3), 24.2, 37.9 (CH2), 84.7, 88.0, 94.9, 101.4 (C≡C), 
119.4, 120.8, 122.1 (C), 124.1 (q, 1JC–F = 272.3 Hz, CF3), 124.7 (q, 3JC–F = 3.8 Hz, CH), 128.4, 
128.6, 129.3, 130.2 (CH), 130.7 (q, 2JC–F = 32.6 Hz, C), 131.3, 132.2 (CH), 140.3, 143.5, 144.3, 
151.0 (C).  
19F NMR (282 MHz, CDCl3): δ = -62.1 (s, 3F, CF3).  
MS (EI, 70 eV): m/z (%) = 707 (M+, 100), 664 (7), 634 (4).  
HRMS (EI, 70 eV): calcd. for C50H36F3N: 707.27944; found: 707.27842.  
IR (ATR, cm-1): ~  = 2928 (w), 2864 (w), 2201 (m), 1499 (m), 1387 (m), 1320 (s), 1166 (s), 
1110 (s), 1064 (s), 846 (m), 751 (s), 684 (s), 528 (m).  
 
 
4-(4-(Trifluoromethyl)phenyl)-2,6-bis(phenylethynyl)-3,5-bis((4-fluorophenyl)ethynyl)–
pyridine (6c) 
 
According to the general procedure, compound 6c was isolated as a yellow solid  
(101 mg, 61%); mp. = 199 – 201 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.91 - 6.99 (m, 4H, CH), 7.13 - 7.20 (m, 4H, CH), 7.31 - 7.40 
(m, 6H, CH), 7.58 - 7.61 (m, 4H, CH), 7.75 - 7.82 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 84.8 (d, 5J = 1.2 Hz, C≡C), 87.8, 95.2, 99.9 (C≡C), 115.8 (d, 
2JC–F = 21.8 Hz, CH), 118.3 (d, 4JC–F = 3.8 Hz, C), 120.5, 121.9 (C), 124.0 (q, 1JC–F = 272.1 Hz, 
CF3), 124.8 (q, 3JC–F = 3.6 Hz, CH), 128.5, 129.5, 130.1 (CH), 130.9 (q, 2JC–F = 32.6 Hz, C), 
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132.1 (CH), 133.4 (d, 3JC-F = 8.3 Hz, CH), 140.2, 143.8, 151.2 (C), 163.0 (d, 1JC–F = 252.3 Hz, 
CF).  
19F NMR (282 MHz, CDCl3): δ = -62.1 (s, 3F, CF3), -108.4 (s, 2F, CF).  
MS (EI, 70 eV): m/z (%) = 659 (M+, 100), 590 (6).  
HRMS (EI, 70 eV): calcd. for C44H22F5N: 659.16669; found: 659.16518.  
IR (ATR, cm-1): ~  = 3048 (w), 2204 (m), 1598 (m), 1502 (s), 1330 (s), 1228 (m), 1104 (s), 
1068 (s), 831 (s), 748 (s), 684 (m), 527 (s), 387 (m).  
 
4-(4-(Trifluoromethyl)phenyl)-2,6-bis((4-fluorophenyl)ethynyl)-3,5-bis(p-
tolylethynyl)pyridine (6d) 
 
According to the general procedure, compound 6d was isolated as a yellow solid  
(155 mg, 90%); mp. = 239 – 241 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.32 (s, 6H, CH3), 6.97 - 7.06 (m, 12H, CH), 7.52 - 7.59 (m, 
4H, CH), 7.75 - 7.81 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.5 (CH3), 84.6, 87.8 (d, 5J = 1.3 Hz, C≡C), 93.7, 101.3 
(C≡C), 115.8 (d, 2JC–F = 22.5 Hz, CH), 118.2 (d, 4JC–F = 3.8 Hz, C), 119.1, 120.8 (C), 124.0 (q, 
1JC–F = 272.1 Hz, CF3), 124.6 (q, 3JC–F = 3.8 Hz, CH), 129.2, 130.2 (CH), 130.7 (q,  
2JC–F = 32.4 Hz, C), 131.2 (CH), 134.1 (d, 3JC-F = 8.3 Hz, CH), 139.6, 140.1, 143.4, 150.9 (C), 
163.1 (d, 1JC–F = 251.7 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -62.1 (s, 3F, CF3), -108.3 (s, 2F, CF).  
MS (EI, 70 eV): m/z (%) = 687 (M+, 100), 672 (12), 624 (27), 609 (13), 593 (21), 573 (25), 262 
(15), 188 (19), 145 (17), 117 (12), 60 (16).  
HRMS (EI, 70 eV): calcd. for C46H26F5N: 687.19799; found: 687.19785. 
IR (ATR, cm-1): ~  = 3045 (w), 2202 (m), 1598 (m), 1507 (s), 1390 (m), 1321 (s), 1227 (s), 
1154 (s), 1122 (s), 1064 (s), 1017 (m), 832 (s), 812 (s), 526 (s).  
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Synthesis of 2,3,5,6-tetraalkynylpyridines from 2,3,5,6-tetrachloropyridines 
0.01 mmol (4 mol%) PdCl2(CH3CN)2, 0.02 mmol (8 mol%) XPhos, 0.0075 mmol (3 mol%) 
CuI and 0,25 mmol of the corresponding 2,3,5,6-tetrachloropyridine 4a or 4b were added to an 
argon-flushed glass pressure tube. The solids were diluted with 3.5 ml of dry 1,4-dioxane and 
2 ml of diisopropylamine. The solution was stirred at ambient temperature for ten minutes. 
Afterward, the appropriate amount of acetylene was added. The pressure tube was closed with 
a teflon cap and the reaction mixture was stirred at 90 °C. After 20h the reaction was cooled 
down to room temperature and diluted with distilled water and dichloromethane. The water 
phase was extracted with dichloromethane (three times). The combined organic layers were 
dried with sodium sulfate, filtered and the solvent was evaporated under reduced pressure. 
Column chromatography (eluents: hexane/dichloromethane) was used to purify the 
corresponding tetraalkynylpyridines. 
 
 
4-(4-Methoxyphenyl)-2,3,5,6-tetrakis(phenylethynyl)pyridine (7a) 
 
According to the general procedure, compound 7a was isolated as a dark yellow solid  
(140 mg, 80%); mp. = 210 – 212 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.90 (s, 3H, OCH3), 7.03 - 7.08 (m, 2H, CH), 7.25 - 7.38 (m, 
16H, CH), 7.62 - 7.70 (m, 6H, CH). 
13C NMR (125 MHz, CDCl3): δ = 55.3 (OCH3), 86.0, 88.3, 94.5, 100.1 (C≡C), 113.0 (CH), 
120.9, 122.2, 122.7 (C), 128.3, 128.4 (CH), 128.5 (C), 128.8, 129.2, 131.3, 131.4, 132.1 (CH), 
144.0, 152.3, 160.1 (C).  
MS (EI, 70 eV): m/z (%) = 585 (M+, 100), 554 (21), 541 (25), 485 (16), 465 (10), 105 (8).  
HRMS (EI, 70 eV): calcd. for C44H27NO: 585.20872; found: 585.208882.  
IR (ATR, cm-1): ~  = 3059 (w), 3035 (w), 3017 (w), 2206 (m), 1605 (m), 1491 (s), 1388 (m), 
1293 (m), 1293 (m), 1254 (s), 1173 (m), 1024 (m), 910 (m), 831 (m), 748 (s), 684 (s), 526 (s).  
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EA: calcd. for C44H27NO (585.69): C, 90.23; H, 4.65; N, 2.39; found: C, 90.03; H, 4.46; 
N, 2.57. 
 
 
4-(4-Methoxyphenyl)-2,3,5,6-tetrakis((4-methoxyphenyl)ethynyl)pyridine (7b) 
 
According to the general procedure, compound 7b was isolated as an orange solid  
(123 mg, 58%); mp. = 191 – 193 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.83 (s, 6H, OCH3), 3.86 (s, 6H, OCH3), 3.94 (s, 3H, OCH3), 
6.81 - 6.86 (m, 4H, CH), 6.89 - 6.93 (m, 4H, CH), 7.05 - 7.10 (m, 2H, CH), 7.27 - 7.32 (m, 4H, 
CH), 7.59 - 7.63 (m, 4H, CH), 7.68 - 7.73 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.3 (3 x OCH3), 85.1, 87.6, 94.6, 99.9 (C≡C), 112.9, 114.0, 
114.1 (CH), 114.4, 115.0, 120.5, 128.8 (C), 131.3, 132.9, 133.7 (CH), 143.6, 151.6, 159.9, 
160.0, 160.3 (C).  
MS (EI, 70 eV): m/z (%) = 705 (M+, 29), 147 (10), 131 (4), 114 (4), 85 (4), 73 (9), 69 (15), 60 
(10), 55 (8), 44 (100).  
HRMS (ESI): calcd. for C48H36NO5 ([M+H]+): 706.2588; found: 706.25855.  
IR (ATR, cm-1): ~  = 2931 (w), 2833 (w), 2196 (m), 1600 (s), 1508 (s), 1387 (m), 1244 (s), 
1167 (s), 1022 (s), 825 (s), 531 (s). 
EA: calcd. for C48H35NO5 (705,80): C, 81.68; H, 5.00; N, 1.98; found: C, 81.64; H, 5.04; 
N, 1.94. 
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4-(4-Methoxyphenyl)-2,3,5,6-tetrakis((4-fluorophenyl)ethynyl)pyridine (7c) 
 
According to the general procedure, compound 7c was isolated as a yellow solid  
(144 mg, 73%); mp. = 238 – 240 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.90 (s, 3H, OCH3), 6.93 - 7.08 (m, 10H, CH), 7.23 - 7.30 (m, 
4H, CH), 7.55 - 7.66 (m, 6H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.4 (OCH3), 85.6 (d, 5J = 1.2 Hz, C≡C), 87.9 (d, 5J = 1.2 Hz, 
C≡C), 93.5, 99.0 (C≡C), 113.0 (CH), 115.8 (d, 2JC–F = 22.5 Hz, CH), 115.9 (d, 2JC–F = 22.5 Hz, 
CH), 118.2 (d, 4JC–F = 3.2 Hz, C), 118.7 (d, 4JC–F = 3.0 Hz, C), 120.7, 128.3 (C), 131.2 (CH), 
133.3 (d, 3JC–F = 8.3 Hz, CH), 134.1 (d, 3JC–F = 8.3 Hz, CH), 143.8, 152.3, 160.2 (C), 162.8 (d, 
1JC–F = 251.7 Hz, CF), 163.1 (d, 1JC–F = 251.7 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -108.2 (s, 2F, CF), -108.7 (s, 2F, CF).  
MS (EI, 70 eV): m/z (%) = 657 (M+, 100), 626 (13), 613 (16), 585 (40), 541 (6).  
HRMS (EI, 70 eV): calcd. for C44H23F4NO: 657.17103; found: 657.171825.  
IR (ATR, cm-1): ~  = 3050 (w), 2930 (w), 2838 (w), 2212 (m), 1600 (m), 1505 (s), 1371 (w), 
1295 (w), 1235 (s), 1177 (m), 1153 (m), 1021 (m), 830 (s), 595 (m), 527 (s), 391 (m).  
EA: calcd. for C44H23F4NO (657.65): C, 80.36; H, 3.53; N, 2.13; found: C, 80.26; H, 3.36; 
N, 2.32. 
 
4-(4-Methoxyphenyl)-2,3,5,6-tetrakis((4-tert-butylphenyl)ethynyl)pyridine (7d) 
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According to the general procedure, compound 7d was isolated as a dark yellow solid  
(172 mg, 71%); mp. = 264 – 266 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.29 (s, 18H, CH3), 1.32 (s, 18H, CH3), 3.91 (s, 3H, OCH3), 
7.01 - 7.03 (m, 2H, CH), 7.25 - 7.33 (m, 8H, CH), 7.35 - 7.39 (m, 4H, CH), 7.56 - 7.61 (m, 4H, 
CH), 7.64 - 7.68 (m, 2H, CH). 
13C NMR (125 MHz, CDCl3): δ = 31.1 (2 x CH3), 34.8, 34.9 (C), 55.3 (OCH3), 85.6, 88.0, 94.7, 
100.2 (C≡C), 113.0 (CH), 119.4, 119.9, 120.8 (C), 125.3, 125.4 (CH), 128.8 (C), 131.2, 131.3, 
132.0 (CH), 143.8, 152.1, 152.2, 152.6, 160.0 (C). 
MS (EI, 70 eV): m/z (%) = 809 (M+, 100), 752 (11), 696 (5), 57 (4).  
HRMS (EI, 70 eV): calcd. for C60H59NO: 809.45912; found: 809.459528.  
IR (ATR, cm-1): ~  = 3036 (w), 2956 (m), 2902 (m), 2865 (m), 2206 (m), 1607 (m), 1502 (m), 
1391 (m), 1247 (s), 1176 (m), 1104 (m), 829 (s), 558 (s).  
EA: calcd. for C60H59NO (810.12): C, 88.96; H, 7.34; N, 1.73; found: C, 88.78; H, 7.25; 
N, 1.66.  
 
 
4-(4-Methoxyphenyl)-2,3,5,6-tetrakis(p-tolylethynyl)pyridine (7e) 
 
According to the general procedure, compound 7e was isolated as an orange solid  
(121 mg, 63%); mp. = 208 – 210 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 6H, CH3), 2.37 (s, 6H, CH3), 3.89 (s, 3H, OCH3), 
7.02 - 7.09 (m, 6H, CH), 7.14 - 7.17 (m, 4H, CH), 7.21 - 7.24 (m, 4H, CH), 7.52 - 7.55 (m, 4H, 
CH), 7.65 - 7.68 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.5, 21.6 (CH3), 55.3 (OCH3), 85.6, 87.9, 94.8, 100.2 (C≡C), 
112.9 (CH), 119.3, 119.7, 120.7, 128.6 (C), 129.1, 129.2, 131.4 (2 x CH), 132.1 (CH), 139.1, 
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139.5, 143.8, 152.0, 160.0 (C). MS (EI, 70 eV): m/z (%) = 641 (M+, 100), 626 (7), 610 (7), 576 
(11), 220 (24).  
HRMS (EI, 70 eV): calcd. for C48H35NO: 641.27132; found: 641.270953.  
IR (ATR, cm-1): ~  = 2951 (w), 2918 (w), 2203 (m), 1604 (m), 1509 (s), 1388 (m), 1292 (m), 
1249 (s), 1176 (s), 1110 (m), 1025 (m), 808 (s), 526 (s).  
EA: calcd. for C48H35NO (641.80): C, 89.83; H, 5.50; N, 2.18; found: C, 89.74; H, 5.31; 
N, 2.11. 
 
4-(4-Methoxyphenyl)-2,3,5,6-tetrakis((4-propylphenyl)ethynyl)pyridine (7f) 
 
According to the general procedure, compound 7f was isolated as an orange solid  
(160 mg, 71%); mp. = 91 – 93 °C. 
1H NMR (300 MHz, CDCl3): δ = 0.88 - 0.96 (m, 12H, CH3), 1.54 - 1.70 (m, 8H, CH2), 
2.53 - 2.62 (m, 8H, CH2), 3.90 (s, 3H, OCH3), 7.01 - 7.10 (m, 6H, CH), 7.13 - 7.17 (m, 4H, 
CH), 7.22 - 7.26 (m, 4H, CH), 7.53 - 7.57 (m, 4H, CH), 7.64 - 7.68 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 13.7, 13.7 (CH3), 24.2, 24.2, 37.9, 38.0 (CH2), 55.3 (OCH3), 
85.6, 87.9, 94.8, 100.2 (C≡C), 112.9 (CH), 119.5, 120.0, 120.7 (C), 128.5, 128.5 (CH), 128.7 
(C), 131.3, 131.4, 131.5 (CH), 132.1, 143.8, 144.2, 152.0, 160.0 (C).  
MS (EI, 70 eV): m/z (%) = 753 (M+, 100), 724 (3), 710 (13), 667 (3), 220 (2), 91 (3), 73 (2).  
HRMS (EI, 70 eV): calcd. for C56H51NO: 753.39652; found: 753.397094.  
IR (ATR, cm-1): ~  = 3028 (w), 2956 (m), 2927 (m), 2868 (m), 2204 (m), 1606 (m), 1508 (s), 
1389 (s), 1292 (m), 1248 (s), 1176 (s), 1111 (m), 1030 (m), 811 (s), 532 (s).  
EA: calcd. for C56H51NO (754.01): C, 89.20; H, 6.82; N, 1.86; found: C, 89.36; H, 6.76; 
N, 1.86. 
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4-(4-Methoxyphenyl)-2,3,5,6-tetra(hex-1-ynyl)pyridine (7g) 
 
According to the general procedure, compound 7g was isolated as a brown oil  
(40 mg, 26%). 
1H NMR (300 MHz, CDCl3): δ = 0.80 (t, 6H, 3J = 7.2 Hz, CH3), 0.89 (t, 6H, 3J = 7.2 Hz, CH3), 
1.16 - 1.28 (m, 4H, CH2), 1.32 - 1.62 (m, 12H, CH2), 2.26 (t, 4H, 3J = 6.8 Hz, CH2), 2.44 (t, 
4H, 3J = 6.8 Hz, CH2), 3.82 (s, 3H, OCH3), 6.86 - 6.91 (m, 2H, CH), 7.32 - 7.37 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 13.5, 13.6 (CH3), 19.3, 19.4, 21.6, 21.9, 30.2, 30.3 (CH2), 55.1 
(OCH3), 76.9, 79.8, 95.2, 100.7 (C≡C), 112.7 (CH), 120.6, 129.3 (C), 130.7 (CH), 143.7, 152.7, 
159.4 (C).  
MS (EI, 70 eV):m/z (%) = 505 (M+, 100), 490 (10), 476 (15), 463 (24), 448 (16), 73 (10), 66 
(16), 43 (10). HRMS (EI, 70 eV): calcd. for C36H43NO: 505.33392; found: 505.333727.  
IR (ATR, cm-1): ~  = 2955 (m), 2929 (m), 2226 (m), 1608 (m), 1495 (s), 1462 (m), 1388 (s), 
1291 (m), 1246 (s), 1176 (m), 1032 (m), 832 (m). 
 
4-(4-(Trifluoromethyl)phenyl)-2,3,5,6-tetrakis(phenylethynyl)pyridine (8a) 
 
According to the general procedure, compound 8a was isolated as a yellow solid  
(88 mg, 50%); mp. = 256 – 258 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.10 - 7.29 (m, 16H, CH), 7.52 - 7.55 (m, 4H, CH), 
7.70 - 7.74 (s, 4H, CH).  
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13C NMR (75 MHz, CDCl3): δ = 85.2, 87.9, 95.1, 100.9 (C≡C), 120.6, 122.0, 122.2 (C), 124.0 
(q, 1JC–F = 272.2 Hz, CF3), 124.7 (q, 3JC–F = 3.6 Hz, CH), 128.4 (2 x CH), 129.1, 129.4, 130.2 
(CH), 130.8 (q, 2JC–F = 32.5 Hz, C), 131.4, 132.2 (CH), 140.2, 143.8, 151.2 (C).  
19F NMR (282 MHz, CDCl3): δ = -62.1 (s, 3F, CF3). MS (EI, 70 eV): m/z (%) = 623 (M+, 100), 
554 (6), 546 (7), 275 (6). 
HRMS (ESI): calcd. for C44H25F3N ([M+H]+): 624.19336; found: 624.19312.  
IR (ATR, cm-1): ~  = 3053 (w), 2203 (m), 1490 (m), 1389 (m), 1321 (s), 1157 (m), 1116 (s), 
1063 (s), 1018 (m), 847 (m), 748 (s), 684 (s), 525 (s), 396 (m). 
 
4-(4-(Trifluoromethyl)phenyl)-2,3,5,6-tetrakis((4-methoxyphenyl)ethynyl)pyridine (8b) 
 
According to the general procedure, compound 8b was isolated as a yellow solid  
(105 mg, 56%); mp. = 223 – 225 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.78 (s, 6H, OCH3), 3.82 (s, 6H, OCH3), 6.76 - 6.81 (m, 4H, 
CH), 6.84 - 6.89 (m, 4H, CH), 7.11 - 7.16 (m, 4H, CH), 7.54 - 7.58 (m, 4H, CH), 7.74 - 7.80 
(m, 4H, CH). 
13C NMR (75 MHz, CDCl3): δ = 55.3 (2 x OCH3), 84.4, 87.3, 95.1, 100.8 (C≡C), 114.1 
(2 x CH), 114.2, 114.5, 120.2 (C), 124.1 (q, 1JC–F = 272.3 Hz, CF3), 124.6 (q, 3JC–F = 3.6 Hz, 
CH), 130.2 (CH), 130.6 (q, 2JC–F = 32.6 Hz, C), 132.9, 133.8 (CH), 140.6, 143.5, 150.5, 160.2, 
160.4 (C).  
19F NMR (282 MHz, CDCl3): δ = -62.0 (s, 3F, CF3).  
MS (EI, 70 eV): m/z (%) = 743 (M+, 100), 688 (13), 613 (6), 330 (40), 69 (14), 44(34).  
HRMS (EI, 70 eV): calcd. for C48H32F3NO4: 743.22779; found: 743.22886.  
IR (ATR, cm-1): ~  = 3009 (w), 2934 (w), 2839 (w), 2202 (m), 1603 (s), 1509 (s), 1440 (m), 
1326 (s), 1291 (s), 1248 (s), 1167 (s), 1114 (s), 1019 (s), 827 (s), 532 (s).  
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4-(4-(Trifluoromethyl)phenyl)-2,3,5,6-tetrakis((4-fluorophenyl)ethynyl)pyridine (8c) 
 
According to the general procedure, compound 8c was isolated as a yellow solid  
(122 mg, 63%); mp. = 252 – 254 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.93 - 7.08 (m, 8H, CH), 7.12 - 7.18 (m, 4H, CH), 7.54 - 7.61 
(m, 4H, CH), 7.73 - 7.82 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 84.7 (d, 5J = 1.2 Hz, C≡C), 87.5 (d, 5J = 1.2 Hz, C≡C), 94.0, 
99.9 (C≡C), 115.9 (d, 2JC–F = 21.8 Hz, CH), 116.0 (d, 2JC–F = 21.8 Hz, CH), 118.0 (d,  
4JC–F = 3.8 Hz, C), 118.2 (d, 4JC–F = 3.8 Hz, C), 120.5 (C), 124.0 (q, 1JC–F = 272.5 Hz, CF3), 
124.8 (q, 3JC–F = 3.8 Hz, CH), 130.1 (CH), 131.0 (q, 2JC–F = 32.6 Hz, C), 133.3 (d,  
3JC–F = 8.3 Hz, CH), 134.1 (d, 3JC–F = 8.3 Hz, CH), 140.1, 143.7, 151.2 (C), 163.0 (d,  
1JC–F = 251.7 Hz, CF), 163.2 (d, 1JC–F = 251.73 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -62.1 (s, 3F, CF3), -107.8 (s, 2F, CF), -108.1 (s, 2F, CF). 
MS (EI, 70 eV): m/z (%) = 695 (M+, 100), 626 (10), 600 (9), 73 (6), 43 (10).  
HRMS (EI, 70 eV): calcd. for C44H20F7N: 695.14785; found: 695.14823.  
IR (ATR, cm-1): ~  = 3069 (w), 2208 (m), 1600 (m), 1505 (s), 1329 (s), 1229 (s), 1153 (s), 1101 
(s), 1067 (s), 1019 (m), 828 (s), 525 (s), 387 (s).  
 
4-(4-(Trifluoromethyl)phenyl)-2,3,5,6-tetrakis((4-(tert-butyl)phenyl)ethynyl)pyridine 
(8d) 
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According to the general procedure, compound 8d was isolated as a yellow solid  
(160 mg, 75%); mp. = 214 – 216 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.29 (s, 18H, CH3), 1.33 (s, 18H, CH3), 7.14 - 7.18 (m, 4H, 
CH), 7.28 - 7.32 (m, 4H, CH), 7.36 - 7.40 (m, 4H, CH), 7.56 - 7.60 (m, 4H, CH), 7.76 - 7.82 
(m, 4H, CH). 
13C NMR (75 MHz, CDCl3): δ = 31.0, 31.1 (CH3), 34.8, 34.9 (C), 84.8, 87.6, 95.4, 101.1 
(C≡C), 119.1, 119.3, 120.5 (C), 124.1 (q, 1JC–F = 272.3 Hz, CF3), 124.7 (q, 3JC–F = 3.8 Hz, CH), 
125.4 (2 x CH), 130.2 (CH), 130.6 (q, 2JC–F = 32.4 Hz, C), 131.2, 132.0 (CH), 140.4, 143.7, 
151.1, 152.5, 152.7 (C).  
19F NMR (282 MHz, CDCl3): δ = -62.0 (s, 3F, CF3).  
MS (EI, 70 eV): m/z (%) = 847 (M+, 100), 832 (7), 409 (7), 57 (7). HRMS (ESI): calcd. for 
C60H57F3N ([M+H]+): 848.44376; found: 848.44333.  
IR (ATR, cm-1): ~ = 2960 (m), 2904 (w), 2868 (w), 2207 (m), 1502 (m), 1392 (m), 1325 (s), 
1266 (m), 1166 (s), 1121 (s), 1064 (s), 1017 (m), 831 (s), 559 (s). 
 
 
4-(4-(Trifluoromethyl)phenyl)-2,3,5,6-tetrakis((4-propylphenyl)ethynyl)pyridine (8e) 
 
According to the general procedure, compound 8e was isolated as a yellow solid  
(165 mg, 74%); mp. = 152 – 154 °C. 
1H NMR (300 MHz, CDCl3): δ = 0.88 - 0.97 (m, 12H, CH3), 1.54 - 1.71 (m, 8H, CH2), 
2.53 - 2.62 (m, 8H, CH2), 7.06 - 7.17 (m, 12H, CH), 7.54 - 7.56 (m, 4H, CH), 7.75 - 7.81 (m, 
4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 13.7 (2 x CH3), 24.2 (2 x CH2), 37.9, 38.0 (CH2), 84.8, 87.7, 
95.3, 101.1 (C≡C), 119.3, 119.5, 120.5 (C), 124.1 (q, 1JC–F = 272.1 Hz, CF3), 124.6 (q,  
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3JC–F = 3.8 Hz, CH), 128.6 (2 x CH), 130.2 (CH), 130.6 (q, 2JC–F = 32.6 Hz, C), 131.3, 132.1 
(CH), 140.4, 143.7, 144.1, 144.4, 150.9 (C).  
19F NMR (282 MHz, CDCl3): δ = -62.0 (s, 3F, CF3). MS (EI, 70 eV): m/z (%) = 791 (M+, 
100), 762 (2), 748 (6).  
HRMS (ESI): calcd. for C56H49F3N ([M+H]+): 792.38116; found: 792.38098.  
IR (ATR, cm-1): ~  = 2956 (w), 2927 (w), 2867 (w), 2200 (m), 1507 (m), 1385 (m), 1323 (s), 
1162 (s), 1123 (s), 1064 (s), 1018 (m), 843 (s), 812 (s), 710 (w), 529 (m), 397 (w). 
 
Synthesis of 2,3,5,6-tetraethynylpyrazines 
An argon-flushed glass pressure tube was charged with 2.3 mg of [PdCl2(CH3CN)2] 
(0.009 mmol, 3 mol%), 8.6 mg of XPhos (0.018 mmol, 6 mol%), 2.8 mg of CuI (0.015 mmol, 
5mol%) and tetrachloropyrazine  (65.4 mg, 0.3mmol), followed by the addition of anhydrous 
1,4-dioxane (4 mL), 0.5 mL of HN(i-Pr)2 and appropriate alkyne (1.8 mmol, 6 equiv.). The tube 
was sealed with a teflon cap and the reaction mixture was stirred at 100 °C for 20 hours. The 
resulting mixture was cooled down to room temperature, diluted with water and extracted with 
dichloromethane. The combined organic layers were dried over Na2SO4, filtered and the solvent 
was evaporated. The crude residue was purified by column chromatography on silica gel using 
a mixture of hexane and dichloromethane as eluent. 
 
2,3,5,6-Tetrakis(phenylethynyl)pyrazine (13a) 
 
According to the general procedure, compound 13a was isolated as a dark yellow solid  
(121 mg, 84%); mp. = 221 – 223 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.34 - 7.45 (m, 12H), 7.62 - 7.67 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 86.0 (C≡C), 97.7, 121.6 (C), 128.5, 129.8, 132.2 (CH), 139.0 
(C).  
MS (EI, 70 eV): m/z (%) = 480 (M+, 100), 226 (47), 127 (3).  
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HRMS (EI, 70 eV): calcd. for C36H20N2: 480.16210; found: 480.16222.  
IR (ATR, cm-1): ~  = 3052 (w), 2208 (m), 1489 (m), 1385 (m), 1164 (m), 1138 (m), 746 (s), 680 
(s), 529 (s), 486 (m). 
 
2,3,5,6-Tetrakis((4-(tert-butyl)phenyl)ethynyl)pyrazine (13b) 
 
According to the general procedure, compound 13b was isolated as a dark yellow solid  
(186 mg, 88%); mp. = 282 – 284 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.33 (s, 36H, CH3), 7.38 - 7.42 (m, 8H), 7.57 - 7.61 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 31.0 (CH3), 34.9 (Ct-Bu), 85.8, 97.9 (C≡C), 118.6 (C), 125.5, 
132.0 (CH), 138.9, 153.2 (C). 
MS (EI, 70 eV): m/z (%) = 704 (M+, 100), 690 (4), 456 (6), 337 (8).  
HRMS (ESI): calcd. for C52H53N2 ([M+H]+): 705.42033; found: 705.4202.  
IR (ATR, cm-1): ~  = 2956 (m), 2863 (w), 2206 (m), 1503 (m), 1386 (m), 1162 (m), 1104 (m), 
828 (s), 557 (s). 
 
2,3,5,6-Tetrakis(p-tolylethynyl)pyrazine (13c) 
 
According to the general procedure, compound 10c was isolated as a dark yellow solid  
(134 mg, 83%); mp. = 296 – 298 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.38 (s, 12H, CH3), 7.16 - 7.19 (m, 8H), 7.51 - 7.55 (m, 8H).  
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13C NMR (75 MHz, CDCl3): δ = 21.6 (CH3), 5.8, 97.9 (C≡C), 118.6 (C), 129.3, 132.1 (CH), 
138.9, 140.2 (C).  
MS (EI, 70 eV): m/z (%) = 536 (M+, 100), 268 (3), 254 (26), 239 (3), 44 (6).  
HRMS (EI, 70 eV): calcd. for C40H28N2: 536.22470; found: 536.22606.  
IR (ATR, cm-1): ~  = 2910 (w), 2195 (m), 1508 (m), 1374 (m), 1157 (m), 807 (s), 527 (s), 417 
(m).  
 
2,3,5,6-Tetra(hex-1-yn-1-yl)pyrazine (13e) 
 
According to the general procedure, compound 13e was isolated as a brown oil 
(53 mg, 44%). 
1H NMR (300 MHz, CDCl3): δ = 0.90 (t, 3J = 7.1 Hz, 12H, CH3), 1.40 - 1.63 (m, 16H, CH2), 
2.46 (t, 3J = 6.9 Hz, 8H, CH2).  
13C NMR (75 MHz, CDCl3): δ = 13.5 (CH3), 19.3, 21.9, 30.1 (CH2), 77.8, 98.8 (C≡C), 138.6 
(C). 
MS (EI, 70 eV): m/z (%) = 400 (M+, 100), 371 (10), 357 (18), 125 (12), 111 (22), 83 (26), 71 
(28), 57 (44).  
HRMS (EI, 70 eV): calcd. for C28H36N2: 400.28730; found: 400.28703.  
IR (ATR, cm-1): ~  = 2956 (m), 2927 (m), 2961 (w), 2228 (m), 1380 (s), 1160 (m), 496 (m). 
 
2,3,5,6-Tetrakis((triisopropylsilyl)ethynyl)pyrazine (13f) 
 
According to the general procedure, compound 13f was isolated as a light yellow solid  
(188 mg, 78%); mp. = 234 – 236 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.08 - 1.17 (m, 84H).  
13C NMR (75 MHz, CDCl3): δ = 11.3 (CH), 18.6 (CH3), 101.1, 102.5 (C≡C), 138.0 (C).  
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MS (EI, 70 eV): m/z (%) = 800 (M+, 11), 757 (33), 715 (100), 611 (8), 569 (16).  
HRMS (EI, 70 eV): calcd. for C48H84N2Si4: 800.57061; found: 800.57168.  
IR (ATR, cm-1): ~  = 2941 (m), 2864 (m), 1460 (m), 1350 (s), 1157 (m), 997 (m), 881 (s), 767 
(m), 678 (s), 655 (s), 580 (m). 
 
2,3,5,6-Tetrakis(o-tolylethynyl)pyrazine (13g) 
 
According to the general procedure, compound 13g was isolated as a yellow solid  
(132 mg, 82%); mp. = 214 – 216 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.49 (s, 12H, CH3), 7.13 - 7.31 (m, 12H), 7.57 (dd, 4H, 
3J = 7.7 Hz, 4J = 1.3 Hz).  
13C NMR (75 MHz, CDCl3): δ = 20.8 (CH3), 89.7, 96.4 (C≡C), 121.4 (C), 125.6, 129.6, 129.7, 
132.7 (CH), 138.9, 141.2 (C).  
MS (EI, 70 eV): m/z (%) = 536 (M+, 100), 521 (7), 268 (8), 252 (93), 239 (11), 140 (8), 115 
(11).  
HRMS (EI, 70 eV): calcd. for C40H28N2: 536.22470; found: 536.22429.  
IR (ATR, cm-1): ~  = 2943 (w), 2200 (m), 1485 (m), 1454 (m), 1375 (m), 1147 (m), 755 (s), 713 
(m), 491 (m). 
 
2,3,5,6-Tetrakis(m-tolylethynyl)pyrazine (13h) 
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According to the general procedure, compound 13h was isolated as a dark yellow solid  
(96 mg, 60%); mp. = 201 – 203 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.32 (s, 12H, CH3), 7.20 - 7.29 (m, 8H), 7.44 - 7.48 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 21.1 (CH3), 85.9, 98.0 (C≡C), 121.4 (C), 128.4, 129.3, 130.7, 
132.8 (CH), 138.2, 139.1 (C).  
MS (EI, 70 eV): m/z (%) = 536 (M+, 100), 254 (28), 69 (5), 44 (13).  
HRMS (ESI): calcd. for C48H28N2 ([M+H]+): 537.23253; found: 537.23248. 
IR (ATR, cm-1): ~  = 2917 (w), 2197 (m), 1483 (m), 1380 (m), 1153 (m), 773 (s), 682 (s), 496 
(s). 
 
2,3,5,6-Tetrakis((2,5-dimethylphenyl)ethynyl)pyrazine (13i) 
 
According to the general procedure, compound 13i was isolated as a yellow solid  
(140 mg, 79%); mp. = 237 – 239 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.25 (s, 12H, CH3), 2.45 (s, 12H, CH3), 7.06 - 7.12 (m, 8H), 
7.39 (bs, 4H).  
13C NMR (75 MHz, CDCl3): δ = 20.3, 20.6 (CH3), 89.5, 96.8 (C≡C), 121.2 (C), 129.4, 130.6, 
133.2 (CH), 135.0, 138.1, 139.0 (C).  
MS (EI, 70 eV): m/z (%) = 592 (M+, 100), 281 (6), 266 (9), 252 (6).  
HRMS (EI, 70 eV): calcd. for C44H36N2: 592.28730; found: 592.28697.  
IR (ATR, cm-1): ~  = 2916 (w), 2201 (m), 1496 (m), 1367 (m), 1154 (m), 828 (m), 809 (s), 496 
(s), 460 (m). 
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2,3,5,6-Tetrakis((4-methoxy-2-methylphenyl)ethynyl)pyrazine (13j) 
 
According to the general procedure, compound 13j was isolated as a dark yellow solid  
(116 mg, 59%); mp. = 220 – 221 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.46 (s, 12H, CH3), 3.80 (s, 12H, OCH3), 6.68 - 6.74 (m, 8H), 
7.49 (d, 4H, 3J = 8.4 Hz).  
13C NMR (75 MHz, CDCl3): δ = 21.1 (CH3), 55.2 (OCH3), 89.1, 96.5 (C≡C), 111.4 (CH), 
113.8 (C), 115.1, 134.2 (CH), 138.7, 143.2, 160.5 (C).  
MS (EI, 70 eV): m/z (%) = 656 (M+, 100), 641 (4), 569 (3), 328 (3), 226 (3), 84 (3), 66 (3), 44 
(6). 
HRMS (EI, 70 eV): calcd. for C44H36N2O4: 656.26696; found: 656.26471.  
IR (ATR, cm-1): ~  = 2931 (w), 2837 (w), 2195 (m), 1602 (m), 1565 (m), 1494 (m), 1280 (m), 
1242 (m), 1115 (m), 1040 (m), 865 (s), 807 (s), 500 (s).  
 
 
2,3,5,6-Tetrakis((4-propylphenyl)ethynyl)pyrazine (13k) 
 
According to the general procedure, compound 13k was isolated as a yellow solid  
(95 mg, 49%); mp. = 189 – 191 °C. 
1H NMR (300 MHz, CDCl3): δ = 0.93 (t, 12H, 3J = 7.3 Hz, CH3), 1.58 - 1.71 (m, 8H, CH2), 
2.58 - 2.63 (m, 8H, CH2), 7.16 - 7.20 (m, 8H), 7.53 - 7.57 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 13.7 (CH3), 24.2, 38.0 (CH2), 85.8, 97.9 (C≡C), 118.9 (C), 
128.7, 132.2 (CH), 138.9, 144.9 (C). 
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MS (EI, 70 eV): m/z (%) = 648 (M+, 100), 281 (11), 252 (6), 66 (6), 44 (17).  
HRMS (EI, 70 eV): calcd. for C48H44N2: 648.34990; found: 648.34993.  
IR (ATR, cm-1): ~  = 2956 (w), 2930 (w), 2860 (w), 2201 (m), 1506 (m), 1378 (m), 1157 (m), 
839 (m), 797 (m), 541 (s), 492 (m). 
 
 
2,3,5,6-Tetrakis((4-ethylphenyl)ethynyl)pyrazine (13l) 
 
According to the general procedure, compound 13l was isolated as a dark yellow solid  
(108 mg, 61%); mp. = 206 – 208 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.24 (t, 12H, 3J = 7.6 Hz, CH3), 2.67 (q, 8H, 3J = 7.6 Hz, 
CH2), 7.18 - 7.22 (m, 8H), 7.54 - 7.58 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 15.2 (CH3), 28.9 (CH2), 85.8, 97.9 (C≡C), 118.8 (C), 128.1, 
132.2 (CH), 138.9, 146.4 (C). 
MS (EI, 70 eV): m/z (%) = 592 (M+, 100), 267 (12), 133 (9), 71 (9), 57 (15), 44 (45).  
HRMS (EI, 70 eV): calcd. for C44H36N2: 592.28730; found: 592.28613.  
IR (ATR, cm-1): ~  = 2963 (w), 2929 (w), 2870 (w), 2199 (m), 1508 (m), 1379 (m), 1157 (m), 
828 (s), 530 (m). 
 
2,3,5,6-Tetrakis((4-butylphenyl)ethynyl)pyrazine (13m) 
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According to the general procedure, compound 13m was isolated as a yellow solid  
(128 mg, 60%); mp. = 140 – 142 °C. 
1H NMR (300 MHz, CDCl3): δ = 0.92 (t, 12H, 3J = 7.3 Hz, CH3), 1.29 - 1.41 (m, 8H, CH2), 
1.55 - 1.65 (m, 8H, CH2), 2.63 (t, 8H, 3J = 7.6 Hz, CH2), 7.16 - 7.20 (m, 8H), 7.53 - 7.57 (m, 
8H).  
13C NMR (75 MHz, CDCl3): δ = 13.8 (CH3), 22.2, 33.2, 35.7 (CH2), 85.8, 97.9 (C≡C), 118.8 
(C), 128.6, 132.2 (CH), 138.9, 145.1 (C).  
MS (EI, 70 eV): m/z (%) = 704 (M+, 100), 619 (14), 352 (7), 295 (13), 267 (17), 252 (12).  
HRMS (EI, 70 eV): calcd. for C52H52N2: 704.41250; found: 704.41019.  
IR (ATR, cm-1): ~  = 2951 (w), 2926 (m), 2860 (w), 2201 (m), 1509 (m), 1377 (s), 1156 (s), 823 
(s), 539 (s).  
EA: calcd. for C52H52N2 (704.98): C, 88.59; H, 7.43; N, 3.97; found: C, 88.56; H, 7.81; N, 3.90. 
 
2,3,5,6-Tetrakis(phenylethynyl)pyrazine (14) 
 
To a dissolved pyrazine 13f (200 mg, 0.25 mmol in 6 mL of THF), 2.2 mL of TBAF (1 M in 
THF, 2.2 mmol) was added at 0°C and stirred for 2h. Afterward, water was added and the 
aqueous phase was three times extracted with Et2O. Combined organic layers were dried over 
Na2SO4, filtered and the solvent was evaporated. The crude material was purified by column 
chromatography on silica gel using a mixture of hexane and dichloromethane as eluent. 
Compound 14 was isolated as a brown solid (38 mg, 86%). 
1H NMR (300 MHz, CDCl3): δ = 3.60 (s, 4H, C≡CH). 
13C NMR (75 MHz, CDCl3): δ = 78.6, 86.0 (C≡C), 139.0 (C). 
MS (EI, 70 eV): m/z (%) = 176 (M+, 62), 74 (100), 61 (5), 51 (10), 37 (9). 
HRMS (ESI): calcd. for C12H5N2 ([M+H]+): 177.04472; found: 177.04475. 
IR (ATR, cm-1): ~  = 3284 (m), 3201 (m), 2105 (m), 1356 (s), 1162 (s), 680 (s), 660 (s), 503 (s). 
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Synthesis of 3,5-chloro-4-(4-methoxyphenyl)-2,6-diarylpyridines 
An argon-flushed glass pressure tube was charged with Pd(PPh3)4 (0.025 mmol, 5 mol%), 4a 
(0.5 mmol), the appropriate aryl boronic acid (1.5 mmol, 3.0 eq.), K3PO4 (1.5 mmol, 3.0 eq.) 
and anhydrous toluene (3.5 mL). The tube was sealed with a teflon cap and the reaction mixture 
was stirred at 100 °C for 20 hours. The resulting mixture was cooled down to room temperature, 
diluted with water and extracted with dichloromethane. The combined organic layers were dried 
over Na2SO4, filtered and the solvent was evaporated. After, the crude residue was purified by 
column chromatography on silica gel using a mixture of hexane and dichloromethane as eluent.  
 
3,5-Dichloro-2,6-bis(4-isopropylphenyl)-4-(4-methoxyphenyl)pyridine (16a) 
 
According to the general procedure, compound 16a was isolated as a white solid  
(169 mg, 69%); mp. = 81 – 83 °C. 
1H NMR (400 MHz, CDCl3): δ = 1.31 (d, 12H, 3J = 6.9 Hz, CH3), 2.99 (sept, 2H, 3J = 6.9 Hz,  
CHi-Pr), 3.89 (s, 3H, OCH3), 7.06 - 7.09 (m, 2H, CH), 7.29 - 7.35 (m, 6H, CH), 7.74 - 7.77 (m, 
4H, CH).  
13C NMR (100 MHz, CDCl3): δ = 23.8 (CH3), 33.9 (CHi-Pr), 55.1 (OCH3), 113.8, 126.0 (CH), 
128.6, 128.7 (C), 129.5, 130.1 (CH), 135.8, 148.9, 149.5, 154.6, 159.5 (C).  
MS (EI, 70 eV): m/z (%) = 489 (M+, 100), 474 (73), 458 (6), 432 (4), 230 (23), 215 (4), 158 
(4).  
HRMS (EI, 70 eV): calcd. for C30H29Cl2NO: 489.16207; found: 489.16144.  
IR (ATR, cm-1): ~  = 2957 (m), 2868 (w), 2835 (w), 1609 (m), 1500 (s), 1460 (m), 1361 (s), 
1290 (m), 1246 (s), 1018 (m), 828 (s), 731 (m), 657 (m), 557 (s).  
EA: calcd. for C30H29Cl2NO (490.46): C, 73.47; H, 5.96; N, 2.86; found: C, 73.25; H, 5.90; 
N, 2.75. 
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3,5-Dichloro-2,6-bis(4-fluorophenyl)-4-(4-methoxyphenyl)pyridine (16b) 
 
According to the general procedure, compound 16b was isolated as a white solid  
(139 mg, 63%); mp. = 224 – 226 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.86 (s, 3H, OCH3), 7.01 - 7.06 (m, 2H, CH), 7.08 - 7.16 (m, 
4H, CH), 7.22 - 7.27 (m, 2H, CH), 7.71 - 7.78 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.2 (OCH3), 113.9 (CH), 115.0 (d, 2JC–F = 21.8 Hz, CH), 
128.3, 129.1 (C), 130.0 (CH), 131.5 (d, 3JC–F = 8.3 Hz, CH), 134.1 (d, 4JC–F = 3.2 Hz, C), 149.4, 
153.7, 159. 7 (C), 163.1 (d, 1JC–F = 249.0 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -111.7 (s, 2F, CF). MS (EI, 70 eV): m/z (%) = 441 (M+, 
100), 406 (34), 363 (10), 327 (8), 207 (14).  
HRMS (EI, 70 eV): calcd. for C24H15Cl2F2NO: 441.04933; found: 441.04912.  
IR (ATR, cm-1): ~  = 3004 (w), 2939 (w), 2838 (w), 1603 (m), 1504 (s), 1359 (m), 1292 (m), 
1230 (s), 1156 (s), 834 (s), 529 (s).  
EA: calcd. for C24H15Cl2F2NO (442.28): C, 65.17; H, 3.42; N, 3.17; found: C, 65.20; H, 3.56; 
N, 3.19. 
 
3,5-Dichloro-2,6-di-m-tolyl-4-(4-methoxyphenyl)pyridine (16c) 
 
According to the general procedure, compound 16c was isolated as a white solid  
(103 mg, 47%); mp. = 130 – 132 °C. 
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1H NMR (300 MHz, CDCl3): δ = 2.40 (s, 6H, CH3), 3.87 (s, 3H, OCH3), 7.01 - 7.06 (m, 2H, 
CH), 7.20 - 7.36 (m, 6H, CH), 7.52 - 7.54 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.4 (CH3), 55.2 (OCH3), 113.8, 126.6, 127.8 (CH), 128.6, 
129.0 (C), 129.6, 130.1 (CH), 137.7, 138.2, 148.9, 155.0, 159.6 (C).  
MS (EI, 70 eV): m/z (%) = 433 (M+, 100), 398 (66), 355 (8), 202 (10), 152 (9). 
HRMS (EI, 70 eV): calcd. for C26H21Cl2NO: 433.09947; found: 433.09915.  
IR (ATR, cm-1): ~  = 3040 (w), 2921 (w), 2830 (w), 1605 (m), 1507 (s), 1356 (s), 1285 (m), 
1243 (s), 1178 (m), 1022 (m), 790 (s), 774 (s), 698 (s), 586 (s).  
EA: calcd. for C26H21Cl2NO (434.36): C, 71.89; H, 4.87; N, 3.22; found: C, 71.81; H, 5.13; 
N, 3.22. 
 
3,5-Dichloro-2,6-bis(4-isopropoxyphenyl)-4-(4-methoxyphenyl)pyridine (16d) 
 
According to the general procedure, compound 16d was isolated as a white solid  
(186 mg, 71%); mp. = 173 – 175 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.37 (d, 12H, 3J = 6.0 Hz, CH3), 3.87 (s, 3H, OCH3), 4.61 
(sept, 2H, 3J = 6.0 Hz, CHi-Pr), 6.94 - 6.99 (m, 4H, CH), 7.02 - 7.07 (m, 2H, CH), 7.25 - 7.30 
(m, 2H, CH), 7.74 - 7.79 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.9 (CH3), 55.1 (OCH3), 69.7 (CHi-Pr), 113.8, 114.9 (CH), 
128.0, 128.9 (C), 130.0 (CH), 130.4 (C), 131.0 (CH), 149.0, 154.1, 158.4, 159.5 (C).  
MS (EI, 70 eV): m/z (%) = 521 (M+, 37), 437 (100), 402 (15), 219 (8), 43 (17).  
HRMS (EI, 70 eV): calcd. for C30H29Cl2NO3: 521.15190; found: 521.15137.  
IR (ATR, cm-1): ~  = 2974 (w), 2934 (w), 2831 (w), 1607 (m), 1500 (s), 1363 (m), 1291 (m), 
1247 (s), 1104 (s), 1040 (m), 950 (m), 830 (s), 785 (m), 638 (m).  
EA: calcd. for C30H29Cl2NO3 (522.46): C, 68.97; H, 5.59; N, 2.68; found: C, 68.83; H, 5.76; 
N, 2.64. 
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Synthesis of 2,3,5,6-tetraaryl-4-(4-methoxyphenyl)pyridines from 3,5-dichloro-4-(4-
methoxyphenyl)-2,6-diarylpyridines 
An argon-flushed glass pressure tube was charged with PdCl2(CH3CN)2 (0.0125 mmol, 
5 mol%), SPhos (0.025 mmol, 10mol%), 3,5-dichloro-4-(4-methoxyphenyl)-2,6-diarylpyridine 
16 (0.25 mmol), the appropriate aryl boronic acid (1.0 mmol, 4.0 eq.), K3PO4 (1.0 mmol, 
4.0 eq.) and anhydrous toluene (3.5 mL). The tube was sealed with a teflon cap and the reaction 
mixture was stirred at 100 °C for 20 hours. The resulting mixture was cooled down to room 
temperature, diluted with water and extracted with dichloromethane. The combined organic 
layers were dried over Na2SO4, filtered and the solvent was evaporated. After, the crude residue 
was purified by column chromatography on silica gel using a mixture of hexane and 
dichloromethane as eluent.  
 
2,6-Bis(4-fluorophenyl)-4-(4-methoxyphenyl)-3,5-di-p-tolylpyridine (17) 
 
According to the general procedure, compound 17 was isolated as a white solid  
(110 mg, 99%); mp. = 234 – 236 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.18 (s, 6H, CH3), 3.63 (s, 3H, OCH3), 6.44 - 6.48 (m, 2H, 
CH), 6.61 - 6.66 (m, 2H, CH), 6.70 - 6.74 (m, 4H, CH), 6.80 - 6.88 (m, 8H, CH), 7.30 - 7.37 
(m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.1 (CH3), 54.9 (OCH3), 112.4 (CH), 114.4 (d,  
2JC–F = 21.2 Hz, CH), 128.3 (CH), 130.3 (C), 131.0, 131.4 (CH), 131.8 (d, 3JC–F = 7.8 Hz, CH), 
134.0, 135.1, 135.8 (C), 136.9 (d, 4JC–F = 3.2 Hz, C), 150.4, 155.2, 157.6 (C), 162.1 (d,  
1JC–F = 246.6 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -114.4 (s, 2F, CF).  
MS (EI, 70 eV): m/z (%) = 552 (M+, 100), 167 (20), 149 (51), 107 (13), 97 (14), 84 (15), 71 
(23), 66 (11), 57 (32), 43 (18).  
HRMS (EI, 70 eV): calcd. for C38H28F2NO: 552.21335; found: 552.21339.  
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IR (ATR, cm-1): ~  =2923 (w), 1596 (m), 1498 (s), 1389 (m), 1287 (m), 1220 (s), 1155 (s), 1038 
(m), 834 (m), 806 (s), 524 (s).  
EA: calcd. for C38H29F2NO (553.64): C, 82.44; H, 5.28; N, 2.53; found: C, 82.54; H, 5.34; 
N, 2.43. 
 
 
Synthesis of 3-chloro-4-(4-methoxyphenyl)-2,5,6-diarylpyridines 
An oven-dried and argon-flushed pressure tube was charged with 4a (0.3 mmol), 
PdCl2(CH3CN)2 (0.015 mmol, 5 mol%), SPhos (0.03 mmol, 10.0 mol%), boronic acid (0.9 
mmol, 3.0 eq.) and K3PO4 (0.9 mmol, 3.0 eq.), followed by anhydrous toluene (3 mL). The tube 
was sealed with a teflon valve and stirred at 100 °C for 20 h. The cooled reaction mixture was 
diluted with water and extracted with DCM. The combined organic layers were dried (Na2SO4), 
filtered and the filtrate was concentrated in vacuo. The residue was purified by column 
chromatography. 
 
3-Chloro-4-(4-methoxyphenyl)-2,5,6-triphenylpyridine (18a) 
 
According to the general procedure, compound 18a was isolated as a white solid  
(73 mg, 54%); mp. = 206 – 208 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.74 (s, 3H, OCH3), 6.73 - 6.78 (m, 2H, CH), 6.85 - 6.87 (m, 
2H, CH), 6.98 - 7.03 (m, 5H, CH), 7.14 - 7.16 (m, 3H, CH), 7.28 - 7.31 (m, 2H, CH), 
7.39 - 7.50 (m, 3H, CH), 7.85 - 7.88 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.0 (OCH3), 113.1, 126.6, 127.5, 127.6 (2 x CH), 127.9, 
128.5 (CH), 128.7, 129.3 (C), 129.7, 129.9, 130.9, 131.0 (CH), 135.5, 137.6, 139.2, 140.0, 
149.6, 155.5, 155.6, 158.7 (C). 
MS (EI, 70 eV): m/z (%) = 446 (M+, 33), 400 (19), 369 (91), 317 (100), 287 (67), 220 (22), 205 
(71).  
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HRMS (ESI): calcd. for C30H23ClNO ([M+H]+): 448.14627; found: 448.14655.  
IR (ATR, cm-1): ~  = 3029 (w), 2924 (w), 2851 (w), 1608 (m), 1507 (m), 1396 (m), 1357 (m), 
1289 (m), 1244 (s), 1172 (m), 1149 (m), 1030 (m), 838 (m), 743 (m), 695 (s), 562 (m), 537 (m). 
 
3-Chloro-4-(4-methoxyphenyl)-2,5,6-tri-p-tolylpyridine (18b) 
 
According to the general procedure, compound 18b was isolated as a white solid  
(50 mg, 34%); mp. = 142 – 144 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.19, (s, 3H, CH3), 2.25 (s, 3H, CH3), 2.40 (s, 3H, CH3), 3.75 
(s, 3H, OCH3), 6.71 - 6.77 (m, 4H, CH), 6.81 - 6.83 (m, 2H, CH), 7.17 - 7.21 (m, 2H, CH), 
7.25 - 7.28 (m, 2H, CH), 7.74 - 7.77 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.1 (2 x CH3), 21.3 (CH3), 55.0 (OCH3), 113.1, 128.2, 128.3, 
128.5, 129.6 (CH), 129.7 (C), 129.8, 130.8, 130.9 (CH), 134.7, 135.1, 136.0, 136.4, 137.1, 
137.3, 138.3, 149.5, 155.2, 155.4, 158.5 (C).  
MS (EI, 70 eV): m/z (%) = 488 (M+, 61), 167 (26), 149 (75), 111 (24), 97 (36), 83 (38), 71 (64), 
57 (100), 43 (85).  
HRMS (EI, 70 eV): calcd. for C33H27ClNO: 488.17757; found: 488.17753.  
IR (ATR, cm-1): ~  = 3026 (w), 2918 (w), 2856 (w), 1610 (m), 1499 (m), 1391 (m), 1347 (m), 
1293 (m), 1244 (s), 1183 (m), 1034 (m), 813 (s), 532 (s). 
 
3-Chloro-2,5,6-tris(4-fluorophenyl)-4-(4-methoxyphenyl)pyridine (18c) 
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Starting with 4a (97 mg, 0.3 mmol), PdCl2(CH3CN)2 (3.9 mg, 5 mol%), SPhos (12.3 mg, 
10 mol%), corresponding boronic acid (210 mg, 1.5 mmol), K3PO4 (318 mg, 1.5 mmol) and 
toluene (3  mL), compound 18c was isolated as a white solid (93 mg, 62%); 
mp. = 181 – 183 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.75 (s, 3H, OCH3), 6.73 - 6.79 (m, 6H, CH), 6.81 - 6.89 (m, 
2H, CH), 6.92 - 6.97 (m, 2H, CH), 7.11 - 7.18 (m, 2H, CH), 7.21 - 7.21 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.1 (OCH3), 113.3 (CH), 114.7 (d, 2JC–F = 21.6 Hz, CH), 
114.9 (d, 2JC–F = 21.6 Hz, CH), 115.0 (d, 2JC–F = 21.6 Hz, CH), 128.8, 129.0 (C), 130.7 (CH), 
131.6 (d, 3JC–F = 8.1 Hz, 2 x CH), 132.5 (d, 3JC–F = 8.1 Hz, CH), 133.3 (d, 4JC–F = 3.7 Hz, C), 
134.5 (C), 134.9 (d, 4JC–F = 3.7 Hz, C), 135.7 (d, 4JC–F = 3.1 Hz, C), 150.0, 154.5, 154.8, 158.8 
(C), 161.5 (d, 1JC–F = 247.3 Hz, CF), 162.3 (d, 1JC–F = 248.1 Hz, CF), 163.0 (d,  
1JC–F = 248.1 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -112.1 (s, 1F, CF), -113.3 (s, 1F, CF), -114.0 (s, 1F, CF).  
MS (EI, 70 eV): m/z (%) = 500 (M+, 90), 223 (19), 179 (18), 160 (18), 149 (23), 112 (61), 109 
(19), 105 (80), 97 (48), 83 (63), 77 (28), 69 (60), 57 (100), 43 (84).  
HRMS (ESI): calcd. for C30H20ClF3NO ([M+H]+): 502.118; found: 502.1185.  
IR (ATR, cm-1): ~  =2922 (w), 2841 (w), 1601 (m), 1498 (s), 1391 (m), 1290 (m), 1218 (s), 
1157 (s), 1033 (m), 831 (s), 752 (m), 539 (s). 
 
3-Chloro-2,4,5,6-tetrakis(4-methoxyphenyl)pyridine (18d) 
 
According to the general procedure, compound 18d was isolated as a yellowish solid  
(64 mg, 40%); mp. = 171 – 173 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.62, (s, 3H, OCH3), 3.66 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 
3.78 (s, 3H, OCH3), 6.48 - 6.53 (m, 2H, CH), 6.60 - 6.64 (m, 2H, CH), 6.66 - 6.72 (m, 4H, CH), 
6.88 - 6.95 (m, 4H, CH), 7.16 - 7.21 (m, 2H, CH), 7.75 - 7.80 (m, 2H, CH).  
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13C NMR (75 MHz, CDCl3): δ = 54.9, 55.0, 55.1, 55.2 (OCH3), 113.0, 113.1 (CH), 113.2 (CH), 
127.9, 129.8, 130.2 (C), 130.8, 131.1, 131.2 (CH), 131.8 (C), 132.1 (CH), 132.7, 134.4, 149.7, 
154.7, 155.0, 158.0, 158.5, 159.0, 159.8 (C).  
MS (EI, 70 eV): m/z (%) = 537 (M+, 100), 539 (16), 313 (15), 149 (14), 99 (23), 85 (14), 71 
(24), 57 (39).  
HRMS (EI, 70 eV): calcd. for C33H28ClNO4: 537.17014; found: 537.16831.  
IR (ATR, cm-1): ~  = 2920 (m), 2849 (w), 1718 (w), 1607 (m), 1497 (m), 1461 (m), 1395 (m), 
1289 (m), 1243 (s), 1173 (s), 1030 (s), 828 (s), 801 (s), 728 (m), 546 (s). 
 
Synthesis of 2,3,5,6-tetraaryl-4-(4-methoxyphenyl)pyridines from 3-chloro-4-(4-
methoxyphenyl)-2,5,6-diarylpyridines 
An oven-dried and argon-flushed pressure tube was charged with 3-chloro-4-(4-
methoxyphenyl)-2,5,6-diarylpyridine 18 (0.2 mmol), PdCl2(CH3CN)2 (0.01 mmol, 5.0 mol%), 
SPhos (0,02 mmol, 10.0 mol%), boronic acid (0.5 mmol, 2.5 eq.) and K3PO4 (0.5 mmol, 2.5 
eq.) followed by anhydrous toluene (3 mL). The tube was sealed with a teflon valve and stirred 
at 100 °C for 20h. The cooled reaction mixture was diluted with water and extracted with DCM. 
The combined organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in 
vacuo. The residue was purified by column chromatography. 
 
3-(4-Isopropylphenyl)-4-(4-methoxyphenyl)-2,5,6-triphenylpyridine (19a) 
 
According to the general procedure, compound 19a was isolated as a yellowish solid  
(104 mg, 98%); mp. = 189 – 191 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.12 (d, 6H, 3J = 6.9 Hz, CH3), 2.74 (sept, 1H, 3J = 6.9 Hz, 
CHi-Pr), 3.61 (s, 3H, OCH3), 6.42 - 6.47 (m, 2H, CH), 6.63 - 6.67 (m, 2H, CH), 6.76 - 6.79 (m, 
2H, CH), 6.84 - 6.92 (m, 4H, CH), 6.98 - 7.02 (m, 3H, CH), 7.13 - 7.18 (m, 6H, CH), 
7.35 - 7.42 (m, 4H, CH).  
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13C NMR (75 MHz, CDCl3): δ = 23.8 (CH3), 33.5 (CHi-Pr), 54.9 (OCH3), 112.3, 125.4, 126.0 
(CH), 127.1 (2 x CH), 127.3 (2 x CH), 127.4, 130.1, 130.2 (CH), 130.4 (C), 131.1, 131.3, 131.6, 
133.8, 134.0, 135.7, 138.6, 141.0, 146.7, 149.8, 156.2, 156.4, 157.6 (C).  
MS (EI, 70 eV): m/z (%) = 530 (M+, 92), 281 (15), 155 (100), 127 (43), 111 (23), 97 (40), 85 
(51), 71 (90), 57 (98), 43 (57).  
HRMS (ESI): calcd. for C39H34NO ([M+H]+): 532.26349; found: 532.2641.  
IR (ATR, cm-1): ~  = 2956 (w), 2923 (w), 2852 (w), 1731 (w), 1607 (w), 1510 (m), 1387 (m), 
1244 (s), 1174 (m), 1028 (m), 835 (m), 753 (m), 693 (s), 671 (s), 564 (m). 
 
4-(4-Methoxyphenyl)-5-(4-(trifluoromethyl)phenyl)-2,3,6-tri-p-tolylpyridine (19b) 
 
According to the general procedure, compound 19b was isolated as a white solid  
(112 mg, 93%); mp. = 188 – 190 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.19, (s, 3H, CH3), 2.27 (s, 6H, CH3), 3.63 (s, 3H, OCH3), 
6.44 - 6.48 (m, 2H, CH), 6.58 - 6.63 (m, 2H, CH), 6.74 - 6.83 (m, 4H, CH), 6.95 - 7.01 (m, 6H, 
CH), 7.21 - 7.30 (m, 6H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.1 (2 x CH3), 21.2 (CH3), 54.9 (OCH3), 112.6 (CH), 124.1 
(q, 1JC–F = 271.9 Hz, CF3), 124.3 (q, 3JC–F = 3.7 Hz, CH), 128.2 (2 x CH), 128.3 (CH), 130.1 
(CH), 131.0, 131.4, 131.6 (CH), 132.1, 133.5, 135.3, 135.6, 137.0, 137.2, 137.5, 137.9, 143.0, 
149.8, 155.8, 156.8, 157.8 (C).  
19F NMR (282 MHz, CDCl3): δ = -61.9 (s, 3F, CF3). MS (EI, 70 eV): m/z (%) = 598 (M+, 100), 
454 (12), 149 (16), 111 (19), 97 (28), 91 (18), 83 (25), 71 (38), 57 (54), 43 (26).  
HRMS (EI, 70 eV): calcd. for C40H31Cl2F3NO: 598.23523; found: 598.23489.  
IR (ATR, cm-1): ~  = 2921 (w), 2853 (w), 1611 (m), 1501 (m), 1387 (m), 1320 (s), 1291 (m), 
1246 (s), 1163 (s), 1123 (s), 1065 (s), 1015 (m), 817 (s), 666 (m). 
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Synthesis of 2,3,5,6-tetraaryl-4-(4-methoxyphenyl)pyridines from 2,3,5,6-tetrachloro-4-
(4-methoxyphenyl)pyridines 
An argon-flushed glass pressure tube was charged with PdCl2(CH3CN)2 (0.015 mmol, 5 mol%), 
SPhos (0.03 mmol, 10mol%), 2,3,5,6-tetrachloro-4-(4-methoxyphenyl)pyridine (4a) 
(0.3 mmol), the appropriate aryl boronic acid (2.4 mmol, 8.0 eq.), K3PO4 (2.4 mmol, 8.0 eq.) 
and anhydrous toluene (6 mL). The tube was sealed with a teflon cap and the reaction mixture 
was stirred at 100 °C for 20 hours. The resulting mixture was cooled down to room temperature, 
diluted with water and extracted with dichloromethane. The combined organic layers were dried 
over Na2SO4, filtered and the solvent was evaporated. After, the crude residue was purified by 
column chromatography on silica gel using a mixture of hexane and dichloromethane as eluent.  
 
2,3,5,6-Tetrakis(4-fluorophenyl)-4-(4-methoxyphenyl)pyridine (20a) 
 
According to the general procedure, compound 20a was isolated as a white solid (131 mg, 
78%); mp. = 252 – 254 °C. 
1H NMR (400 MHz, CDCl3): δ = 3.65 (s, 3H, OCH3), 6.47 - 6.51 (m, 2H, CH), 6.58 - 6.61 (m, 
2H, CH), 6.70 - 6.75 (m, 4H, CH), 6.78 - 6.83 (m, 4H, CH), 6.84 - 6.90 (m, 4H, CH), 
7.29 - 7.34 (m, 4H, CH).  
13C NMR (100 MHz, CDCl3): δ = 54.9 (OCH3), 112.8 (CH), 114.6 (d, 2JC–F = 21.1 Hz, CH), 
114.7 (d, 2JC–F = 21.9 Hz, CH), 129.6 (C), 131.3 (CH), 131.8 (d, 3JC–F = 8.2 Hz, CH), 132.7 (d,  
3JC–F = 7.8 Hz, CH), 133.1 (C), 134.1 (d, 4JC–F = 3.6 Hz, C), 136.4 (d, 4JC–F = 2.8 Hz, C), 150.5, 
155.6, 157.9 (C), 161.3 (d, 1JC–F = 246.7 Hz, CF), 162.2 (d, 1JC–F = 247.6 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -113.8 (s, 2F, CF), -114.8 (s, 2F, CF). MS 
(EI, 70 eV): m/z (%) = 560 (M+, 100), 516 (12), 244 (4), 183 (4).  
HRMS (EI, 70 eV): calcd. for C36H22F4NO: 560.16320; found: 560.16315.  
IR (ATR, cm-1): ~  = 2932 (w), 2832 (w), 1603 (m), 1510 (s), 1389 (m), 1247 (s), 1220 (s), 1156 
(s), 1040 (m), 815 (s), 533 (s).  
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EA: calcd. for C36H23F4NO (561.57): C, 77.00; H, 4.13; N, 2.49; found: C, 77.25; H, 4.48; 
N, 2.51. 
 
 
4-(4-Methoxyphenyl)-2,3,5,6-tetra-p-tolylpyridine (20b) 
 
According to the general procedure, compound 20b was isolated as a white solid (100 mg, 
61%); mp. = 234 – 236 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.18 (s, 6H, CH3), 2.26 (s, 6H, CH3), 3.63 (s, 3H, OCH3), 
6.42 - 6.47 (m, 2H, CH), 6.60 - 6.64 (m, 2H, CH), 6.71 - 6.75 (m, 4H, CH), 6.79 - 6.81 (m, 4H, 
CH), 6.94 - 6.97 (m, 4H, CH), 7.25 - 7.29 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.1, 21.2 (CH3), 54.9 (OCH3), 112.3, 128.1, 130.1 (CH), 
130.7 (C), 131.1, 131.5 (CH), 133.6, 135.4, 136.9, 155.8, 157.5 (C).  
MS (EI, 70 eV): m/z (%) = 544 (M+, 100), 529 (5), 500 (7), 234 (4), 227 (4), 220 (4), 69 (10), 
44 (7).  
HRMS (EI, 70 eV): calcd. for C40H34NO: 544.26349; found: 544.26318.  
IR (ATR, cm-1): ~  = 3025 (w), 2918 (w), 1611 (m), 1499 (m), 1242 (s), 1171 (m), 1049 (m), 
808 (s), 748 (m), 521 (m).  
EA: calcd. for C40H35NO (545.71): C, 88.04; H, 6.46; N, 2.57; found: C, 88.26; H, 6.48; 
N, 2.45. 
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4-(4-Methoxyphenyl)-2,3,5,6-tetrakis(4-(trifluoromethyl)phenyl)pyridine (20c) 
 
According to the general procedure, compound 20c was isolated as a white solid (185 mg, 
81%); mp. = 240 – 242 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.65 (s, 3H, OCH3), 6.47 - 6.52 (m, 2H, CH), 6.56 - 6.61 (m, 
2H, CH), 7.00 (d, 4H, 3J = 8.1 Hz, CH), 7.32 (d, 4H, 3J = 8.1 Hz, CH), 7.41 - 7.47 (m, 8H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.0 (OCH3), 113.1 (CH), 123.8 (q, 1JC–F = 272.3 Hz, CF3), 
123.9 (q, 1JC–F = 272.1 Hz, CF3), 124.8 (q, 3JC–F = 3.8 Hz, CH), 128.3 (CH), 129.5 (q,  
2JC–F = 32.9 Hz, C), 130.3, 131.2, 131.4 (CH), 133.5, 141.4, 143.4, 150.5, 155.7, 158.4 (C).  
19F NMR (282 MHz, CDCl3): δ = -62.1 (s, 3F, CF3), -62.2 (s, 3F, CF3).  
MS (EI, 70 eV): m/z (%) = 760 (M+, 100), 742 (5), 716 (10), 381 (5).  
HRMS (EI, 70 eV): calcd. for C40H22F12NO: 760.15043; found: 760.14943.  
IR (ATR, cm-1): ~  = 2936 (w), 1616 (m), 1516 (m), 1321 (s), 1163 (s), 1106 (s), 1065 (s), 1015 
(s), 853 (s), 833 (s), 669 (m).  
EA: calcd. for C40H23F12NO (761.60): C, 63.08; H, 3.04; N, 1.84; found: C, 63.34; H, 3.36; 
N, 1.85. 
 
2,3,5,6-Tetrakis(4-ethoxyphenyl)-4-(4-methoxyphenyl)pyridine (20d) 
 
According to the general procedure, compound 20d was isolated as a white solid  
(158 mg, 79%); mp. = 231 – 233 °C. 
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1H NMR (300 MHz, CDCl3): δ = 1.30 - 1.37 (m, 12H, CH3), 3.63 (s, 3H, OCH3), 3.88 (q, 4H, 
3J = 7.0 Hz, CH2), 3.96 (q, 4H, 3J = 7.0 Hz, CH2), 6.44 - 6.48 (m, 2H, CH), 6.51 - 6.56 (m, 4H, 
CH), 6.59 - 6.64 (m, 2H, CH), 6.65 - 6.70 (m, 4H, CH), 6.72 - 6.76 (m, 4H, CH), 7.29 - 7.34 
(m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 14.7, 14.8 (CH3), 54.9 (OCH3), 63.0, 63.1 (CH2), 112.4, 
113.4, 113.5 (CH), 130.8, 131.0 (C), 131.4, 131.5, 132.3 (CH), 132.8, 155.6, 157.0, 157.4, 
158.1 (C).  
MS (EI, 70 eV): m/z (%) = 665 (M+, 100), 636 (8), 575 (11), 99 (14), 44 (10).  
HRMS (EI, 70 eV): calcd. for C44H43NO5: 665.31357; found: 665.31230.  
IR (ATR, cm-1): ~  = 2979 (w), 2923 (w), 1605 (m), 1514 (m), 1388 (m), 1239 (s), 1172 (s), 
1112 (s), 1040 (s), 824 (s), 655 (m), 553 (s).  
EA: calcd. for C44H43NO5 (665.82): C, 79.37; H, 6.51; N, 2.10; found: C, 78.89; H, 6.86; 
N, 2.09. 
 
 
Synthesis of 2,3,5,6-tetraarylpyrazines 
First of all, solutions of Pd(OAc)2 and P(Cy)3 were prepared in dried and filled with argon 
Schlenk tubes (both 0.0125 mmol, 5 mol%) using 1 mL of extra dry THF and toluene, 
respectively. Solutions were stirred at room temperature for 10 mins. 
To an argon-flushed glass pressure tube, 50 µL of Pd(OAc)2 solution (0.000625 mmol, 
0.25 mol%) was added4. After the removal of THF via evacuation of pressure tube, 100µL of 
P(Cy)3 (0.00125 mmol, 0.5 mol%), tetrachloropyrazine (54 mg, 0.25 mmol), the aryl boronic 
acid (2 mmol, 8.0 equiv.) and K3PO4 (2 mmol, 8.0 equiv.) were added, followed by the injection 
of dry toluene (3.5 mL). The tube was closed with a teflon screw cap and the reaction mixture 
was stirred at 100 °C for 18 hours. Subsequently, the mixture was cooled down to room 
temperature and diluted with water and dichloromethane. The aqueous layer was extracted three 
times with dichloromethane. Combined organic layers were dried over Na2SO4 and filtered. 
Unless otherwise noted, the solvent was evaporated and the residue was purified by column 
chromatography on silica gel using a mixture of hexane and dichloromethane as eluent. 
                                                          
4 In case of compounds 21k-p, better yields have been obtained by increasing the amount of catalyst:  
Pd(OAc)2 (1.1 mg, 2 mol%), P(Cy)3 (2.8mg, 4 mol%). 
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2,3,5,6-Tetraphenylpyrazine (21a) 
 
According to the general procedure, compound 21a was isolated as a white solid  
(93 mg, 97%); mp. = 248 – 250 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.29 - 7.34 (m, 12H), 7.60 - 7.66 (m, 8H). 
13C NMR (75 MHz, CDCl3): δ = 128.2 (CH), 128.5 (CH), 129.8 (CH), 138.4 (C), 148.4 (C).  
MS (EI, 70 eV): m/z (%) = 384 (M+, 100), 305 (7), 178 (44), 152 (8), 103 (10).  
HRMS (ESI): calcd. for C28H21N2 ([M+H]+): 385.16993; found: 385.17036.  
IR (ATR, cm-1): ~  = 3038 (w), 1389 (m), 1170 (m), 1104 (m), 1011 (m), 762 (s), 692 (s), 536 
(s). 
 
2,3,5,6-Tetrakis(4-(trifluoromethyl)phenyl)pyrazine (21b) 
 
According to the general procedure, compound 21b was isolated as a white solid 
(139 mg, 85%); mp. = 265 – 266 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.62 (d, 8H, 3J = 8.2 Hz), 7.74 (d, 8H, 3J = 8.2 Hz).  
13C NMR (75 MHz, CDCl3): δ = 123.8 (q, 1JC–F = 272.3 Hz, CF3), 125.5 (q, 3JC–F = 3.8 Hz, 
CH), 130.1 (CH), 131.3 (q, 2JC–F = 32.6 Hz, C), 140.8 (C), 147.9 (C). 
19F NMR (282 MHz, CDCl3): δ = -62.3 (s, 12F, CF3). 
MS (EI, 70 eV): m/z (%) = 656 (M+, 100), 637 (15), 587 (14), 314 (77), 295 (15), 264 (10), 225 
(7), 171 (7).  
HRMS (ESI): calcd. for C32H17F12N2([M+H]+): 657.11946; found: 657.1192.  
IR (ATR, cm-1): ~  = 1322 (s), 1167 (m), 1105 (s), 1011 (m), 849 (s), 631 (m), 535 (m).  
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EA: calcd. for C32H16F12N2 (656.46): C, 58.55; H, 2.46; N, 4.27; found: C, 57.92; H, 2.32; 
N, 4.23. 
 
2,3,5,6-Tetra-p-tolylpyrazine (21c) 
 
According to the general procedure, compound 21c was isolated as a white solid 
(103 mg, 93%); mp. = 284 – 286 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.35 (s, 12H, CH3), 7.09 - 7.13 (m, 8H), 7.52 - 7.56 (m, 8H). 
13C NMR (75 MHz, CDCl3): δ = 21.3 (CH3), 128.9 (CH), 129.6 (CH), 135.8 (C), 138.3 (C), 
147.7 (C).  
MS (EI, 70 eV): m/z (%) = 440 (M+, 100), 425 (10), 206 (19), 189 (8).  
HRMS (ESI): calcd. for C32H29N2 ([M+H]+): 441.23253; found: 441.23245.  
IR (ATR, cm-1): ~  = 2917 (w), 1385 (s), 1172 (m), 1096 (m), 1009 (m), 820 (s), 728 (s), 626 
(m), 530 (s), 513 (s). 
 
2,3,5,6-Tetrakis(4-isopropylphenyl)pyrazine (21d) 
 
According to the general procedure, compound 21d was isolated as off-white solid  
(133 mg, 96%); mp. = 279 – 281 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.24 (d, 24H, 3J = 6.9 Hz, CH3), 2.90 (sept, 4H, 3J = 6.9 Hz,  
CHi-Pr), 7.13 - 7.17 (m, 8H), 7.56 - 7.60 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 23.8 (CH3), 33.8 (C Hi-Pr), 126.2 (CH), 129.7 (CH), 136.1 (C), 
147.5 (C), 149.2 (C).  
MS (EI, 70 eV): m/z (%) = 552 (M+, 100), 537 (11), 509 (7).  
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HRMS (ESI): calcd. for C40H45N2 ([M+H]+): 553.35773; found: 553.35861.  
IR (ATR, cm-1): ~  = 2959 (m), 2926 (w), 2866 (w), 1388 (s), 1181 (m), 1098 (m), 1006 (m), 
839 (s), 632 (m), 552 (s). 
 
2,3,5,6-Tetrakis(4-methoxyphenyl)pyrazine (21e) 
 
According to the general procedure, compound 21e was isolated as a light brown solid  
(113 mg, 90%); mp. = 278 – 280 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.81 (s, 12H, OCH3), 6.81 - 6.86 (m, 8H), 7.56 - 7.61 (m, 
8H).  
13C NMR (75 MHz, CDCl3): δ = 55.2 (OCH3), 113.6 (CH), 131.0 (CH), 131.2 (C), 146.8 (C), 
159.8 (C).  
MS (EI, 70 eV): m/z (%) = 504 (M+, 100), 252 (12), 238 (15), 223 (34), 195 (10), 152 (12), 133 
(11).  
HRMS (EI, 70 eV): calcd. for C32H28N2O4: 504.20436; found: 504.20469.  
IR (ATR, cm-1): ~  = 2926 (w), 2834 (w), 1602 (s), 1573 (m), 1511 (s), 1418 (m), 1381 (s), 1295 
(s), 1244 (s), 1164 (s), 1027 (s), 830 (s), 796 (s), 740 (m), 529 (s). 
 
2,3,5,6-Tetrakis(3-(trifluoromethyl)phenyl)pyrazine (21f) 
 
According to the general procedure, compound 21f was isolated as a white solid  
(157 mg, 96%); mp. = 165 – 167 °C. 
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1H NMR (300 MHz, CDCl3): δ = 7.48 (t, 4H, 3J = 7.8 Hz), 7.65 (d, 4H, 3J = 7.8 Hz), 7.75 (d, 
4H, 3J = 7.8 Hz), 7.86 (bs, 4H).  
13C NMR (75 MHz, CDCl3): δ = 123.6 (q, 1JC–F = 271.9 Hz, CF3), 125.9 (q, 3JC–F = 3.6 Hz, 
CH), 126.7 (q, 3JC–F = 3.8 Hz, CH), 129.1 (CH), 131.1 (q, 2JC–F = 32.6 Hz, C), 133.0 (CH), 
138.0 (C), 148.1 (C).  
19F NMR (282 MHz, CDCl3): δ = -62.5 (s, 12F, CF3).  
MS (EI, 70 eV): m/z (%) = 656 (M+, 100), 637 (12), 314 (99), 295 (10), 264 (7), 225 (11), 171 
(17).  
HRMS (EI, 70 eV): calcd. for C32H16F12N2: 656.11164; found: 656.11102.  
IR (ATR, cm-1): ~  = 1323 (s), 1280 (m), 1164 (s), 1127 (s), 1069 (s), 908 (m), 801 (m), 700 (s).  
EA: calcd. for C32H16F12N2 (656.46): C, 58.55; H, 2.46; N, 4.27; found: C, 58.85; H, 2.28; 
N, 4.35. 
 
 
2,3,5,6-Tetrakis(4-ethylphenyl)pyrazine (21g) 
 
According to the general procedure, compound 21g was isolated as a white solid 
(108 mg, 87%); mp. = 235 – 236 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.23 (t, 12H, 3J = 7.5 Hz, CH3), 2.65 (q, 8H,3J = 7.5 Hz, 
CH2), 7.12 - 7.14 (m, 8H), 7.55 - 7.59 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 15.3 (CH3), 28.6 (CH2), 127.7 (CH), 129.7 (CH), 136.0 (C), 
144.6 (C), 147.6 (C).  
MS (EI, 70 eV): m/z (%) = 496 (M+, 100), 467 (12), 219 (28), 204 (14), 116 (11).  
HRMS (EI, 70 eV): calcd. for C36H36N2: 496.28730; found: 496.28760.  
IR (ATR, cm-1): ~  = 2961 (m), 2929 (w), 2870 (w), 1387 (s), 1180 (s), 1097 (m), 1007 (m), 632 
(m), 536 (m).  
EA: calcd. for C36H36N2 (496.68): C, 87.05; H, 7.31; N, 5.64; found: C, 86.96; H, 7.31; N, 5.63. 
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2,3,5,6-Tetrakis(4-fluorophenyl)pyrazine (21h) 
 
According to the general procedure, compound 21h was isolated as a white solid  
(113 mg, 99%); mp. = 233 – 234 °C. 
1H NMR (300 MHz, CDCl3): δ = 6.97 - 7.05 (m, 8H), 7.54 - 7.61 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 115.4 (d, 2JC–F = 21.8 Hz, CH), 131.6 (d, 3JC-F = 8.3 Hz, CH), 
134.0 (d, 4JC-F = 3.2 Hz, C), 147.3 (C), 163.1 (d, 1JC–F = 250.1 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -111.7 (s, 4F, CF).  
MS (EI, 70 eV): m/z (%) = 456 (M+, 100), 359 (6), 214 (36).  
HRMS (EI, 70 eV): calcd. for C28H16F4N2: 456.12441; found: 456.12366. 
IR (ATR, cm-1): ~  = 1602 (s), 1510 (s), 1415 (m), 1384 (s), 1226 (s), 1152 (s), 1108 (m), 1011 
(m), 839 (s), 735 (m), 617 (m), 526 (s).  
EA: calcd. for C28H16F4N2 (456.43): C, 73.68; H, 3.53; N, 6.14; found: C, 73.64; H, 3.33; 
N, 6.09. 
 
2,3,5,6-Tetrakis(3,5-dimethylphenyl)pyrazine (21i) 
 
According to the general procedure, compound 21i was isolated as a white solid  
(101 mg, 81%); mp. = 275 – 277 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.24 (s, 24H, CH3), 6.94 (bs, 4H), 7.19 (bs, 8H).  
13C NMR (75 MHz, CDCl3): δ = 21.2 (CH3), 127.6 (CH), 129.9 (CH), 137.3 (C), 138.5 (C), 
148.8 (C).  
MS (EI, 70 eV): m/z (%) = 496 (M+, 100), 248 (10), 133 (22).  
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HRMS (EI, 70 eV): calcd. for C36H36N2: 496.28730; found: 496.28686.  
IR (ATR, cm-1): ~  = 3025 (w), 2912 (m), 2855 (w), 1600 (m), 1391 (s), 1374 (s), 1187 (m), 
1154 (m), 855 (s), 843 (s), 691 (s), 424 (m).  
EA: calcd. for C36H36N2 (496.68): C, 87.05; H, 7.31; N, 5.64; found: C, 86.89; H, 7.44; N, 5.39. 
 
2,3,5,6-Tetra-m-tolylpyrazine (21j) 
 
According to the general procedure, compound 21j was isolated as a white solid 
(104 mg, 94%); mp. = 153 – 154 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 12H, CH3), 7.13 - 7.16 (m, 8H), 7.28 - 7.32 (m, 4H), 
7.55 (bs, 4H).  
13C NMR (75 MHz, CDCl3): δ = 21.4 (CH3), 127.0 (CH), 127.8 (CH), 129.2 (CH), 130.4 (CH), 
137.8 (C), 138.5 (C), 148.6 (C).  
MS (EI, 70 eV): m/z (%) = 440 (M+, 100), 425 (12), 384 (26), 258 (16), 206 (11), 102 (17), 69 
(13), 57 (13).  
HRMS (EI, 70 eV): calcd. for C32H28N2: 440.22470; found: 440.22433.  
IR (ATR, cm-1): ~  = 3034 (w), 2915 (w), 1371 (m), 1167 (m), 847 (m), 778 (s), 704 (s), 471 
(s), 447 (m).  
EA: calcd. for C32H28N2 (440.58): C, 87.24; H, 6.41; N, 6.36; found: C, 87.30; H, 6.36; N, 6.32. 
 
2,3,5,6-Tetrakis(4-isopropoxyphenyl)pyrazine (21k) 
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According to the general procedure, but with increased amount of Pd(OAc)2 (1.1 mg, 2 mol%) 
and P(Cy)3 (2.8mg, 4 mol%), compound 21k was isolated as a white solid 
(142 mg, 92%); mp. = 241 – 243 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.33 (d, 24H, 3J = 6.1 Hz, CH3), 4.55 (sept, 4H, 3J = 6.1 Hz, 
CHi-Pr), 6.79 - 6.82 (m, 8H), 7.55 - 7.59 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 22.0 (CH3), 69.7 (C Hi-Pr), 115.3 (CH), 131.0 (CH), 131.0 (C), 
146.7 (C), 158.1 (C).  
MS(EI, 70 eV): m/z (%) = 616 (M+, 100), 574 (13), 447 (37), 224 (12), 210 (16), 57 (14), 43 
(14).  
HRMS (EI, 70 eV): calcd. for C40H44N2O4: 616.32956; found: 616.32852.  
IR (ATR, cm-1): ~  = 2974 (m), 2923 (w), 1603 (s), 1510 (s), 1382 (s), 1287 (m), 1240 (s), 1163 
(s), 1116 (s), 948 (s), 834 (s), 742 (m), 742 (m), 623 (m), 536 (s). 
 
 
2,3,5,6-Tetrakis(4-vinylphenyl)pyrazine (21l) 
 
According to the general procedure, but with increased amount of Pd(OAc)2 (1.1 mg, 2 mol%) 
and P(Cy)3 (2.8mg, 4 mol%), compound 21l was isolated as an off-white solid  
(93 mg, 76%); mp. > 375 °C. 
1H NMR (300 MHz, CDCl3): δ = 5.27 (dd, 4H, 3Jcis = 10.9 Hz, 2Jgem = 0.7 Hz, CH=CHcis-H), 
5.77 (dd, 4H, 3Jtrans = 17.5 Hz, 2Jgem = 0.7 Hz, CH=CH-Htrans), 6.71 (dd, 4H,Jtrans = 17.5 Hz, 
3Jcis = 10.9 Hz, CH=CH2), 7.34 - 7.38 (m, 8H), 7.60 - 7.64 (m, 8H).  
13C NMR (75 MHz, CDCl3): δ = 114.5 (CH), 126.1 (CH), 130.0 (CH), 136.3 (CH), 137.7 (C), 
137.8 (C), 147.5 (C).  
MS (EI, 70 eV): m/z (%) = 488 (M+, 100), 461 (4), 230 (17), 202 (5), 71 (4).  
HRMS (EI, 70 eV): calcd. for C36H28N2: 488.22470; found: 488.22447.  
IR (ATR,  cm-1): ~  = 2950 (w), 2917 (w), 2851 (w), 1627 (m), 1388 (s), 1174 (m), 1101 (m), 
987 (s), 901 (s), 845 (s), 534 (s). 
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2,3,5,6-Tetrakis(3-methoxyphenyl)pyrazine (21m) 
 
According to the general procedure, but with increased amount of Pd(OAc)2 (1.1 mg, 2 mol%) 
and P(Cy)3 (2.8mg, 4 mol%), compound 21m was isolated as a light brown solid 
(125 mg, 99%); mp. = 170 – 172 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.69 (s, 12H, OCH3), 6.85 - 6.89 (m, 4H), 7.15 - 7.22 (m, 
12H).  
13C NMR (75 MHz, CDCl3): δ = 55.2 (OCH3), 114.8 (2 x CH), 122.4 (CH), 129.2 (CH), 139.6 
(C), 148.2 (C), 159.2 (C).  
MS (EI, 70 eV): m/z (%) = 504 (M+, 100), 262 (12), 207 (9), 188 (16), 145 (14), 117 (10), 73 
(10). 60 (12), 43 (15).  
HRMS (EI, 70 eV): calcd. for C32H28N2O4: 504.20436; found: 504.20339.  
IR (ATR, cm-1): ~  = 3006 (w), 2921 (m), 2853 (w), 1578 (s), 1424 (m), 1377 (s), 1290 (m), 
1229 (s), 1028 (s), 775 (s), 719 (s).  
EA: calcd. for C32H28N2O4 (504.58): C, 76.17; H, 5.59; N, 5.55; found: C, 76.49; H, 5.50; 
N, 5.42. 
 
 
2,3,5,6-Tetra-o-tolylpyrazine (21n) 
 
According to the general procedure, but with increased amount of Pd(OAc)2 (1.1 mg, 2 mol%) 
and P(Cy)3 (2.8mg, 4 mol%), compound 21n was isolated as a white solid 
(109 mg, 99%); mp. = 252 – 254 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.27 (s, 12H, CH3), 6.99 - 7.06 (m, 4H), 7.08 - 7.15 (m, 12H).  
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13C NMR (75 MHz, CDCl3): δ = 20.1 (CH3), 125.2 (CH), 128.2 (CH), 130.2 (CH), 130.4 (CH), 
136.2 (C), 137.7 (C), 151.6 (C).  
MS (EI, 70 eV): m/z (%) = 440 (M+, 100), 425 (60), 349 (16), 205 (12), 73 (16), 60 (17), 43 
(14).  
HRMS (EI, 70 eV): calcd. for C32H28N2: 440.22470; found: 440.22351.  
IR (ATR, cm-1): ~  = 3016 (w), 2921 (w), 2852 (w), 1382 (s), 1081 (m), 1016 (m), 757 (s), 723 
(s), 460 (s).  
EA: calcd. for C32H28N2 (440.58): C, 87.24; H, 6.41; N, 6.36; found: C, 87.47; H, 6.69; N, 6.20. 
 
 
2,3,5,6-Tetrakis(2,5-dimethoxyphenyl)pyrazine (21o) 
 
Reaction was made according to the general procedure, but with increased amount of Pd(OAc)2 
(1.1 mg, 2 mol%) and P(Cy)3 (2.8mg, 4 mol%). After combined organic layers were dried over 
sodium sulphate, filtered and solvent was removed, compound 21o was isolated as a white solid 
by recrystallization of crude mixture from warm dichloromethane.(116 mg, 74%);  
mp. = 260 – 262 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.36 (s, 12H, OCH3), 3.70 (s, 12H, OCH3), 6.64 (d, 4H, 
3J = 8.9 Hz), 6.77 (dd, 4H, 3J = 8.9 Hz, 4J = 3.0 Hz), 7.05 (d, 4J = 3.0 Hz, 4H).  
13C NMR (75 MHz, CDCl3): δ = 55.4 (OCH3), 55.8 (OCH3), 111.9(CH), 115.3 (CH), 116.6 
(CH), 129.4 (C), 149.4 (C), 150.8 (C), 153.3 (C).  
MS (EI, 70 eV): m/z (%) = 624 (M+, 100), 609 (45), 593 (71), 579 (12), 487 (23), 312 (11), 60 
(10).  
HRMS (EI, 70 eV): calcd. for C36H36N2O8: 624.24662; found: 624.24559.  
IR (ATR, cm-1): ~  = 3002 (w), 2960 (w), 2833 (w), 1499 (s), 1447 (m), 1424 (s), 1275 (s), 1229 
(s), 1079 (m), 1042 (s), 1016 (s), 873 (m), 802 (s).  
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EA: calcd. for C36H36N2O8 (624.68): C, 69.22; H, 5.81; N, 4.48; found: C, 69.58; H, 5.74; 
N, 4.66. 
 
2,3,5,6-Tetrakis(3-cyanophenyl)pyrazine (21p) 
 
According to the general procedure, but with increased amount of Pd(OAc)2 (1.1 mg, 2 mol%) 
and P(Cy)3 (2.8mg, 4 mol%), compound 21p was isolated as a white solid 
(61 mg, 50%); mp. = 296 – 297 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.48 (t, 4H, 3J = 7.8 Hz), 7.70 - 7.76 (m, 8H), 7.96 (bs, 4H).  
13C NMR (75 MHz, CDCl3): δ = 113.4 (C), 117.9 (C), 129.6 (CH), 133.1 (CH), 133.2 (CH), 
133.8 (CH), 138.0 (C), 147.2 (C).  
MS (EI, 70 eV): m/z (%) = 484 (M+, 100), 380 (7), 355 (5), 228 (38), 201 (8), 60 (5), 44 (5).  
HRMS (EI, 70 eV): calcd. for C32H16N6: 484.14310; found: 484.14195.  
IR (ATR, cm-1): ~  = 3062 (w), 2953 (w), 2227 (m), 1371 (m), 1164 (m), 917 (m), 799 (s), 697 
(s), 515 (m). 
 
Synthesis of 2,3,4,5-tetraalkenylpyrazines 
An argon-flushed glass pressure tube was charged with Pd(dba)2 (0.005 mmol, 2 mol%), 
CataCXium A (0.01 mmol, 4 mol%), tetrachloropyrazine (54.4 mg, 0.25 mmol), the 
appropriate alkenyl boronic acid or pinacol ester (2 mmol, 8.0 eq.), K3PO4 (2 mmol, 8.0 eq.) 
and anhydrous 1,4-dioxane (4 mL). The tube was sealed with a teflon cap and the reaction 
mixture was stirred at 100 °C for 20 hours. The resulting mixture was cooled down to room 
temperature, diluted with water and extracted with dichloromethane. The combined organic 
layers were dried over Na2SO4, filtered and the solvent was evaporated. After, the crude residue 
was purified by column chromatography on silica gel using a mixture of hexane and 
dichloromethane as eluent. Gained solids, in the end, were washed with cold hexane to give 
pure orange-coloured products. 
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2,3,5,6-Tetra((E)-styryl)pyrazine (22a) 
 
According to the general procedure, compound 22a was isolated as an orange solid  
(119 mg, 97%); mp. = 258 – 259 °C. 
1H NMR (400 MHz, CDCl3): δ = 7.31 - 7.35 (m, 4H, CH), 7.39 - 7.43 (m, 8H, CH), 7.54 (d, 
4H, 3J = 15.5 Hz, CH=CH), 7.66 - 7.68 (m, 8H, CH), 7.96 (d, 4H, 3J = 15.5 Hz, CH=CH).  
13C NMR (100 MHz, CDCl3): δ = 122.2 (CH=CH), 127.4, 128.6, 128.8 (CH), 135.9 (CH=CH), 
136.8, 145.2 (C).  
MS (EI, 70 eV): m/z (%) = 488 (M+, 100), 411 (63), 397 (34), 320 (14), 167 (10), 115 (11), 91 
(16). HRMS (EI, 70 eV): calcd. for C36H28N2: 488.22470; found: 488.22372.  
IR (ATR, cm-1): ~  = 3019 (w), 1622 (m), 1493 (m), 1381 (m), 1165 (s), 955 (s), 740 (s), 685 
(s), 588 (s), 457 (s).  
EA: calcd. for C36H28N2 (488.62): C, 88.49; H, 5.78; N, 5.73; found: C, 88.64; H, 5.54; N, 5.71. 
 
2,3,5,6-Tetrakis((E)-4-methylstyryl)pyrazine (22b) 
 
According to the general procedure, compound 22b was isolated as an orange solid  
(129 mg, 95%); mp. = 292 – 294 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.39 (s, 12H, CH3), 7.21 (d, 8H, 3J = 7.9 Hz, CH), 7.48 (d, 
4H, 3J = 15.5 Hz, CH=CH), 7.55 (d, 8H, 3J = 7.9 Hz, CH), 7.91 (d, 4H, 3J = 15.5 Hz, CH=CH).  
13C NMR (75 MHz, CDCl3): δ = 21.4 (CH3), 121.3 (CH=CH), 127.3, 129.4 (CH), 134.2 (C), 
135.5 (CH=CH), 138.6, 145.1 (C).  
MS (EI, 70 eV): m/z (%) = 544 (M+, 100), 453 (35), 439 (28), 287 (13), 195 (21), 119 (14), 105 
(19), 44 (17), 36 (10). HRMS (EI, 70 eV): calcd. for C40H36N2: 544.28730; found: 544.28748.  
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IR (ATR, cm-1): ~  = 2913 (w), 1622 (m), 1508 (m), 1382 (m), 1165 (s), 956 (s), 797 (s), 474 
(s).  
EA: calcd. for C40H36N2 (544.73): C, 88.20; H, 6.66; N, 5.14; found: C, 88.05; H, 6.61; N, 5.07. 
 
2,3,5,6-Tetrakis((E)-4-fluorostyryl)pyrazine (22c) 
 
According to the general procedure, compound 22d was isolated as an orange solid  
(139 mg, 99%); mp. = 284 – 286 °C. 
1H NMR (300 MHz, DMSO-d6): δ = 7.25 - 7.33 (m, 8H, CH), 7.88 (d, 4H, 3J = 15.5 Hz, 
CH=CH), 7.97 - 8.05 (m, 12H, CH, CH=CH).  
13C NMR (75 MHz, DMSO-d6): δ = 115.8 (d, 2JC–F = 21.6 Hz, CH), 121.9 (CH=CH), 130.2 (d, 
3JC-F = 8.3 Hz, CH), 133.3 (d, 4JC-F = 3.2 Hz, C), 134.5 (CH=CH), 144.8 (C), 162.5 (d,  
1JC–F = 246.2 Hz, CF).  
19F NMR (282 MHz, CDCl3): δ = -111.6 (s, 4F, CF). MS (EI, 70 eV): m/z (%) = 560 (M+, 
100), 465 (38), 451 (19), 356 (10), 109 (16), 69 (11), 44 (13).  
HRMS (ESI): calcd. for C36H24F4N2 ([M+H]+): 561.19484; found: 561.19421.  
IR (ATR, cm-1): ~  = 1590 (m), 1503 (s), 1415 (m), 1226 (s), 1153 (s), 1091 (m), 964 (s), 813 
(s), 529 (s), 479 (s).  
EA: calcd. for C36H24F4N2 (560.58): C, 77.13; H, 4.32; N, 5.00; found: C, 77.44; H, 4.42; 
N, 4.99. 
 
2,3,5,6-Tetrakis((E)-4-methoxystyryl)pyrazine (22d) 
 
According to the general procedure, compound 22d was isolated as an orange solid  
(142 mg, 93%); mp. = 229 – 230 °C. 
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1H NMR (300 MHz, CDCl3): δ = 3.85 (s, 12H, OCH3), 6.93 (d, 8H, 3J = 8.5 Hz, CH), 7.35 (d, 
4H, 3J = 15.5 Hz, CH=CH), 7.58 (d, 8H, 3J = 8.5 Hz, CH), 7.85 (d, 4H, 3J = 15.5 Hz, CH=CH).  
13C NMR (75 MHz, CDCl3): δ = 55.3 (OCH3), 114.1(CH), 120.2 (CH=CH), 128.7 (CH), 129.8 
(C), 134.7 (CH=CH), 144.9, 159.9 (C).  
MS (EI, 70 eV): m/z (%) = 608 (M+, 100), 501 (34), 487 (18), 227 (18), 121 (74).  
HRMS (ESI): calcd. for C40H36N2O4 ([M+H]+): 609.27478; found: 609.27537.  
IR (ATR, cm-1): ~  = 3007 (w), 2929 (w), 2834 (w), 1602 (s), 1573 (m), 1508 (s), 1420 (m), 
1245 (s), 1162 (s), 1028 (s), 965 (s), 810 (s), 561 (s). 
 
2,3,5,6-Tetrakis((E)-3-methylstyryl)pyrazine (22e) 
 
According to the general procedure, compound 22e was isolated as an orange solid  
(96 mg, 70%); mp. = 200 – 202 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.41 (s, 12H, CH3), 7.16 (d, 4H, 3J = 7.5 Hz, CH), 7.28 - 7.33 
(m, 4H, CH), 7.44 - 7.50 (m, 12H, CH, CH=CH), 7.90 (d, 4H, 3J = 15.5 Hz, CH=CH).  
13C NMR (75 MHz, CDCl3): δ = 21.4 (CH3), 122.0 (CH=CH), 124.5, 128.2, 128.6, 129.4 (CH), 
135.8 (CH=CH), 136.8, 138.3, 145.2 (C).  
MS (EI, 70 eV): m/z (%) = 544 (M+, 100), 453 (43), 439 (27), 195 (12), 119 (10), 105 (15), 44 
(12).  
HRMS (ESI): calcd. for C40H36N2 ([M+H]+): 545.29513; found: 545.29509.  
IR (ATR, cm-1): ~  = 2913 (w), 1623 (m), 1597 (m), 1371 (m), 1232 (m), 1156 (m), 962 (s), 766 
(s), 685 (s), 431 (s).  
EA: calcd. for C40H36N2 (544.73): C, 88.20; H, 6.66; N, 5.14; found: C, 87.99; H, 6.64; N, 5.15. 
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Synthesis of 2,7-diaryl-1,8-naphthyridines 
To an argon flushed glass pressure tube were added Pd2(dba)3 (0.01 mmol, 2.5 mol%), S-Phos 
(0.04 mmol, 10 mol%), 26 (80 mg, 0.4 mmol), the aryl boronic acid (1.2 mmol, 3.0 equiv.), 
K3PO4 (1.2 mmol, 3.0 equiv.), followed by dry 1,4-dioxane (3 mL). The tube was closed by a 
teflon screw cap and the reaction mixture was stirred at 100 °C for 20 hours. Subsequently, the 
mixture was cooled to room temperature and diluted with water and dichloromethane. The 
layers were separated and the aqueous layer was extracted two times with dichloromethane. 
The combined organic layers were dried with sodium sulfate, filtered and the solvent was 
evaporated. The residue was purified by column chromatography (silica gel, hexane/ 
dichloromethane).  
 
 
2,7-Bis(4-(trifluoromethyl)phenyl)-1,8-naphthyridine (27b) 
 
According to the general procedure compound 27b was isolated as a white solid  
(141 mg, 84%) with mp. = 216 – 218 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.75 – 7.78 (m, 4H, CH), 7.98 (d, 3J = 8.4 Hz, 2H, CH), 8.29 
(d, 3J = 8.4 Hz, 2H, CH), 8.36 – 8.39 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 119.9 (CH), 121.2 (C), 124.0 (q, 1JC-F = 271.8 Hz, CF3), 125.7 
(q, 3JC-F = 3.86 Hz, CH), 128.3 (CH), 131.7 (q, 2JC-F = 32.6 Hz, C), 137.9 (CH), 141.7, 155.9, 
159.6 (C).  
IR (ATR, cm-1): ~  = 1602 (w), 1525 (w), 1322 (m), 1128 (s), 1103 (s), 1063 (s), 1014 (m), 842 
(s), 809 (s), 779 (m), 597 (m), 395 (w).  
MS (EI, 70 eV): m/z (%) = 418 (M+, 100), 399 (10), 349 (47), 209 (4), 199 (6), 189 (3), 177 
(3), 165 (3).  
HRMS (EI, 70 eV): calcd. for C22H12N2F6: 418.08992; found: 418.089463. 
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2,7-Bis(4-tert-butylphenyl)-1,8-naphthyridine (27c) 
 
According to the general procedure compound 27c was isolated as a white solid  
(145 mg, 92%) with mp. = 316 – 318 °C. 
1H NMR (300 MHz, CDCl3): δ = 1.36 (s, 18H, CH3), 7.51 – 7.55 (m, 4H, CH), 7.89 (d, 
3J = 8.5 Hz, 2H, CH), 8.15 (d, 3J = 8.5 Hz, 2H, CH), 8.20 – 8.24 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 31.2 (CH3), 34.7 (C), 119.1 (CH), 120.3 (C), 125.6, 127.7 
(CH), 135.9 (C), 137.2 (CH), 153.2, 156.2, 160.6 (C).  
IR (ATR, cm-1): ~  = 2960 (m), 1597 (s), 1494 (s), 1362 (w), 1308 (w), 1268 (m), 1111 (m), 
1014 (w), 780 (m), 748 (w), 562 (s), 541 (m).  
MS (EI, 70 eV): m/z (%) = 394 (M+, 41), 379 (100), 363 (22), 349 (7), 182 (13), 168 (11), 154 
(8), 41 (4).  
HRMS (EI, 70 eV): calcd. for C28H30N2: 394.24035; found: 394.240085. 
 
2,7-Bis(4-fluorophenyl)-1,8-naphthyridine (27d) 
 
According to the general procedure compound 27d was isolated as a white solid  
(92 mg, 72%) with mp. = 199 – 200 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.14 – 7.22 (m, 4H, CH), 7.87 (d, 3J = 8.5 Hz, 2H, CH), 8.19 
(d, 3J = 8.5 Hz, 2H, CH), 8.22 – 8.29 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 115.7 (d, 2JC-F = 21.7 Hz, CH), 119.1 (CH), 120.3 (C), 129.9 
(d, 3JC-F = 8.5 Hz, CH), 134.8 (d, 4JC-F = 2.9 Hz, C), 137.5 (CH), 155.9, 159.8 (C), 164.1 (d, 
1JC-F = 250.0 Hz, CF).  
IR (ATR, cm-1): ~ = 1596 (s), 1510 (w), 1435 (w), 1308 (w), 1222 (s), 1160 (m), 839 (s), 808 
(s), 779 (m), 677 (m), 554 (w), 535 (m), 518 (s), 500 (s), 485 (w).  
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MS (EI, 70 eV): m/z (%) = 318 (M+, 100), 297 (3), 221 (3), 195 (4), 169 (3), 159 (4), 149 (7), 
120 (4), 75 (4).  
HRMS (EI, 70 eV): calcd. for C20H12F2N2: 318.09631; found: 318.095518.  
EA: calcd. for C20H12F2N2 (318.10): C, 75.46; H, 3.80; N, 8.80; found: C, 75.45; H, 3.89; 
N, 8.58. 
 
2,7-Bis(4-acetylphenyl)-1,8-naphthyridine (27e) 
 
According to the general procedure compound 27e was isolated as a white solid  
(120 mg, 82%) with mp. = 248 – 250 °C. 
1H NMR (400 MHz, CDCl3): δ = 2.62 (s, 6H, CH3), 7.97 (d, 3J = 8.5 Hz, 2H, CH), 8.05 – 8.08 
(m, 4H, CH), 8.26 (d, 3J = 8.5 Hz, 2H, CH), 8.33 – 8.36 (m, 4H, CH).  
13C NMR(100 MHz, CDCl3): δ = 26.7 (CH3), 120.0 (CH), 121.2 (C), 128.1, 128.6, 137.7 (CH), 
137.8, 142.6, 155.9, 159.7 (C), 197.7 (C=O).  
IR (ATR, cm-1): ~ = 1676 (s), 1602 (s), 1518 (m), 1356 (m), 1262 (s), 1135 (w), 1076 (w), 1013 
(w), 957 (m), 831 (m), 805 (s), 779 (m), 650 (w), 579 (m).  
MS (EI, 70 eV): m/z (%) = 366 (M+, 49), 351 (100), 323 (24), 280 (24), 168 (18), 140 (26), 126 
(5), 43 (9).  
HRMS (EI, 70 eV): calcd. for C24H18N2O2: 366.13628; found: 366.136075. 
 
2,7-Bis(3-(trifluoromethyl)phenyl)-1,8-naphthyridine (27f) 
 
According to the general procedure compound 27f was isolated as a white solid  
(156 mg, 93%) with mp. = 144 – 146 °C. 
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1H NMR (300 MHz, CDCl3): δ = 7.61 – 7.66 (m, 2H, CH), 7.72 – 7.74 (m, 2H, CH), 7.98 (d, 
3J = 8.5 Hz, 2H, CH), 8.30 (d, 3J = 8.5 Hz, 2H, CH), 8.44 – 8.47 (m, 2H, CH), 8.54 – 8.55 (m, 
2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 119.7 (CH), 121.1 (C), 124.0 (q, 1JC-F = 272.3 Hz, CF3), 124.8 
(q, 3JC-F = 3.8 Hz, CH), 126.6 (q, 3JC-F = 3.8 Hz, CH), 129.3, 131.2 (CH), 131.3 (q,  
2JC-F = 32.3 Hz, C), 138.0 (CH), 139.3, 155.9, 159.5 (C).  
IR (ATR, cm-1): ~  = 1603 (w), 1333 (s), 1254 (m), 1173 (m), 1118 (s), 1095 (s), 1066 (s), 798 
(s), 699 (s), 690 (s), 653 (m), 432 (w).  
MS (EI, 70 eV): m/z (%) = 418 (M+, 100), 399 (10), 349 (40), 209 (6), 199 (5), 189 (3), 164 
(3).  
HRMS (EI, 70 eV): calcd. for C22H12N2F6: 418.08992; found: 418.089450.  
EA: calcd. for C22H12N2F6 (418.09): C, 63.16; H, 2.89; N, 6.70; found: C, 63.01; H, 2.78; 
N, 6.64. 
 
2,7-Bis(4-vinylphenyl)-1,8-naphthyridine (27g) 
 
According to the general procedure compound 27g was isolated as a yellow solid  
(86 mg, 64%) with mp. = 217 – 218 °C. 
1H NMR (300 MHz, CDCl3): δ = 5.32 (dd, 3Jcis= 10.9 Hz, 2Jgem = 0.7 Hz, 2H, CH=CHcis-H), 
5.85 (dd, 3Jtrans= 17.5 Hz, 2Jgem= 0.7 Hz, 2H, CH=CH-Htrans), 6.77 (dd, Jtrans = 17.5 Hz, 
3Jcis = 10.9 Hz, 2H, CH=CH2), 7.53 – 7.57 (m, 4H, CH), 7.92 (d, 3J = 8.5 Hz, 2H, CH), 8.18 (d, 
3J = 8. 5 Hz, 2H, CH), 8.25 – 8.29 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 115.0 (C H2=CH), 119.3 (CH), 120.6 (C), 126.5, 128.2 (CH), 
136.2 (CH=CH2), 137.3 (CH), 137.9, 139.1, 156.1, 160.2 (C).  
MS (EI, 70 eV): m/z (%) = 334 (M+, 100), 307 (13), 207 (8), 193 (4), 159 (10), 44 (28), 32 (5).  
HRMS (ESI, 70 eV): calcd. for C24H19N2 ([M+H]+): 335.15428; found: 335.15362.  
IR (ATR, cm-1): ~  = 3003 (w), 2981 (w), 1596 (m), 1401 (w), 1140 (w), 990 (m), 909 (m), 840 
(s), 809 (s), 779 (m), 455 (m).  
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EA: calcd. for C24H18N2 (334.41): C, 86.20; H, 5.43; N, 8.38; found: C, 85.90; H, 5.27; N, 8.13. 
 
2,7-Distyryl-1,8-naphthyridine (27h) 
 
According to the general procedure compound 27h was isolated as a yellow solid  
(122 mg, 91%) with mp. = 250 – 252 °C. 
1H NMR (300 MHz, CDCl3): δ = 7.29 – 7.42 (m, 8H, CH)5, 7.55 (d, 3J = 8.2 Hz, 2H, CH), 
7.60 – 7.64 (m, 4H, CH), 7.95 (d, 3J = 16.2 Hz, 2H, CH=CH), 8.03 (d, 3J = 8.2 Hz, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 120.4 (CH), 120.9 (C), 127.4 (CH), 128.0 (C H=CH), 128.7, 
128.8 (CH), 136.0 (CH=C H), 136.2 (C), 136.7 (CH), 156.1, 159.2 (C).  
IR (ATR, cm-1): ~  = 2995 (w), 1594 (w), 1507 (w), 1447 (w), 956 (s), 805 (s), 782 (m), 745 
(s), 690 (s), 643 (m), 620 (m), 502 (m), 486 (m).  
MS (EI, 70 eV): m/z (%) = 333 (M+, 100), 257 (12), 229 (15), 166 (9), 159 (3), 77 (3).  
HRMS (ESI, 70 eV): calcd. for C24H19N2 ([M+H]+): 335.15428; found: 335.15422. 
 
 
Syntheses of N-phenyl-2,5-diarylpyrroles  
In argon flushed glass pressure tube were placed 0.01 mmol (1.0 mol%) of Pd(OPiv)2, 
1.0 mmol of N-phenylpyrrole, 2.4 mmol of the appropriate aryl bromide or aryl chloride and 
2.4 mmol of CsOPiv, followed by 1.5 g of tetrabutylammonium acetate. The pressure tube was 
closed with a teflon cap and the reaction mixture was stirred at 140 °C for 20 h. Afterward, the 
mixture was cooled to room temperature and diluted with distilled water and ethyl acetate. The 
water layer was extracted 2 times with ethyl acetate and the combined organic layers were 
washed with brine. The combined organic layers were dried with sodium sulfate and filtered. 
The solvent of the filtrate was evaporated and the product was purified by column 
chromatography.  
 
                                                          
5 Another peak of CH=CH  can be detected under multiplet via 2D NMR: 7.39 (d, 3J = 16.3 Hz, 2H, CH=CH). 
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1,2,5-Triphenyl-1H-pyrrole (32a) 
 
According to the general procedure, 32a was isolated as a light yellow solid (Ar-Br: 154 mg, 
52%), mp. = 231 – 232 °C.  
1H NMR (300 MHz, CDCl3): δ = 6.47 (s, 2H, CH), 7.00 - 7.06 (m, 6H, CH), 7.11 – 7.17 (m, 
6H, CH), 7.20 – 7.23 (m, 3H, CH).  
13C NMR (75 MHz, CDCl3): δ = 109.9 (CH), 126.2 (CH), 127.2 (CH), 127.8 (CH), 128.7 
(2 x CH), 128.8 (CH), 133.2 (C), 135.8 (C), 138.9 (C).  
IR (ATR, cm-1): ~  = 3052 (w), 2916 (w), 1596 (m), 1494 (m), 1481 (m), 1395 (w), 1334 (w), 
774 (s), 692 (s), 595 (m).  
MS (EI, 70 eV): m/z (%) = 295 (M+, 100), 217 (10), 191 (25), 165 (11), 139 (7), 115 (8), 77 
(19), 51 (13).  
HRMS (EI, 70 eV): calcd. for C22H17N: 295.13555; found: 295.13543. 
 
N-Phenyl-2,5-bis(4-(trifluoromethyl)phenyl)-1H-pyrrole (32b or 32h) 
 
According to the general procedure, title compound was isolated as a light yellow solid  
(32b with Ar-Br: 223 mg, 52%; 32h with Ar-Cl: 95 mg, 22%). mp. = 187 – 189 °C.  
1H NMR (300 MHz, CDCl3): δ = 6.56 (s, 2H, CH), 7.01 – 7.04 (m, 2H, CH), 7.11 – 7.14 (m, 
4H, CH), 7.29 – 7.32 (m, 3H, CH), 7.39 – 7.42 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 111.4 (CH), 124.1 (q, 1JC-F = 271.9 Hz, CF3), 124.9 (q,  
3JC-F = 3.9 Hz, CH), 128.0 (CH), 128.2 (q, 2JC-F = 32.2 Hz, C), 128.4 (CH), 128.7 (CH), 129.3 
(CH), 135.1 (C), 136.3 (C), 138.2 (C).  
IR (ATR, cm-1): ~  = 1610 (w), 1497 (w), 1421 (m), 1347 (s), 1323 (s), 1162 (s), 1115 (s), 901 
(m), 774 (s), 697 (s).  
MS (EI, 70 eV): m/z (%) = 431 (M+, 100), 412 (9), 259 (8), 191 (10), 146 (9), 77 (10).  
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HRMS (EI, 70 eV): calcd. for C24H15F6N: 431.11032; found: 431.10984.  
 
N-Phenyl-2,5-di(p-tolyl)-1H-pyrrole (32c) 
 
According to the general procedure, 32c was isolated as a light yellow solid  
(Ar-Br: 119 mg, 37%), mp. = 215 – 217 °C.  
1H NMR (300 MHz, CDCl3): δ = 2.27 (s, 6H, CH3), 6.43 (s, 2H, CH), 6.93 – 6.98 (m, 8H, CH), 
7.02 – 7.04 (m, 2H, CH), 7.22 – 7.24 (m, 3H, CH).  
13C NMR (75 MHz, CDCl3): δ = 21.0 (CH3), 109.4 (CH), 127.0 (CH), 128.5 (2 x CH), 128.6 
(CH), 128.9 (CH), 130.4 (C), 135.6 (C), 135.7 (C), 139.1 (C).  
IR (ATR, cm-1): ~  = 2917 (w), 1494 (s), 1332 (m), 814 (s), 768 (s), 693 (s), 579 (s), 521 (s), 
401 (s). MS (EI, 70 eV): m/z (%) = 323 (M+, 100), 205 (8), 191 (9), 77 (13), 51 (6).  
HRMS (EI, 70 eV): calcd. for C24H21N: 323.16685; found: 323.16660.  
 
N-Phenyl-2,5-bis(4-nitrophenyl)-1H-pyrrole (32d or 32i) 
 
According to the general procedure, title compound was isolated as an orange solid using  
(32d with Ar-Br: 180 mg, 47%; 32i with Ar-Cl: 135 mg, 35%), mp. = 253 – 255 °C.  
1H NMR (300 MHz, CDCl3): δ = 6.67 (s, 2H, CH), 7.04 – 7.07 (m, 2H, CH), 7.12 – 7.17 (m, 
4H, CH), 7.30 – 7.40 (m, 3H, CH), 7.99 – 8.04 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 112.9 (CH), 123.4 (CH), 128.4 (CH), 128.5 (CH), 128.7 (CH), 
129.7 (CH), 135.2 (C), 137.7 (C), 138.8 (C), 145.9 (C). 
IR (ATR, cm-1): ~  = 1585 (s), 1501 (s), 1320 (s), 1105 (s), 850 (s), 772 (s), 747 (s), 697 (s), 
521 (m).  
MS (EI, 70 eV): m/z (%) = 385 (M+, 100), 339 (7), 291 (24), 278 (8), 265 (6), 189 (7), 146 (10), 
30 (6).  
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HRMS (EI, 70 eV): calcd. for C22H15N3O4: 385.10571; found: 385.10543.  
EA: calcd. for C22H15N3O4 (385.37): C, 68.57; H, 3.92; N, 10.90; found: C, 68.37; H, 3.80; 
N, 11.03.  
 
N-Phenyl-2,5-bis(4-methoxyphenyl)-1H-pyrrole (32e or 32j) 
 
According to the general procedure, title compound was isolated as a yellow solid  
(32e with Ar-Br: 53 mg, 15%; 32j with Ar-Cl: 18 mg, 5%), mp. = 149 – 151 °C.  
1H NMR (300 MHz, CDCl3): δ = 3.73 (s, 6H, OCH3), 6.37 (s, 2H, CH), 6.67 – 6.72 (m, 4H, 
CH), 6.94 – 7.02 (m, 6H, CH), 7.20 – 7.23 (m, 3H, CH).  
13C NMR (75 MHz, CDCl3): δ = 55.1 (OCH3), 108.9 (CH), 113.3 (CH), 125.9 (C), 127.0 (CH), 
128.6 (CH), 128.9 (CH), 129.9 (CH), 135.1 (C), 139.0 (C), 158.0 (C).  
IR (ATR, cm-1): ~  = 2927 (w), 2831 (w), 1496 (s), 1382 (m), 1281 (m), 1239 (s), 1173 (s), 
1025 (s), 824 (s), 751 (s), 695 (s), 583 (s), 523 (s). 
MS (EI, 70 eV): m/z (%) = 355 (M+, 100), 340 (56), 296 (6), 268 (10), 178 (9), 77 (10).  
HRMS (EI, 70 eV): calcd. for C24H21NO2: 355.15668; found: 355.15638. 
 
N-Phenyl-2,5-bis(4-cyanophenyl)-1H-pyrrole (32f) 
 
According to the general procedure, 32f was isolated as a white solid (217 mg, 63%), 
mp. = 289 – 291 °C.  
1H NMR (300 MHz, CDCl3): δ = 6.59 (s, 2H, CH), 7.00 – 7.03 (m, 2H, CH), 7.06 – 7.10 (m, 
4H, CH), 7.28 – 7.37 (m, 3H, CH), 7.40 – 7.44 (m, 4H, CH).  
13C NMR (75 MHz, CDCl3): δ = 109.7 (C), 112.2 (CH), 118.8 (C), 128.4 (CH), 128.5 (2 x CH), 
129.5, 131.8 (CH), 135.1, 136.9, 137.8 (C).  
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IR (ATR, cm-1): ~  = 2221 (s), 1598 (s), 1532 (s), 1490 (s), 1428 (m), 1344 (s), 1178 (m), 840 
(s), 778 (s), 697 (s), 560 (s).  
MS (EI, 70 eV): m/z (%) = 345 (M+, 100), 242 (6), 216 (13), 190 (8), 77 (16), 51 (12).  
HRMS (EI, 70 eV): calcd. for C24H15N3: 345.12605; found: 345.12565.  
 
N-Phenyl-2,5-bis(3-(trifluoromethyl)phenyl)-1H-pyrrole (32g) 
 
According to the general procedure, 32g was isolated as a white solid (185 mg, 43%), 
mp. = 201 – 203 °C.  
1H NMR (300 MHz, CDCl3): δ = 6.55 (s, 2H, CH), 7.00 – 7.03 (m, 2H, CH), 7.18 – 7.21 (m, 
2H, CH), 7.26 – 7.30 (m, 7H, CH), 7.36 – 7.39 (m, 2H, CH).  
13C NMR (75 MHz, CDCl3): δ = 110.8 (CH), 122.9 (q, 3JC-F = 3.8 Hz, CH), 123.8 (q,  
1JC-F = 272.3 Hz, CF3), 125.2 (q, 3JC-F = 3.8 Hz, CH), 128.0 (CH), 128.3 (CH), 128.7 (CH), 
129.2 (CH), 130.3 (q, 2JC-F = 32.2 Hz, C), 131.5 (CH), 133.5 (C), 134.8 (C), 138.0 (C).  
IR (ATR, cm-1): ~  = 1611 (m), 1498 (m), 1433 (m), 1318 (s), 1168 (s), 1104 (s), 1061 (s), 1013 
(s), 837 (s), 778 (s), 703 (s), 597 (s), 493 (m).  
MS (EI, 70 eV): m/z (%) = 431 (M+, 100), 412 (7), 259 (10), 191 (9), 77 (12), 51 (6).  
HRMS (EI, 70 eV): calcd. for C24H15F6N: 431.11032; found: 431.10999.  
EA: calcd. for C24H15F6N (431.37): C, 66.82; H, 3.50; N, 3.25; found: C, 67.01; H, 3.46; 
N, 3.28. 
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Crystallographic Data 
 
Data of crystal structure analysis of 21b. 
Crystal data for 21b: C32H16F12N2, M = 656.47, monoclinic, a = 11.6303(4), b = 10.9593(2),  
c = 22.1529(8) Å, β = 102.842(3)°, V = 2752.98(15) Å3, T = 150(2) K, space group P21/n, Z = 
4, 45142 reflections measured, 6328 independent reflections (Rint = 0.0361), final R values  
(I > 2σ(I)): R1 = 0.0420, wR2 = 0.1122, final R values (all data): R1 = 0.0666, wR2 = 0.1184, 443 
refined parameters. 
 
 
 
Figure 24. ORTEP of 21b. Displacement ellipsoids are drawn at the 30% probability 
level. 
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Crystal data and structure refinement for compound 21b. 
Identification code  ks1361 
Empirical formula  C32 H16 F12 N2 
Formula weight  656.47 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 11.6303(4) Å = 90°. 
 b = 10.9593(2) Å = 102.842(3)°. 
 c = 22.1529(8) Å  = 90°. 
Volume 2752.98(15) Å3 
Z 4 
Density (calculated) 1.584 Mg/m3 
Absorption coefficient 0.150 mm-1 
F(000) 1320 
Crystal size 0.50 x 0.20 x 0.12 mm3 
Theta range for data collection 1.83 to 27.50°. 
Index ranges -15<=h<=15, -14<=k<=14, -28<=l<=28 
Reflections collected 45142 
Independent reflections 6328 [R(int) = 0.0361] 
Completeness to theta = 27.50° 100.0%  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6328 / 39 / 443 
Goodness-of-fit on F2 1.015 
Final R indices [I>2sigma(I)] R1 = 0.0420, wR2 = 0.1122 
R indices (all data) R1 = 0.0666, wR2 = 0.1184 
Largest diff. peak and hole 0.551 and -0.383 e.Å-3 
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